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Invertebrates show enhanced immunity and even specific primed immunity in response to 
repeat infections, analogous to vertebrate adaptive immunity. Little is known of the 
mechanism for this phenomenon, or which molecules are involved. A candidate gene for the 
underlying mechanism for a pathogen-specific response in invertebrate immunity is Down 
syndrome cell adhesion molecule (Dscam). Dscam can produce thousands of different 
protein isoforms through the mutually exclusive splicing of many exon variants contained 
within variable regions of the gene. It is an important receptor of the invertebrate nervous 
system but has been implicated in having a role in immunity. Dscam has been shown to be 
involved in phagocytosis across members of the Pancrustacea, and it has been reported to 
respond in a pathogen-specific manner in mosquitoes and crayfish. In this thesis, I have 
investigated the splicing of Dscam in response to diverse pathogens in different host species. 
 
In the Anopheles mosquito, I cloned and sequenced a fragment of Dscam spanning across 
two of its variable exon regions to enable me to detect mutually exclusively splice variants 
and their associations in different treatments (Chapter 2). I discovered that the expression 
diversity of the hypervariable Dscam is higher in parasite-exposed mosquitoes. In Chapter 3, 
I extended the study to the more experimentally amenable Drosophila fruit fly. A new 
Illumina-based sequencing assay was developed and implemented to examine more closely 
Dscam expression in response to diverse pathogens. The new method successfully quantified 
non-random expression of Dscam variable exons 4 and 6. I also describe a small but 
detectable effect of pathogen-exposure on the expression of Dscam exon 4 variants. In 
Chapter 4, I expanded the work of Chapter 3 to study tissue-specific Dscam expression in 
response to well-characterised immune elicitors of Drosophila. I describe how exon 4 
variants were expressed in a tissue-specific manner, but not exon 6 variants. I also found a 
small exon 4-by-tissue-by-pathogen effect, which although detectable, did not dominate over
iv 
 the tissue effects. Finally, in Chapter 5, I turned to the crustacean, Daphnia, to study Dscam 
expression in a natural host-parasite interaction and in a clonal organism. I describe the non-
random expression of exons 4 and 6, and another small effect of pathogen-exposure on the 
expression of Dscam exon 4. 
 
My work aimed to further investigate the putative pathogen-specific alternative splicing of 
the hypervariable Dscam receptor. The data presented quantified the constitutive expression 
of Dscam exons 4 and 6 in different pancrustacean species. The data also suggest that 
infection-responsive splicing of Dscam may occur but that effects are small, and may be 
diluted within the background of the highly important Dscam expression of the nervous 
system if they exist at all. The study supports the high-throughput sequencing method for 
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1. General introduction 
 



























1.1. Overview of host-parasite interaction and immunity 
Parasitic organisms, defined broadly to include pathogenic bacteria, viruses, fungi, protozoa 
and helminths, can negatively affect their hosts’ fitness. Often causing death or sterility, 
parasites can exert a selective pressure on populations (Combes 2000; Schlenke and Begun 
2003). The Metazoa have evolved an immune system to detect and destroy parasites (Du 
Pasquier 2006), thus increasing the chances of a host organism resisting debilitating disease 
and successfully reproducing. Conflict between hosts and parasites has led to the evolution 
of a complex frontline immune system for both invertebrates and vertebrates, but also to an 
anticipatory immune system for the jawed vertebrates (Du Pasquier 1992; Cooper and Alder 
2006). 
 
The two subdivisions of the metazoan immune system are the innate response, shared by 
invertebrates and vertebrates, and the adaptive response, found only in some vertebrates. The 
adaptive immune system is the best studied subdivision of immunity (Hoffmann, Kafatos et 
al. 1999). It is exclusive to the gnathostomes (the jawed vertebrates), and exhibits a highly-
specific pathogen-recognition capability. The highly-specific aspect of adaptive immunity is 
attributed largely to specialised cells and the clonally selected functional antibodies they 
produce (Du Pasquier 2001). Antibodies can effectively identify and neutralise infectious 
organisms previously exposed to the immune system. Thus, antibodies bestow some animals 
with an anticipatory response to subsequent exposure of repeat infections. The innate 
immune system on the other hand is common to both invertebrates and vertebrates, and 
similarities between invertebrate and vertebrate recognition and effector mechanisms suggest 
a common ancestry of the immune defences (Fig.1) (Hoffmann, Kafatos et al. 1999; Cooper 







Figure 1: Phylogenetic tree indicating the theoretical emergence of vertebrate adaptive 
immunity. Innate immunity is common to both invertebrates and vertebrates, whereas adaptive 
immunity conferred by antibodies (Ig) is exclusive to the gnathostomes only. Image adapted from 




Innate immunity is a rapidly acting frontline response and probably eliminates the majority 
of infectious organisms and in a non-specific manner. It consists of constitutive as well as 
inducible defence mechanisms. Constitutive mechanisms include anatomical barriers such as 
epithelia and some antimicrobial peptides like the vertebrate antibacterial enzyme, lysozyme. 
Inducible defences are only activated in response to injury or the presence of infectious 
organisms. They can include mediators of inflammation, proteolytic complement proteins, 
non-specific reactive intermediates, components of the melanization process, and 
phagocytosis (Hoffmann 1995; Medzhitov and Janeway 2000). Invertebrates, having no 
antibodies, appear to lack the type of adaptive immunity seen in vertebrates (Kurtz 2004). 




1.2. Mechanisms of invertebrate immunity 
It is thought that recognition of pathogens in invertebrate immunity happens with a limited 
repertoire of germ-line encoded pattern recognition receptors (PRRs) (Janeway and 
Medzhitov 2002). PRRs detect and respond to pathogen-associated molecular patterns 
(PAMPs): conserved molecular motifs of many types of microbes (Medzhitov and Janeway 
2000). These receptors can be cell-bound or secreted, and principally function to trigger both 
cellular and humoral responses to infectious organisms (Medzhitov and Janeway 2000; 
Beutler 2004). 
 
Cell-mediated immunity in invertebrates is conferred by haemocytes, the equivalent to white 
blood cells in vertebrates. An effective cellular response mediated by haemocytes against 
parasites is phagocytosis (Stuart and Ezekowitz 2008). Phagocytosis is the process of 




interaction triggers the modification of the intracellular structure of a phagocyte and 
internalisation and destruction of the target follows (Lemaitre and Hoffmann 2007). A 
prerequisite of phagocytosis in invertebrates may be the opsonisation of pathogens by 
immune factors (Ulvila, Vanha-Aho et al. 2011). Opsonisation is a process of labelling 
pathogenic surfaces with immune proteins for phagocytic recognition. In mammals, 
opsonisation is carried out by complement proteins, which are an array of proteins which can 
interact to create a membrane attack complex for cell-killing, but can also label pathogens 
before binding cell-surface receptors to mediate phagocytosis (Ulvila, Vanha-Aho et al. 
2011). For example, insect thioester-containing proteins (TEPs), which share homology with 
mammalian complement proteins, have been shown to be strongly up-regulated in response 
to infection in Drosophila and Anopheles (Blandin, Shiao et al. 2004), and required for the 
efficient uptake of bacteria in Drosophila cell culture (Stroschein-Stevenson, Foley et al. 
2006). As such, phagocytosis is an important immune response in invertebrate immunity, 
and may be partly facilitated by other immune recognition molecules. 
 
Significantly, PRRs play a leading role in the activation of complex signal transduction 
pathways leading to humoral immunity (Medzhitov and Janeway 2000; Christophides, 
Vlachou et al. 2004). Important signalling pathways of the innate immune system in 
arthropods for example, include the Toll, Imd and Jak/STAT pathways, the activation of 
which leads to the production of effector genes specific to the individual pathway (Fig.2). 
 
The Toll pathway is primarily triggered by constituents of gram-positive bacteria and fungi 
(e.g. bacterial peptidoglycan, yeast zymosan) (Hoffmann 2003; Akira and Takeda 2004), and 
through the transcription factor Dif, up-regulates the production of antimicrobial peptides 
(AMPs) such as Drosomycin (Fig.2) (Lemaitre and Hoffmann 2007). The Imd pathway 




De Gregorio et al. 2002) and triggers the production of the AMP Diptericin via the 
transcription  
 
factor Relish (Fig 2) (Lemaitre and Hoffmann 2007). The Jak/STAT pathway, although less 
well characterised than the Toll and Imd pathways, appears to respond to the presence of 
viral proteins by triggering the production of anti-viral factors (Fig.2) (Dostert, Jouanguy et 
 
Figure 2: Signalling pathways of the innate immune response in arthropods. Three important 
pathways of the innate immune response in arthropods are Toll, Imd and Jak/STAT, each 
responding to different pathogen types. The Toll pathway primarily responds to constituents of 
fungi and gram-positive bacteria, and downstream signalling of Toll results in the production of 
antimicrobial peptides such as Drosomycin via the transactivator Dif. The Imd pathway principally 
responds to elements of gram-negative bacteria, and downstream signalling of Imd results in the 
production of antimicrobial peptides such as Diptericin via the transcription factor Relish. Finally, 
the Jak/STAT pathway produces anti-viral factors in response to the presence of viral proteins 





al. 2005; Cherry and Silverman 2006). Therefore, not all invading pathogens are treated in 
the same way by the invertebrate immune system, and as different types of pathogens trigger 




1.3. Evidence for greater specificity in invertebrate immunity 
How specific is the invertebrate immune response, and what molecules and cells confer 
specificity in invertebrates? The concept of vertebrate-like specificity in invertebrate 
immunity was initially rejected after the failure to detect analogous components in the more 
‘primitive’ immune system (Klein 1989) (but see Cooper, Rinkevich et al. 1992). However, 
the scarcity of similar components of a vertebrate-like anticipatory response cannot rule out a 
functional equivalent in invertebrates (Little, Hultmark et al. 2005). Despite the availability 
of a limited repertoire of PRRs, there is much evidence for a high degree of molecular 
diversity and specificity in invertebrate immunity (discussed in detail below). 
 
1.3.1. The immune system can be ‘primed’ for a generalist or a specific response 
Immune responses can be long or short-term, general or specific, and even within and 
between generations. For example, immune responses can be general (i.e. non-specific) and 
short-term, e.g. a brief up-regulation of the highly-reactive non-specific antimicrobial 
compound nitric oxide (James 1995), or longer-term, e.g. the persistence of the antimicrobial 
peptide defensin (Bulet, Cociancich et al. 1992). Additionally, a long-term specific immune 
response within a generation can occur, such as the life-long immunity in humans facilitated 
by memory lymphocytes and antibodies. Moreover, transgenerational priming of the immune 
system can also occur. For example, mammals can pass maternal antigen-specific antibodies 




Thus, it is important to understand clearly the difference between general and specific 
immunity and how these types of responses can be conferred, especially in invertebrate 
immune systems which are devoid of long-lived lymphocytes and highly-specific antibodies. 
 
1.3.2. Invertebrates show some evidence of ‘enhanced immunity’ following immune 
challenge 
The first hint of a more complex invertebrate immune response was provided by Boman et al 
(1972), who found evidence of enhanced immunity in Drosophila. The researchers 
discovered that after an initial immune challenge, a long-lasting up-regulation of 
antimicrobial peptides in the insect’s haemolymph (insect circulatory fluid; equivalent of 
vertebrate blood serum) conferred protection against subsequent challenges (Boman, Nilsson 
et al. 1972). Since this discovery, more examples of similarly-defined enhanced immunity 
have been presented (Hildemann, Raison et al. 1977; Rheins, Karp et al. 1978; Cooper and 
Roch 1986; Hartman and Karp 1989; Moret and Siva-Jothy 2003; Cong, Song et al. 2008) 
(also see Sequeira, Tavares et al. 1996). These observations could not rule out a sustained 
up-regulation of general immune mechanisms, which is quite different from parasite-specific 
memory following initial infection. However, indications of a more specific innate immune 
response have been also been reported (discussed below). 
 
1.3.3. Invertebrates show evidence of non-specific and specific ‘transgenerational 
priming’ upon infection 
While the adaptive value of maternal transfer of specific immunity in mammals and birds 
has been well acknowledged (Grindstaff, Brodie et al. 2003; Baintner 2007; Boulinier and 
Staszewski 2008), the maternal transfer of immunity to offspring in invertebrates has been 
controversial. Moret et al (2001) discovered that offspring from bacterial lipopolysaccharide 




component in the melanization process in insects and crustaceans (Soderhall and Cerenius 
1998; Liu, Jiravanichpaisal et al. 2007). However, this enhanced prophylaxis effect across 
generations did not strictly demonstrate pathogen-borne specificity, and the possibility of 
socially-conferred immunity could not be ruled out. Indeed, horizontally transferred parasite-
resistance is a phenomenon found in other animals including beetles and termites (Barnes 
and Siva-Jothy 2000; Traniello, Rosengaus et al. 2002). In termites for example, individuals 
had increased resistance to infection when placed in direct contact with previously 
immunized nest-mates (Traniello, Rosengaus et al. 2002). 
 
In the flour moth Ephestia kuehniella, Schmidt and co-workers discovered that 
experimentally-induced tolerance of a bacterial endotoxin could be vertically transferred to 
offspring. After a few generations, insects were tolerant of endotoxin levels which would 
have otherwise been lethal to the starting colony (Rahman, Roberts et al. 2004). The 
tolerance effect correlated with significantly increased melanization reactions, and hence 
with elevated levels of immunity. Thus, it seems enhanced immunity can be vertically 
transferred to invertebrate offspring without the provision of specificity. 
 
Finally, in the crustacean Daphnia magna, evidence for the maternal transfer of parasite-
specificity was found following the artificial infection of adult Daphnia with two different 
strains of the endoparasitic bacterium Pasteuria ramosa (Little, O'Connor et al. 2003). 
Daphnia offspring were initially exposed to one Pasteuria strain or the other, and following 
a second homologous immune challenge (i.e. with the same pathogen), but not with a 
heterologous immune challenge, Daphnia newborns had a relatively enhanced fitness. Thus, 






1.3.4. Invertebrates may have ‘specific memory’ 
A strain-specific response can be transferred to offspring after ‘priming’ the mother with a 
specific immune challenge (Little, O'Connor et al. 2003), but what about a sustained and 
specific memory response to pathogens during the lifetime of an individual invertebrate? 
Studies have provided evidence showing that, following a second homologous immune 
challenge during a single lifetime, some invertebrates show either a significant reduction in 
the rate of re-infection (e.g. in the copepod (Kurtz and Franz 2003), and the scallop (Cong, 
Song et al. 2008)), or a significant increase in survival rate (e.g. in the cockroach (Faulhaber 
and Karp 1992), the red flour beetle (Roth, Sadd et al. 2009), and the shrimp (Witteveldt, 
Cifuentes et al. 2004)), when compared to the administering of a subsequent heterologous 
challenge. In one study, bumblebees were exposed to either homologous or heterologous 
immune challenges with different types of bacteria. Those receiving homologous re-
exposures of bacteria showed significantly higher survival rates than those given 
heterologous re-exposures, even several weeks after the initial challenge (Sadd and Schmid-
Hempel 2006). In addition, following zone-of-inhibition assays, the authors confirmed that 
this specific response was independent of any protection from lingering antimicrobial 
peptides. Thus, studies based mainly on the assay of non-immune parameters (i.e. survival, 
rate of re-infection) have been strongly suggestive of specific memory in invertebrates. 
 
A recent study in Drosophila may provide the best evidence for within-generation 
invertebrate immune specificity and memory to date. Flies were injected with sub-lethal 
doses (‘priming doses’) of the gram-positive bacterium Streptococcus pneumoniae, and the 
natural fly fungal pathogen, Beauveria bassiana, followed by a second and otherwise-lethal 
dose one week later. The results showed that the priming dose had a protective effect. Flies 
which were primed prior to being given a lethal dose of S. pneumoniae or B. bassiana either 
died more slowly or at the same rate as wounded controls. The authors concluded that the 




specific pathogen, an effect which also persisted for the life of the insect. Additionally, S. 
pneumoniae-primed flies were tested for their ability to kill the gram-negative bacterium 
Escherichia coli. They found no difference between naïve PBS-injected flies and S. 
pneumoniae-primed flies in their ability to clear E. coli. This confirmed the remarkable 
observation that priming with S. pneumoniae protected the fly against subsequent exposure 
to S. pneumoniae (Pham, Dionne et al. 2007). 
 
Interestingly, a more recent study found mixed results when testing for a specific primed 
response in Drosophila using diverse combinations of bacteria of varying relatedness to one 
another. Parasite-specificity on the level of species was shown, but it depended upon which 
bacterial combination was used for the priming and secondary challenges. In other words, 
not all pathogens used in the experiment induced a specific primed immune response. Fully 
reciprocally designed experiments also found no evidence that a higher degree of specificity 
above the level of bacteria species (i.e. between strains of the same parasite) occurred 
(Sophie Armitage, personal communication). Here, specific immune priming in Drosophila 
appears to be bacteria and bacteria-combination specific. 
 
1.3.5. PRR-triggered signalling pathways and phagocytic cells may be the effectors 
of specific memory in invertebrates 
In an attempt to characterise the priming response in Drosophila, Pham et al (2007) tested 
loss-of-function mutants for the Toll and Imd pathways and discovered the priming effect 
was Toll pathway-dependent, but not Imd pathway-dependent. Thus, a specific immune 
signalling pathway is required for the specific primed response to the gram-positive S. 
pneumoniae. As PRRs are important effectors for triggering signal transduction pathways, 
one could speculate that one or more PRRs could play an integral part in a specific memory 





Schneider and co-workers also discovered that by blocking phagocytosis with polystyrene 
beads in both primed and naïve flies, the protective effect against S. pneumoniae disappeared 
(Pham, Dionne et al. 2007). Specifically, after lethal doses of S. pneumoniae were given to 
primed as well as naïve flies with inhibited phagocytosis, it was discovered that flies of both 
treatments died at the same rate. This presented indirect evidence that phagocytosis was 
critical in the primed response in Drosophila (Pham, Dionne et al. 2007). Independently, 
Roth and Kurtz (2009) having developed in vitro phagocytosis assays in a fully reciprocal 
design, directly demonstrated that phagocytic activity in the woodlouse, Porcellio scaber, 
increased in a pathogen strain-specific manner. Using two different strains of heat-killed 
Bacillus thuringiensis bacteria, challenge with homologous combinations (i.e. strain 1 
followed by strain 1, or strain 2 followed by strain 2) resulted in significantly higher 
phagocytic activity than challenge with heterologous combinations (e.g. strain 1 followed by 
strain 2) (Roth and Kurtz 2009). Thus, phagocytic cells appear to be essential for the specific 
primed immune response seen in Drosophila, and are at least important in the Porcellio 
woodlouse. 
 
Interestingly, similar to the recent work on specific primed immune responses in Drosophila 
(Sophie Armitage; personal communication), both studies found that the characteristics of 
the specific primed response were not ubiquitous across all bacteria tested. Thus, this further 
strengthens the evidence against a general induction of the immune system being a cause of 
the effect. Consequently, it is tempting to speculate that these coarse specificity and memory 
responses may only have evolved to detect natural pathogens of Drosophila and other 
invertebrates, allowing for some cross-reactivity with those most closely resembling natural 
pathogens. Furthermore, it has been proposed that “organisms may be selected to only 
develop acquired immunity to some of the diseases that they encounter” (Boots and Bowers 
2004); a proposal supported by both the presumed costliness of evolving and utilising an 




repertoire of germline encoded PRRs available to invertebrates (Janeway and Medzhitov 
2002). Nevertheless, invertebrate defences do not appear to lack complexity, but the genetic 




1.4. Down syndrome cell adhesion molecule 
A potential candidate for the phenomenon of specific memory in invertebrates is Down 
syndrome cell adhesion molecule (Dscam). Dscam is a receptor of the vertebrate and 
invertebrate nervous systems which has recently been implicated in having a role in the 
invertebrate immune response (Watson, Puttmann-Holgado et al. 2005). In invertebrates, it is 
unique in displaying truly exceptional diversity by producing many different isoforms from a 
single gene through the mechanism of mutually exclusive alternative splicing (Schmucker, 
Clemens et al. 2000). For example, in Drosophila melanogaster, more than 38,000 different 
isoforms are theoretically possible, and almost all are thought to be expressed and convey 
equally different interaction specificities. In theory, the provision of hyper immunological 
diversity for invertebrate immunity could be conferred by Dscam and as a consequence the 
gene could convey a much greater level of pathogen-recognition specificity and even 
specific memory in invertebrates. Thus, the alternative splicing of Dscam in invertebrate 
immune responses could have important implications for the control of infectious diseases. 
 
Originally, the vertebrate DSCAM was the first of the Dscam genes to be isolated and 
characterised as a neural cell adhesion molecule which mapped to the chromosome band 
associated with the Down syndrome in humans (Yamakawa, Huo et al. 1998). While looking 
for candidate genes for the Down syndrome, the researchers discovered that human DSCAM 




isolated Dscam in Drosophila and discovered it had a role in axon guidance of the insect’s 
nervous system. Interestingly, while Drosophila Dscam exhibits a remarkable level of 
molecular diversity through alternative splicing (Schmucker, Clemens et al. 2000), the 
vertebrate DSCAM appears to generate only three transcripts through cryptic splicing sites; 
indicative of functional divergence of vertebrate and insect Dscam (Crayton, Powell et al. 
2006). Dscam was originally linked to an immune function when an extensive diversity of 
Dscams was found to be expressed in Drosophila haemocytes (Watson, Puttmann-Holgado 
et al. 2005).  
 
1.4.1. Dscam molecular biology 
Dscam is a single-pass membrane receptor and a member of the immunoglobulin 
superfamily of proteins, a large group of proteins primarily involved in recognition and 
adhesion (Schmucker, Clemens et al. 2000). One of its functions is to guide axons and 
dendrites of the nervous system thus ensuring organisation of the intricate nerve cell circuitry 
(Chen, Kondo et al. 2006; Hattori, Demir et al. 2007; Schmucker 2007). It has a relatively 
conserved structure across diverse taxa and contains ten immunoglobulin (Ig) domains and 
six fibronectin type III (FnIII) domains usually in a 9Ig-4FnIII-Ig-2FnIII arrangement, 
followed by transmembrane and intracellular domains (Hattori, Demir et al. 2007; Shapiro, 
Love et al. 2007) (but see Chou, Chang et al. 2009). Highly variable exon clusters which 
express only one of several exon variants in the final mRNA transcript encode part or all of 
three of the N-terminus-end Ig domains of Dscam. In Drosophila Dscam, exon 4 encodes 
only one alternative version of the first half of Ig2, exon 6 encodes one alternative version of 
the first half of Ig3, exon 9 encodes alternative versions of the entire Ig7, while exon 17 






The variable expression of many exon variants gives Dscam its ability to generate many 
unique isoforms. For example, through the alternative splicing of a total of 95 variable 
exons, Drosophila melanogaster Dscam can potentially produce as many as 38,016 different 
isoforms (Schmucker, Clemens et al. 2000), whereas in comparison, the repertoire of D. 
yakuba can theoretically reach 31,488 isoforms using 87 variable exons (Lee, Kim et al. 
 
Figure 3: The gene and protein structure of Drosophila and Anopheles Dscam. (A) Dscam 
gene structure of Drosophila melanogaster, D. yakuba, D. erecta, D. pseudoobscura and 
Anopheles gambiae. Vertical black lines represent constitutive exons. Variable exons encoding 
Ig2, Ig3, Ig7 and the transmembrane domain are coloured green, red, blue and yellow respectively. 
Mutually exclusive alternative splicing ensures only one variant from each variable exon cluster is 
present in the final mRNA transcript. (B) The Dscam protein structure. The relatively conserved 
structure contains ten immunoglobulin (Ig) domains and six fibronectin (Fn) domains. In 
Drosophila, variable exon 4 codes the first half of Ig2 (coloured green), variable exon 6 codes the 
first half of Ig3 (red), variable exon 9 (or exon 10 in Anopheles) codes the entire Ig7 (blue) and 




2010). In Anopheles gambiae, 84 exon variants provide the scope for 31,920 splice forms 
(Dong, Taylor et al. 2006), while 75 alternatively spliced variants could confer the crayfish 
with up to 22,272 different Dscam receptors (Watthanasurorot, Jiravanichpaisal et al. 2011). 
The crustacean Daphnia magna has the relatively smaller number of 49 variable exons. 
Moreover, unlike the insect Dscams characterised so far, which have two alternatively 
spliced variants coding for the transmembrane domain, D. magna Dscam appears to have 
only one. However, unlike insect Dscams, which have a single cytoplasmic tail, four 
different cytoplasmic tails have been discovered in this crustacean. As a result, D. magna 
may produce up to 13,056 different protein isoforms (Brites, McTaggart et al. 2008). Thus, 
the generation of many different Dscam isoforms each with different recognition and binding 
specificities, could render a system capable of equally unique and diverse interactions 
(Hattori, Demir et al. 2007; Zinn 2007). 
 
1.4.2. Dscam interactions involve homophilic and heterophilic binding 
The tertiary structure of the Dscam protein accommodates two different types of 
interactions; homophilic and heterophilic. Homophilic interactions have been shown to be 
facilitated by a part of the protein surface known as epitope I, and heterophilic interactions 
are thought to occur via a part of the protein surface known as epitope II (Fig.4) (Meijers, 
Puettmann-Holgado et al. 2007). 
 
Epitope I is coded by the 5’ portions of the alternative exons 4 and 6, while epitope II is 
coded by the 3’ portion of alternative exon 4 variants and the central portion of alternative 
exon 6 variants (Meijers, Puettmann-Holgado et al. 2007). Through homophilic interaction 
with epitope I of one Dscam molecule, and the epitope I of a homolog, the Dscam-Dscam 
dimer complex is important in cell-to-cell interactions during the development of the nervous 
system (Wojtowicz, Flanagan et al. 2004; Chen, Kondo et al. 2006; Hattori, Demir et al. 




epitope II interacts with molecules other than Dscam homologs, and it has been suggested 
epitope II could engage in immune responses in invertebrates (discussed further below) 
(Boehm 2007; Meijers, Puettmann-Holgado et al. 2007; Brites, Encinas-Viso et al. 2011). 
 
 
1.4.3. Dscam splicing is complex and unique to each variable exon cluster 
The combinatorial splicing of multiple exon variants which complete the final Dscam 
transcript is important to confer each protein isoform with its unique epitope I and II 
structure and interaction specificity. Splicing of Dscam appears to be complex. It has been 
shown that each variable exon cluster in Drosophila Dscam could potentially have different 
alternative splicing mechanisms (Graveley 2005). For example, the alternative splicing 
mechanism for exon 6 uses a docking site and a selector sequence, along with a cluster-
specific splicing repressor to ensure that only one alternative exon 6 variant is selected for 
the Dscam mRNA transcript. The docking site is located within the intron between 
 
Figure 4: Dscam protein structure accommodates homophilic and heterophilic interactions. 
Homophilic binding occurs when epitope I (shown in blue) of a Dscam receptor interacts with 
epitope I of another Dscam molecule. Heterophilic interaction with molecules other than Dscam 




conserved exon 5 and exon variant 6.1, while the selector sequences for each exon 6 variant 
are located in most cases within the short introns downstream of each variant (Fig.5). 
 
In order for a specific exon 6 variant to be included in the final mRNA transcript, the 
selector sequence must interact with the docking site. Each of the selector sequences is 
complementary for a part of the docking site, and interaction occurs by the juxtaposition of 
the selector sequence and the docking site sequence. Importantly, only one selector sequence 
can interact with the docking site at any one time. This helps ensure mutually exclusive 
splicing of Dscam exon 6 (Graveley 2005). In addition, the splicing repressor has been 
shown to be crucial for the fidelity of Dscam exon 6 splicing also. RNAi depletion of hrp36, 
a globally acting RNA binding protein, results in Dscam transcripts with the inclusion of 
multiple exon 6 variants (Olson, Blanchette et al. 2007). Such Dscam transcripts with 
multiple exon 6 variants do not produce functional proteins (Graveley 2005). Conserved 
elements similar to the docking site or selector sequences of exon 6 are not readily apparent 
in either exon 4 or exon 9. Thus, this mechanism of ensuring mutually exclusive alternative 
splicing appears to be unique to exon 6 only (Graveley 2005). Indeed, a separate study in 
Drosophila tested whether the choice of one exon 9 variant biased the choice of variants 
from exons 4 and 6. Researchers amplified cDNA with one primer bound in constitutive 
exon 3, and the other bound in one of the alternative variants of exon 9. They discovered that 
no particular exon 4 or exon 6 variant specifically associated with the selected exon 9 
variant, confirming that alternative splicing occurred independently at exons 4, 6 and 9 in 
Drosophila (Neves, Zucker et al. 2004). Thus, it appears that there are different alternative 
splicing mechanisms for each of the variable exon clusters. At the present time, some 
information on the regulation of Drosophila exon 4 splicing is available (Kreahling and 
Graveley 2005), but the splicing mechanisms for exons 4 and 9 remain to be more fully 








Figure 5: The mechanism of Dscam exon 6 mutually exclusive alternative splicing. Key 
components of Dscam exon 6 splicing are the selector sequences which are downstream of each 
exon 6 variant, and the docking site, located in the intron between conserved exon 5 and variable 
exon 6.1. Splicing repressors ensure exon 6 variants do not become spliced together, thus ensuring 
mRNAs do not contain multiple exon 6 variants. Alternative exons 6.36 and 6.37 are used here as 
examples. For exon 6.36 to be included in the Dscam mRNA for instance, the selector sequence 
downstream of this variant interacts with the docking site by juxtaposition. The repressor is 
inactivated allowing exon 5 and exon 6.36 to be spliced together. As all other exon 6 variants 
remain actively repressed, and only one selector sequence can interact with the docking site at any 
one time, exon 7 is then spliced to the 3’ end of exon 6.36, thus ensuring the mutually exclusive 




1.4.4. Dscam has a role in neuronal development  
Dscam operates to direct the movement of sensory neurons in proper nervous-system circuit 
assembly (Hattori, Demir et al. 2007). More specifically, isoform-specific homophilic 
binding of Dscam receptors results in the coordination of neighbouring cells or cell processes 
sharing the same receptive field (Hattori, Demir et al. 2007; Matthews, Kim et al. 2007). 
This homophilic interaction mediates self-avoidance by triggering downstream signalling 
cascades which ultimately control the neuron’s directionality and interaction with 
surrounding cells and tissues (Hattori, Millard et al. 2008; Millard and Zipursky 2008). In 
Drosophila, Dscam binds directly to Dock (Schmucker, Clemens et al. 2000). Dock is a 
protein that functions upstream of Pak, which is involved in intracellular signalling networks 
controlling cell migration and phagocytosis (Hing, Xiao et al. 1999; Cote and Vuori 2002). 
Dscam, Dock and Pak, appear to act synergistically to direct neuronal path-finding, and may 
accomplish this by making changes to the actin-based cytoskeleton of cells (Schmucker, 
Clemens et al. 2000). 
 
The diversity of splice forms has been shown to be essential for Dscam’s role as a neural cell 
adhesion molecule. For example, a study in Drosophila which reduced the Dscam repertoire 
to a single isoform discovered that the neural circuits of the mutant animals were severely 
disorganised (Hattori, Demir et al. 2007). It is estimated that each nerve cell expresses 
between 14 and 50 unique Dscam mRNA molecules (Neves, Zucker et al. 2004). Although 
the mRNA expression profile doesn’t necessarily reflect the Dscam proteins present in a cell 
at any one time, this observation appears to be evidence for a mechanism for distinguishing 
cells in Drosophila. Chess and co-workers (2004) also discovered that Drosophila Dscam 
splice variant expression was regulated both spatially and temporally. In other words, the 
alternative splicing of Dscam appears to be regulated both during development and also in 




complicated but essential for the integral role of organising signalling networks involved in 
development. 
 
1.4.5. The origin of Dscam diversity predates the split of the pancrustaceans 
The origin of the alternatively splicing form of the Dscam gene predates the common 
ancestral split between insects and crustaceans around 450-500 million years ago (Lee, Kim 
et al. 2010). A longstanding question surrounding the evolution of Dscam’s multiple exon 
arrays and the mechanism of alternative splicing concerns when and where these features 
first appeared. While sequence homology has only been found within the vertebrates, 
nematodes and arthropods, the common ancestor of which lived on the order of a billion 
years ago, only the arthropods appear to have multiple exon arrays and the capacity for 
alternative splicing (Graveley, Kaur et al. 2004; Crayton, Powell et al. 2006; Lee, Kim et al. 
2010). However, Dscam in the deer tick, Ixodes scapularis, has no capacity for hyper-
diversity: a recent study found no evidence of alternative splicing in Ixodes in the regions 
between the exons orthologous to Drosophila exons 3 and 5, 5 and 7, and 8 and 10, 
suggesting that this feature may be absent in arachnids (Armitage, Freiburg et al. 2012). 
Furthermore, although searches have been made in many genomes beyond the 
pancrustaceans, including within the phyla Deuterostomia and Nematoda, homologs of exon 
6 have so far only been discovered in the insect and crustacean lineages (Crayton, Powell et 
al. 2006; Brites, McTaggart et al. 2008). Thus, it appears that the multiple exon arrays and 
alternative splicing mechanism could have either been lost several times along the lineage 
leading to the mammals, or originated along the lineage leading to the insects and 





1.4.6. Dscam variable exon clusters may have evolved independently in response to 
different evolutionary pressures 
The Dscam gene is thought to have evolved its expansive alternatively splicing ability by 
staggered homologous recombination (Lee, Kim et al. 2010). Across the Pancrustacea, the 
number of individual variants within each variable exon cluster is different; indicative of 
ongoing rapid evolution (Lee, Kim et al. 2010). The exception is the exon 4 cluster, which is 
older than the ancestor of insects and appears to have changed very little over the past 300 
million years (Crayton, Powell et al. 2006; Lee, Kim et al. 2010). Notably, all characterised 
Drosophilidae Dscams have 12 variants of exon 4. However, exons 6 and 9 have different 
numbers of variants even within families of arthropods, and these clusters have been 
constructed mainly during the last 300 million years (Lee, Kim et al. 2010). For example in 
Drosophila, the number of exon 6 variants ranges from 41 to 52 across species, while the 
exon 9 variants range between 29 and 33 variants across species (Lee, Kim et al. 2010). This 
suggests that the exon 4 cluster is anciently conserved, while exons 6 and 9 are evolving 
much more quickly. In fact, this pattern is seen across all characterised arthropod Dscams, 
though most strikingly in the insects. Thus, some evolutionary pressure is driving a rapid 
expansion of the exon 6 and 9 cassettes, but not of the exon 4 cassette, of every lineage of 
insect. Exons 6 and 9 may have a more important role in the development of the nervous 
system than exon 4 based on relative tissue-specific expression levels of variants (Watson, 
Puttmann-Holgado et al. 2005). Thus, the variability of internal exon duplications within 
exons 6 and 9 may not be surprising. Different evolutionary pressures across the different 
exon clusters may also reflect the different alternative splicing mechanisms conferred to each 
cluster (Graveley 2005). Exon 4 has been implicated in having an important role in immunity 
(Dong, Taylor et al. 2006). The fact that this exon has been relatively quiescent over the past 
300 million years suggests that, if so, it may interact with ancient molecular patterns. Also, 
the nucleotide alignment between the Drosophila Dscam variable exons shows much less 




found that most exon 4 variants were orthologous to exon 4 variants in other species, an 
observation not seen in exons 6 and 9. Thus, one could speculate that exon 4 codes for a part 
of the Dscam protein which interacts only with PAMPs which have changed very little over 
evolutionary time, such as bacterial peptidoglycan. This may also reflect the lack of 
ubiquitous specificity for bacteria seen in specific primed immune responses (Pham, Dionne 
et al. 2007; Roth and Kurtz 2009). 
 
Finally, epitopes I and II appear to be under different selective pressures. Epitope II has been 
suggested as a part of the protein which interacts with parasites (Meijers, Puettmann-
Holgado et al. 2007). Brites et al (2011) found that sequences coding for epitope II in 
Daphnia Dscam showed much greater non-synonymous divergence than those coding for 
epitope I, which is involved in homophilic binding with other Dscams. Interestingly, 
although sequences coding for epitope II have diverged more than the rest of the gene in 
both Drosophila and Daphnia, studies have not found any evidence for the adaptive 
evolution in either species (Obbard, Welch et al. 2009; Brites, Encinas-Viso et al. 2011). 
Subsequently, it has been proposed that the elevated non-synonymous diversity may be 
maintained by some form of balancing selection, or is indicative of the segregating of weakly 
deleterious alleles, and thus of fewer selective constraints in the supposed pathogen-binding 
region of Dscam (Brites, Encinas-Viso et al. 2011). The evolution of Dscam splicing 
diversity remains to be fully explained, as does its requirement within the context of innate 
immunity. 
 
1.4.7. Dscam diversity could have important implications in invertebrate immunity 
Alternative splicing, together with other mediators of molecular complexity such as post-
translational modification (of which there are over 200 different types known), allows for the 
significant expansion of coding capacity of the invertebrate genome (Brett, Pospisil et al. 




accommodated through these mechanisms. Thus, alternative splicing together with post-
translational modification could permit a single gene to mediate alternative immune 
responses via the production of multiple proteins. At present, the importance of the high 
diversity of Dscam splice forms in the invertebrate immune response remains to be 
determined. Recently however, some key studies have provided evidence for the role of 
Dscam and Dscam diversity in invertebrate immunity (Watson, Puttmann-Holgado et al. 




1.5. Previous research – Dscam in Immunity 
1.5.1. Dscam is implicated in phagocytosis 
Dscam has been associated with phagocytosis so far in the fly, the mosquito and the crayfish 
(Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006; Watthanasurorot, 
Jiravanichpaisal et al. 2011). Schmucker and co-workers, using anti-Dscam antibodies to 
block Dscam function, discovered that haemocyte-specific loss of Dscam substantially 
lowered phagocytosis of bacteria in Drosophila (Watson, Puttmann-Holgado et al. 2005). 
Dong et al (2006), studying Dscam in the Anopheles mosquito, also implicated the receptor 
in the phagocytosis of bacteria. RNA interference-mediated depletion of Anopheles gambiae 
Dscam (AgDscam) decreased the phagocytic activity of an immune-competent mosquito cell 
line by around 60% compared to controls. Finally, Dscam in the crayfish, Pacifastacus 
leniusculus, was associated with pathogen clearance. Recombinant proteins of Dscam 
isoforms that specifically interacted with bacteria were found to interfere with bacterial 
binding to haemocytes. This demonstrated that Dscam could have an important function in 




appears to play a critical role in the removal of pathogens via phagocytosis across these 
different classes of arthropods. 
 
1.5.2. Dscam could play a role in the opsonisation of parasites 
Phagocytosis and opsonisation act together in the clearance of pathogens (see section 1.2). 
Immunoprecipitation assays revealed a soluble Dscam protein in the haemolymph of 
Drosophila (Watson, Puttmann-Holgado et al. 2005). In addition, Schmucker and co-
workers directly confirmed that D. melanogaster S2 cells secreted Dscam splice forms. 
Soluble Dscam isoforms have also been found in the mosquito (Dong, Taylor et al. 2006), 
whereas in the shrimp, Litopenaeus vannamei, the first reported Dscam lacking a 
transmembrane domain and cytoplasmic tail was discovered (Chou, Chang et al. 2009). L. 
vannamei Dscam (LvDscam) is unique among Dscams because a cell-bound protein form 
has yet to be isolated and described. However, unexpectedly low levels of LvDscam were 
detected in nervous tissues, and thus, may not be involved in neuronal wiring in L. vannamei. 
The authors speculate however that LvDscam could retain opsonic characteristics and also 
play a role in phagocytosis in the shrimp using an integrin binding motif detected between its 
Ig6 and Ig7 domains. Thus, soluble Dscams are found circulating in the haemolymph of 
different species of invertebrate, and may play a role in the opsonisation of pathogens. 
 
1.5.3. Dscam exhibits pathogen-specific splice form expression and may bind 
directly to pathogens 
The hyper-diversity of Dscam splice forms may be utilised for specificity in the invertebrate 
immune response. Dong et al (2006) challenged Anopheles cell culture and whole adult 
mosquitoes with a range of pathogens, and used quantitative RT-PCR to show that AgDscam 
appeared to produce pathogen-specific splice form repertoires. The authors demonstrated 




diverse pathogens including both gram-types of bacteria; strongly suggestive of an infection-
responsive alternative splicing of AgDscam. Additionally, they showed that AgDscam was a 
‘determinant of resistance’ to both bacteria and Plasmodium infection by silencing the 
Dscam gene through dsRNA-targeting and monitoring the effects. Subsequently, Dscam 
receptors appear to recognise and respond to pathogens as evolutionary divergent as bacteria 
and Plasmodium. Söderhäll and co-workers (2011) reported that specific isoforms could also 
be induced in the crayfish in response to different pathogens. Moreover, using recombinant 
proteins of the isoforms induced by gram-positive and gram-negative bacteria, they 
discovered that crayfish Dscam receptors may directly bind to their corresponding bacteria. 
Finally, it was discovered that Dscam may also bind directly to bacteria in the mosquito after 
AgDscam isoforms were eluted from the surface of the gram-negative E. coli after bacterial 
binding assays (Dong, Taylor et al. 2006). Thus, infection-responsive alternative splicing of 
Dscam could ascribe diversity with specificity to the invertebrate immune response. 
 
1.5.4. Dscam could have multiple roles in the invertebrate immune response 
Dscam appears to be an important receptor of the immune response in different invertebrate 
species, and one could envisage models for Dscam’s role in invertebrate immunity. Dscam 
expressed on the surface of haemocytes could bind directly to pathogens which may trigger 
conformational changes of the receptor to facilitate interaction with the Dock protein. 
Alternatively, Dscam expression could be connected with the Toll signalling pathway and its 
response to infection. In addition to the evidence suggesting that the Toll pathway is 
essential for the specific primed response in Drosophila (Pham, Dionne et al. 2007), it has 
been recently discovered that components of the Toll pathway, namely Rel-1 and Rel-2, 
regulate Dscam alternative splicing in the Anopheles mosquito (Yuemei Dong and George 
Dimopoulos, personal communication of unpublished data). Thus, it is possible that Dscam 




alternatively, components of the Toll pathway may regulate the alternative splicing of Dscam 
retrospective of the first detection of infection. 
 
It is also conceivable that the interaction of cell-bound Dscams with pathogens stimulate the 
clonal proliferation of those phagocytic cells expressing the responsive Dscam receptors. For 
instance, the increased phagocytic activity seen in the specific primed immune response of 
the woodlouse (Roth and Kurtz 2009) may be explained by increased quantities of pathogen-
induced Dscam-expressing phagocytes. Moreover, a study in a pancrustacean has shown 
increased quantities of haemocytes following infection with a natural parasite (Auld, 
Scholefield et al. 2010), and it is possible that Dscam-mediated responses may be involved. 
Finally, Dscam could synergistically interact with other components of the innate immune 
system in as yet uncharacterised signalling cascades to contribute toward specificity and 
memory in the invertebrate. Needless to say, many questions remain to be answered about 
Dscam’s role in the invertebrate immune response. Does Dscam confer specificity for 
pathogens or pathogen types? What degree of discriminatory ability exists? What is the 
function of soluble forms of Dscam? How is the alternative splicing of exon clusters 
controlled within the context of an immune response? And is the hyper-diversity of Dscam 
only conferred to the pancrustaceans? 
 
In this thesis I will address the question of the functional importance of Dscam’s diversity in 
immunity, and whether highly-sensitive elicitor-specific splicing occurs in response to 






1.6. Aims and objectives 
In Chapter 2, I follow up on the work of Dong et al (2006) who reported pathogen-specific 
splice-form expression of AgDscam exon 4 variants in response to diverse pathogens in a 
mosquito immune-competent cell line. I began by asking whether overall Dscam expression 
diversity in adult field-caught mosquitoes increased in response to increasing within-species 
parasite diversity using the natural and medically relevant mosquito parasite, Plasmodium 
falciparum. Recording the expression of both exons 4 and 6, I show that Dscam expression 
diversity significantly increases in parasite-exposed mosquitoes. 
 
In Chapter 3, I set out to develop and adopt a more powerful method for the study of 
differential Dscam expression in invertebrate immunity. Switching to the more easily 
handled and better understood model organism, Drosophila melanogaster, and having 
developed a PCR and sequencing assay using Illumina to obtain detailed splicing patterns in 
collaboration with Dr Darren Obbard, I report the success of the technique by determining 
characteristics of Dscam variant expression across treatments exposed to diverse pathogens. 
Moreover, I report the non-random splicing of exons 4 and 6 in Drosophila, and a small but 
detectable effect of pathogen-exposure on exon 4-expression. However, I found no strong 
patterns of Dscam expression between treatments overall. Thus, I concluded that while the 
technique appeared to be effective, the use of whole flies may have ‘contaminated’ possible 
immune effects with the presupposed higher levels of Dscam present of the nervous system. 
In Chapter 4, lessons taken from the previous experiment encouraged the investigation of 
tissue-specific Dscam expression in Drosophila in response to well-characterised immune 
elicitors. Using the same PCR and Illumina sequencing assay as Chapter 3, I found non-
random constitutive expression of exons 4 and 6 in all tissues assayed, and detected tissue-
specific expression of exon 4 but not exon 6. Furthermore, the small effect of challenge on 





In Chapter 5, in order to collect data on Dscam expression on a more distantly related 
pancrustacean, I studied the differential expression of Dscam in the crustacean Daphnia 
magna in response to different strains of its natural endoparasite, Pasteuria ramosa. I 
adopted a PCR and Illumina sequencing approach to detect tissue-specific Dscam expression 
in response to within-species infection diversity. Here, I show that Daphnia Dscam exons 4 
and 6 are non-randomly expressed in all tissues assayed, and that a small but detectable 
effect on exon 4-expression in response to parasite-exposure was also evident. 
 
Finally, in Chapter 6 (General Discussion), I summarise the field, discuss my own work and 
its implications, and briefly speculate upon the role of Dscam in invertebrate immunity in 
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In invertebrates, including Anopheles mosquitoes, Dscam (Down syndrome cell adhesion 
molecule) appears to be involved in phagocytosis of pathogens, and shows pathogen-specific 
splice-form expression between divergent pathogen (or parasite) types (e.g. between bacteria 
and Plasmodium or P. berghei and P. falciparum). Here, we present the first study of Dscam 
expression in response to genetic diversity within a parasite species. In independent field and 
laboratory studies, we compared Dscam expression diversity between mosquitoes fed on 
blood that was free of P. falciparum to mosquitoes exposed to either single or mixed 
genotype infections of P. falciparum. We observed significant increases in Anopheles 
gambiae Dscam (AgDscam) receptor diversity in parasite-exposed mosquitoes, but found 
only weak evidence that AgDscam diversity rises further upon exposure to mixed genotype 
parasite infections. Finally, we identified a cluster of AgDscam exon 4 variants that become 


















The innate immune system is common to both invertebrates and vertebrates, and although 
less well studied than the adaptive immune response, is probably responsible for eliminating 
the majority of infectious organisms. This is achieved through engulfing cells (e.g. 
phagocytes), antimicrobial compounds (e.g. defensins) and non-specific reactive 
intermediates such as nitric oxide (Hoffmann 1995; Medzhitov and Janeway 2000; Janeway 
and Medzhitov 2002; Beutler 2004; Chang and Klotman 2004). The vertebrate adaptive 
immune system appears to have more complex features: functional antibodies assembled by 
V-(D)-J joining of gene segments and diversified by somatic hypermutation accommodate an 
unrivalled resolution in terms of pathogen recognition for the vertebrate adaptive immune 
response (Murphy, Travers et al. 2007). Invertebrates, lacking antibodies and having only an 
innate immune system, rely on germline encoded pattern recognition receptors (PRRs) to 
detect pathogen associated molecular patterns and initiate a response (Medzhitov and 
Janeway 2000; Akira and Takeda 2004; Christophides, Vlachou et al. 2004; Christensen, Li 
et al. 2005). 
 
The absence of an equivalent of the vertebrate adaptive immune system has long fostered 
doubts that the invertebrate immune system could incorporate specificity and/or memory 
(Klein 1997; Hauton and Smith 2007; Rowley and Powell 2007). However, the absence of 
the cellular and genetic components of a vertebrate-like anticipatory immune system does 
not preclude a functional equivalent in invertebrates (Little, Hultmark et al. 2005), and there 
exists evidence of enhanced secondary responses to homologous infectious challenges 
(Cooper and Roch 1986; Hartman and Karp 1989; Kurtz and Franz 2003; Little, O'Connor et 
al. 2003; Sadd, Kleinlogel et al. 2005; Sadd and Schmid-Hempel 2006; Sadd and Schmid-
Hempel 2007; Johnson, van Hulten et al. 2008; Roth, Sadd et al. 2009). Moreover, in 




determining the probability of infection, a phenomenon called genetic specificity (Carius, 
Little et al. 2001; Schmid-Hempel and Ebert 2003; Little, Hultmark et al. 2005). Thus 
invertebrate defences do not lack sophistication, but the genetic and cellular mechanisms that 
underlie either invertebrate genetic specificity or enhanced secondary responses remain 
obscure (but see Pham, Dionne et al. 2007). 
 
Alternative splicing could permit a single gene to mediate alternative immune responses via 
the production of multiple proteins, and the flexibility of such a mechanism could have 
important implications for the spread of resistance alleles (Harding, Hansen et al. 2005). The 
Down syndrome cell adhesion molecule (Dscam), which can take some tens of thousands of 
different forms through alternative splicing, is commonly associated with its function in the 
vertebrate and invertebrate nervous systems, but seems to also play a role in invertebrate 
immunity (Du Pasquier 2005; Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 
2006; Brites, McTaggart et al. 2008). In the fruit fly Drosophila, Dscam is expressed in cell 
types that play major roles in the fly’s immune system, and RNA interference-mediated 
depletion of Dscam was shown to impair the insect’s capacity to engulf bacteria by 
phagocytosis (Watson, Puttmann-Holgado et al. 2005). Similarly, the silencing of Anopheles 
gambiae Dscam (AgDscam) compromises the mosquito’s ability to resist Plasmodium 
(Dong, Taylor et al. 2006). Moreover, AgDscam produces pathogen-specific splice form 
repertoires upon immune challenge (Dong, Taylor et al. 2006). In particular, the Dscam 
repertoire in response to parasite exposure differs between bacteria and Plasmodium and 
between Plasmodium berghei and Plasmodium falciparum (Dong, Taylor et al. 2006). 
However, such specificity has so far only been observed in studies comparing these 
divergent Plasmodium parasites, which probably last shared a common ancestor around 55 





The response of AgDscam transcription to P. falciparum diversity (i.e. within-species rather 
than between-species parasite exposure) may shed light on the resolution of the innate 
immune system’s specificity and dynamics, as well as its limitations. In theory, 31,920 
unique splice forms of AgDscam can be generated through the alternative splicing of 84 
variable exons contained within three variable exon cassettes (these are exon 4, exon 6, and 
exon 10) (Dong, Taylor et al. 2006), and which could potentially contribute to a capability to 
distinguish between different genotypes of Plasmodium. This capability would imply a more 
specific innate immune response than previously supposed. Here, research is described that 
relates P. falciparum genetic diversity to the expression characteristics of the alternatively 
spliced Dscam receptor in the An. gambiae mosquito. 
 
Two independent experiments were performed. The first was a field study that utilized 
freshly harvested blood from human subjects for which the genetic diversity of naturally 
acquired P. falciparum infections was characterized. The second experiment was based in 
the laboratory, where mosquitoes were exposed to either single parasite clones or mixtures of 
clones contained within human red blood cells in culture following an established protocol 
(Carter, Ranford-Cartwright et al. 1993). AgDscam receptor diversity was studied in two 
ways. First, a diversity index was calculated based on exon 4 and exon 6 frequencies to 
assess whether overall AgDscam expression diversity increased under exposure to P. 
falciparum parasites, and if it increased further with greater parasite infection diversity. 
Second, it was assessed whether particular Dscam exon transcripts were associated with 








2.3.1. Mosquito infection in Kenya 
Blood was obtained from primary school students in Iguhu (34°45’E, 0°10’N) in Kakamega 
district, western Kenya. The predominant malaria vector species in the area is An. gambiae 
s.s. (Githeko and Ndegwa 2001; Minakawa, Sonye et al. 2004). During and shortly after the 
rainy season, children (5–14 years of age) were screened for gametocytes by thick blood-
films stained in Giemsa’s stain. 
 
Gametocyte carriers who had >40 gametocytes/µL of blood and who consented to participate 
in the study were asked to donate 10 mL of blood, which was obtained intravenously by a 
clinician, and drawn into heparinized tubes. A total of six gametocyte donors were used in 
this study (two donors per gametocyte-positive infection group). Most of this blood was used 
for mosquito infections through membrane feeders, with around 50 µL also spotted onto 
Whatman paper for later DNA extraction using a Chelex-100 isolation technique (Wooden, 
Kyes et al. 1993). Methods for infecting mosquitoes are described in (Afrane, Little et al. 
2008). Drawn blood was immediately centrifuged at 700 x g, and the serum discarded and 
replaced with human AB serum (Cambrex Bio Science, Walkersville, MD, USA). Blood was 
then placed in warmed membrane feeders. Five to seven-day old An. gambiae Kisumu strain 
mosquitoes were placed in paper cups at a density of 60/cup and allowed to feed on the 
infected blood for 30 minutes. Mosquitoes used in this experiment were originally obtained 
near the Kenya Medical Research Institute in Kisumu (Vulule, Beach et al. 1994), but had 
been bred in an insectary and adapted to feed from a membrane feeder for many years (thus 
the mosquitoes were unlikely to be highly polymorphic). 
 
A total of twenty four mosquitoes were used in the field study (three mosquitoes per 




to cages post-blood meal, and then placed into RNAlater (Ambion) at 24-hours post-blood 
meal. Mosquitoes were harvested 24-hours post-feeding because this is the peak time that 
Plasmodium ookinetes penetrate the mosquito midgut (Dong, Taylor et al. 2006). Total RNA 
extraction was carried out using a Qiagen RNeasy Mini kit. On day 7 after they had been 
exposed to infected blood, the remaining fed mosquitoes from each cage were dissected in 
2% mercurochrome and examined for oocysts to confirm the presence of Plasmodium 
infections. 
 
2.3.2. Plasmodium microsatellite typing 
To estimate P. falciparum diversity, microsatellite loci were chosen based on their strength 
in terms of percentage PCR positives, frequency distributions of allele length important for 
sizing amplicons (Anderson, Su et al. 1999), size in base-pairs (Su and Wellems 1996), and 
allele frequencies (Anderson, Haubold et al. 2000). A hemi-nested PCR reaction was carried 
out to amplify six select microsatellite loci from each DNA extraction sample (Anderson, Su 
et al. 1999). Applied Biosystems Genemapper v4.0 software was used to automate the 
measurement of allele length and to quantify peaks in samples containing multiple alleles per 
locus. Only peaks from samples that amplified >200 fluorescent units were included in the 
deduction of infection diversity. Multiple alleles per locus were scored if the minor 
microsatellite peaks were >33% the height of the predominant allele. 
 
2.3.3. Mosquito infection in the laboratory 
Five to seven-day old female An. gambiae (Keele strain) mosquitoes were offered blood 
meals containing in vitro grown gametocytes of two different genotypes of P. falciparum 
(clone 3D7 (Walliker, Quakyi et al. 1987) and clone HB3 (Bhasin and Trager 1984)) through 
membrane feeders, and three whole mosquitoes per treatment were harvested after 24-hours. 
Three independent experiments on three different dates were performed. A total of thirty six 




three independent replicates). The gametocyte culture and membrane feeding protocols 
followed those previously described (Carter, Ranford-Cartwright et al. 1993). The isolation 
of total RNA was carried out using a Qiagen RNeasy Mini technology kit. 
 
2.3.4. Quantifying Dscam diversity 
RNA extracted from three individual mosquitoes per treatment was reverse transcribed using 
random hexamers and primers were designed to amplify a fragment of AgDscam spanning 
from exon 3 to exon 7 (primer sequences were: (F) 5’ - GTATACGCCTGCATGGCTAAGA 
- 3’, (R) 5’ - GCCCTTATCCTCCTTCTTG - 3’). Thus, the amplicons comprised variable 
exons 4 and 6, and the conserved exon 5. PCR products were cloned using a TOPO TA 
cloning kit with pCR®4-TOPO® vector and transformed in chemically competent 
Escherichia coli. Around 50 clones per mosquito were sequenced in a 96-capillary ABI 
3730xl DNA Analyzer (provided by the GenePool Sequencing Facility, University of 
Edinburgh). Sequences were aligned using BioEdit version 7.0.9.0 and identified by cross-
referencing with the known An. gambiae genome sequence available from the Ensembl 
genome browser (http://www.ensembl.org/index.html). 
 
2.3.5. Statistical analyses 
Diversity was measured with Simpson’s Index (1-D) (Simpson 1949), which quantified the 
combination of expressed exon 4 and exon 6 variants in each transcript as determined by 
sequencing. The presence and abundance of each individual exon, and exon 4-6 combination 
was identified. Statistical analysis of data using general linear modelling and one-way 
analysis of variance was carried out using Minitab 15.1.1.0 software. For the laboratory 
study, ‘clone’ was the single fixed effect with three levels, 3D7, HB3 or mixture of both, and 
for the field study, the number of genotypes detected (single, double or triple infection) was 
a fixed effect and donor was added as a random effect to account for variation. Data were 




Neighbour-Joining trees (see appendices) were produced using PHYLIP and variation in 
counts of exon groupings was analysed using Pearson’s chi-square. 
 
 
2.4. Results and Discussion 
For the field study, An. gambiae were membrane-fed on blood samples taken from 
gametocyte-carrying children, and RNA was harvested from the insects 24-hours post-
exposure, a time when parasites are traversing the midgut epithelium (Dong, Taylor et al. 
2006). cDNAs were then cloned and sequenced to identify specific AgDscam gene variants 
(at exons 4 and 6) expressed within insects fed from different blood samples. Control blood 
was taken from children carrying no Plasmodium (as detected with microscopy). A set of P. 
falciparum microsatellite markers (Anderson, Su et al. 1999) were used to identify parasite 
genotypes in gametocyte carriers. As blood samples contain whole populations of parasites, 
it is not possible to precisely estimate the number of genotypes present. However, by simply 
counting alleles at each locus, it is possible to identify the minimum number of genotypes 
present in a sample, and thus the methods used yielded a lower-bound of parasite genetic 
diversity. Single, double and triple infections were subsequently identified. 
 
AgDscam expression, as characterized by a diversity index (Simpson 1949) and averaged 
over both studied exons, was affected by the blood that the mosquitoes fed upon in the field 
(F3,20 = 3.22, P = 0.045; Fig. 1). It appears that AgDscam is more diverse when parasites are 
present (diversity was significantly lower in uninfected blood controls than in all other 
samples; Fig. 1). It is the combined diversity at exons 4 and 6 that drive this pattern, as a 
relationship between expression diversity and parasite diversity was not apparent when the 






It was interesting to note that there was a non-statistically significant trend for an association 
between exon 4 (but not exon 6) diversity and parasite diversity. This may imply that exon 4 
has a bigger role than exon 6 in responding to Plasmodium in the field. Additionally, 
AgDscam diversity was also higher when mosquitoes fed upon blood with double infections 
when compared to single infections, but diversity did not rise further with triple infections 
(Fig. 1). Thus, these field data provided only limited evidence of a link between host 
response recognition capacity and parasite intraspecific diversity. As the blood stage 
diversity as measured by microsatellites could not be certain to be representative of 
gametocyte diversity, i.e. it is conceivable that not all parasite types were producing 
gametocytes (see Nwakanma, Kheir et al. 2008), a laboratory-based study was carried out 
 
Figure 1: Anopheles gambiae Dscam expression diversity versus increasing parasite diversity 
in the field. AgDscam diversity (as 1- Simpson’s Index) increased between controls and exposed 
treatments and between single and double genotype-exposures only. Levels not connected by same 
letter are significantly different. Error bars represent standard error (SE). Key: Control; blood meal 
with no parasites, Single; mosquitoes exposed to a minimum of one P. falciparum genotype, 
Double; mosquitoes exposed to a minimum of two P. falciparum genotypes, Triple; mosquitoes 




using gametocyte-producing lines of P. falciparum. In this way, the diversity of gametocytes 
entering the experimental mosquitoes could be certain. 
 
For the laboratory study, mosquitoes were membrane-fed on blood infected with 
gametocytes of either P. falciparum clone 3D7 (Walliker, Quakyi et al. 1987) or HB3 
(Bhasin and Trager 1984), or a mixture of the two, and RNA was harvested from the insects 
24-hours post-exposure. cDNAs were cloned and sequenced and AgDscam exon 4 and exon 
6 variants expressed were identified within mosquitoes exposed to different treatments 
(control blood with no Plasmodium, clone 3D7, clone HB3, and clones 3D7 and HB3 
mixed). It was found that AgDscam expression was affected by the blood that the mosquitoes 
fed upon (F3,32 = 5.29, P = 0.004; Fig. 2).  
 
Thus, as with the field study, it appears that AgDscam is more diverse when parasites are 
present (diversity was significantly lower in uninfected blood controls than in all other 
samples; Fig. 2). Although diversity increased under exposure to either laboratory parasite 
clone, it did not increase further in response to a mixture of the two clones (Fig. 2). As with 
the field data, it was the combined diversity at exons 4 and 6 that drove this pattern, as 
variation in Dscam diversity was not apparent when the exons were studied separately (exon 
4: F1,34 = 3.10, P = 0.087; exon 6: F1,34 = 0.16, P = 0.690). Again, there was some evidence of 
a trend for exon 4 but not exon 6, as previously seen in the field study, implying that the 
variability rendered by exon 4 in responding to Plasmodium may be relatively more 








 analysis was used to identify whether particular splice variants were over- or under-
represented in any of the field (control, single, double or triple) or laboratory (control, clone  
3D7, clone HB3, mixed) infections. Because the extreme splice variation leads to very low 
counts for individual exons, exon variants were grouped into categories based on their 
genetic distance. Although this grouping may not reflect any relationship between biological 
function and antigen recognition similarity, varying the cut-off points did not change the 
qualitative results. Based on a Neighbour-Joining (NJ) tree (exon 4, see Fig. S1; exon 6, see 
Fig. S2), genetic groupings of exon variants were defined such that exon 4 variants were 
clustered into 3 groups (Fig. S1), and exon 6 into 3 groups also (Fig. S2). 
 
 
Figure 2: Anopheles gambiae Dscam expression diversity versus increasing parasite diversity 
in the lab. AgDscam diversity (as 1- Simpson’s Index) increased between controls and exposed 
treatments, but did not increase between the single genotype-exposure and the mixed genotype-
exposure. Levels not connected by same letter are significantly different. Error bars represent 
standard error (SE). Key: Control; blood meal with no parasites, 3D7; mosquitoes exposed to 
Plasmodium falciparum clone 3D7, HB3; mosquitoes exposed to Plasmodium falciparum clone 






contingency tests were used to determine whether the number of observations (counts) of 
each group differed between the infection categories (see appendix for raw data). In general, 
no exons were over- or under-represented in any particular infection grouping in either the 
field or laboratory experiments. The only exceptions to this were exon 4 variants 4.11, 4.12 
and 4.13 which are clearly a distinct genetic grouping (see Fig. S1), and were under-
represented in control mosquitoes compared to exposed treatments in the field (Pearson’s 
Chi-Square = 6.318, DF = 2, P = 0.042), and exon 6 variants 6.1 and 6.9 which are also a 
distinct genetic grouping (see Fig. S2), and were under-represented in control mosquitoes, 
but also over-represented in mosquitoes exposed to a single genotype of P. falciparum in the 
field (Pearson Chi-Square = 19.975, DF = 6, P-Value = 0.003). These data suggests that exon 
4 variants 4.11, 4.12 and 4.13, and exon 6 variants 6.1 and 6.9, may be particularly important 
for the mosquito’s immune response to Plasmodium in the field. 
 
2.5. Conclusion 
The results show an increase in AgDscam splice-form diversity at 24-hours post-exposure, 
when the parasites are crossing the insect’s midgut epithelium (Dimopoulos, Seeley et al. 
1998; Dong and Dimopoulos 2006; Dong, Taylor et al. 2006). This observation, confirmed 
both in the field and the laboratory, reinforce that the AgDscam receptor responds to 
Plasmodium at a vital stage for the parasite’s development. The limited association between 
AgDscam diversity and P. falciparum genotype-diversity in the field raises the possibility 
that the alternatively-spliced receptor could be responding to P. falciparum diversity. This 
observation, however, was not seen between double- and triple-exposed treatments. 
Although it cannot be assumed that every parasite genotype detected in the blood samples in 
the field is represented in the sexual stage, there is an apparent consistency in the results 
showing a lack of genotype-specific Dscam expression diversity following two different 




by unmeasured factors, for example some of the blood samples could conceivably have 
harboured other parasite species. This possibility was investigated using PCR detection for 
other Plasmodium parasites (specifically Plasmodium malariae, Plasmodium ovale and 
Plasmodium vivax), and the presence of P. malariae in both of the blood samples containing 
a single genotype of P. falciparum was recorded (see appendix, Table S3). Consequently, the 
single infections were confounded with multi-species infections, and yet AgDscam diversity 
of these multi-species exposures was lower than the diversity levels of the double and triple 
P. falciparum exposures. Although even higher Dscam expression diversity could be 
expected in this instance, this was not observed, and thus other interpretations are possible 
depending on whether one species has a stronger influence on Dscam expression within a 
particular multiple-infection than another. It was also interesting to note that the over-
representation of the group of exon 6 variants (variants 6.1 and 6.9) found in these multi-
species infections was not found in the single-species infections, implying that these variants 
could be influenced by the presence of P. malariae. The significance of these observations 
remains to be investigated. It was also determined whether P. falciparum infection intensity 
in the blood samples, i.e. abundance of parasite stages (as determined by quantitative PCR), 
could have affected our results, but we found no relationship between parasite abundance 
and Dscam diversity (see appendix, figure S3). Finally, future studies may benefit from the 
use of multiple mosquito genotypes. It is possible that different genotypes may respond 
differently to the same parasite challenge in terms of AgDscam expression. This may be a 
logical direction for future work as the relative absence of related studies on AgDscam 
allows little speculation on whether the colonies used in this study would be a good proxy 
for what can be expected in natural populations. Thus, in summary, the data clearly indicate 
that AgDscam diversity increases with parasite exposure, but they do not suggest that 





Chapter 3: Dscam gene expression 
in response to diverse pathogens in 
the fruit fly Drosophila 
melanogaster 
 
This chapter was written with comments from Darren Obbard and Tom Little. Statistical 
analyses were done in collaboration with Darren Obbard. The quality trimming, counting 
and sorting of raw Illumina sequencing reads was done using a custom R pipeline written by 
Darren Obbard. Illumina library construction, sequencing and base-calling were performed 




















Evidence of enhanced immunity and pathogen-specific memory has been reported in several 
members of the pancrustaceans (see Chapter 1, General Introduction). For example in 
Drosophila, a specific primed response was found after flies were injected with a sub-lethal 
dose of Streptococcus pneumoniae which conferred protection from a subsequent lethal dose 
of the same gram-positive bacterium, but did not protect against other pathogens (Pham, 
Dionne et al. 2007). The specific priming effect was dependent upon phagocytes, immune 
cells required for the removal of pathogens (Lemaitre and Hoffmann 2007), and the Toll 
signalling pathway, which responds to the presence of gram-positive bacteria and fungi 
(Akira and Takeda 2004). 
 
A candidate gene for the specific primed response in Drosophila is Down syndrome cell 
adhesion molecule (Dscam). Dscam is an axon guidance receptor that displays exceptional 
diversity of isoforms through the mutually exclusive alternative splicing of many different 
gene variants. For example, in Drosophila melanogaster, 95 variable exons contained within 
3 exon cassettes can produce up to 38,016 different proteins with different interaction 
specificities (Schmucker, Clemens et al. 2000). This diversity has been shown to be essential 
for Dscam’s role in the fly’s nervous system (Hattori, Demir et al. 2007), and evidence is 
emerging that suggests the alternative splicing gene may also be important in invertebrate 
immunity. In other species, specific Dscam exon variants have been reported to be over-
expressed in response to particular pathogens and pathogen-types (Dong, Taylor et al. 2006; 
Watthanasurorot, Jiravanichpaisal et al. 2011). Additionally, Dscam has also been implicated 
in phagocytosis and may be connected with the Toll signalling cascade in response to 
infection. Specifically, the silencing of Dscam results in significant depletion of phagocytic 
activity in both the fly and the mosquito (Watson, Puttmann-Holgado et al. 2005; Dong, 




bacterial binding by phagocytic cells in the crayfish (Watthanasurorot, Jiravanichpaisal et al. 
2011). Furthermore, components of the Toll signalling pathway have been shown to regulate 
Dscam alternative splicing in the mosquito (Yuemei Dong and George Dimopoulos, personal 
communication of unpublished data). Thus, the capacity for high expression diversity and 
recognition specificity together with an implicated role in phagocytosis and possible 
involvement with the Toll signalling pathway, make Dscam a candidate for specific 
recognition in pathogen-clearance in Drosophila. 
 
In Chapter 2, I set out to determine whether overall Dscam expression diversity increased in 
the adult Anopheles gambiae mosquito in response to its natural parasite, Plasmodium 
falciparum. The data suggested that Dscam expression diversity increased in response to the 
presence of parasites in both the lab and the field, but showed only weak evidence of a 
further increase in response to increasing parasite diversity. Thus, while Anopheles Dscam 
appeared to play a role in the mosquito immune response to parasites, the phenomenon of 
parasite genotype-specific splicing in adult mosquitoes could not be confirmed. However, 
‘diversity’ was a relatively uninformative measure in this case as the diversity of exon 
variant expression is very high in Dscam, and subsequently the sensitivity of detection was 
low. In other words, the cloning and sequencing approach carried out in Chapter 2 could not 
give enough power to enable a good estimate of splice-variant frequencies as there are so 
many of them. To quantify the relative frequencies of more than 400 different entities (the 
number of possible exon 4-6 combinations of Anopheles Dscam) by making a total of just 50 
observations per insect is unrealistic. As such, a more desirable measure would be a 
quantification of the Dscam expression pattern. Thus, methods which could permit a greater 
sampling of Dscam transcripts would be preferred. 
 
Here, I infected an invertebrate host with several pathogens and then used qRT-PCR assays 




chosen post-infection harvest time was appropriate to study Dscam expression (i.e. during 
heightened immune responses). I then used a new Illumina-based sequencing protocol to 
identify expression levels of Dscam exon variants, and carried out an independent cloning 
and sequencing assay to compare the output of the different sequencing methods. I also 
compared the Illumina sequencing results to a past microarray study to establish whether 
they were consistent. I used two main complementary approaches to the statistical analysis. 
A generalised linear mixed model implemented in MCMCglmm (Hadfield 2009) was used to 
infer the effect of immune challenge on Dscam expression patterns, and the widely used 
DESeq (Anders and Huber 2010) analysis was implemented to study differential expression 
of individual Dscam exon variants between treatments. 
 
The remainder of this introduction is dedicated to (1) describing the assays currently used to 
study gene expression and alternative splicing of Dscam, (2) to outline a new high-
throughput sequencing approach designed to study alternative splicing of Dscam in the 
present study, (3) to introduce the organisms used in this work, and (4) to outline the aims of 
the study. 
 
Assays currently used for the study of gene expression and alternative splicing in 
Dscam 
Cloning and Sequencing 
The sequencing of cloned PCR products has been widely used to study Dscam gene 
expression. The differential use of alternative Dscam exons was first detected in Drosophila 
by sequencing across the variable and constitutive exons of the gene (Schmucker, Clemens 
et al. 2000), and different combinations of exon variants spliced together in the same 
transcripts were found in the olfactory receptor neurons of fruit fly antennae by sequencing 
cloned Dscam cDNAs (Hummel, Vasconcelos et al. 2003). Watson et al (2005) cloned 




discovered that Dscam mRNAs in different tissues contained many different expressed exons 
and exon 4-6 combinations (Watson, Puttmann-Holgado et al. 2005). Later, Brites et al 
(2008) sequenced clones of Dscam cDNAs in Daphnia magna to obtain the first Dscam 
sequences from this crustacean and also identify associations between different exon variants 
in individual Dscam transcripts. Finally, Chou et al (2010) cloned and sequenced partial 
cDNA fragments from the shrimp Litopenaeus vannamei, to also identify individual and 
combinatorial expression of Dscam exon variants. 
 
The cloning and sequencing assay employed in Chapter 2 of this thesis was effective in 
determining the expression of exon 4 and 6 variants independently, and the specific exon 4-6 
combinations. As such, this method provided both quantitative information (counts of 
individual exon variants) and qualitative information (combinations of exons) about Dscam 
gene expression in a natural host-parasite system. However, to permit more robust 
conclusions from cloning and sequencing, extensive sequencing of a statistically large 
number of randomly selected cDNAs is essential (Hall 2007). In Drosophila for instance, 
Dscam exon 4-6 combination-diversity alone extends up to 576 possible isoforms, and my 
previous work in Anopheles (see Chapter 2) found the distribution of exon combination-
expression to be in the direction of even, indicating that all isoforms may be rare. The 
sampling of high numbers of Dscam transcripts using the cloning and sequencing method 
would be impractical. Thus, to properly investigate Dscam’s putative pathogen-specificity, a 
method enabling the sampling of a much larger amount of Dscam mRNAs is needed. 
 
Single-strand conformation polymorphism gel electrophoresis 
Single-strand conformation polymorphism (SSCP) gel electrophoresis has also been used to 
analyse alternative splicing in Dscam (Celotto and Graveley 2001). Conformational 
differences between single-stranded nucleotide sequences of the same length can be 




and Graveley (2001) used SSCP gel electrophoresis to distinguish most of the 12 different 
exon 4 variants of D. melanogaster from RT-PCR products. As all D. melanogaster exon 4 
variants are similarly sized (ranging between 159 and 171 base pairs) the identification of 
individual variants using traditional agarose gel electrophoresis would not be possible 
(Celotto and Graveley 2001). However, a drawback of SSCPs is that some Dscam exon 4 
variants co-migrate on gels (Celotto and Graveley 2001). As such, the relative frequency of 
most but not all exon 4 variants expressed in each RNA sample can be determined. This 
problem may be elevated in exon clusters which contain even more variants such as the D. 
melanogaster exons 6 and 9, which contain 48 and 33 mutually exclusive splice variants, 
respectively. 
 
Quantitative RT-PCR  
Quantitative RT-PCR (qRT-PCR) has been used to detect relative expression levels of 
Dscam exon variants. Dong et al (2006) used qRT-PCR to study the relative expression 
levels of Dscam exon 4 variants in response to immune elicitors in Anopheles, and 
subsequently discovered that some exon 4 variants were over-represented in response to 
specific pathogens. Moreover, the abundance of Dscam transcripts and the specific usage of 
exon 4 variants in response to parasites were quantified in the crustacean D. magna using 
this method (Brites 2010). The study of Dscam exon-exon combinations using qRT-PCR has 
not been attempted to my knowledge, and it would not only require primers for all exon-
exon junctions to determine exon to exon splicing, but would also require the amplification 
of fragment sizes much larger than would normally be considered optimal for high primer 
efficiency. For example, to detect the splicing of exon 4 and exon 6 in D. melanogaster, 
fragment sizes of over 200bp would need to be amplified, more than the preferred 75-150bp 
fragments, while substantially larger fragments would be required to determine the splicing 
of variable exon 6 with variable exon 9. Furthermore, similarities between exon variant 






Microarray technology has been used to measure the total level of expression of Dscam gene 
variants in Drosophila. Using microarrays, Watson et al (2005) detected a high diversity of 
isoform expression in different tissues of the insect (Watson, Puttmann-Holgado et al. 2005). 
Although microarrays can simultaneously detect the expression intensities of Dscam’s many 
gene variants individually, the splicing together of specific exon 4-6 combinations is missed, 
and would require the design of complex splice-sensitive arrays. Detecting the combinatorial 
splicing of Dscam using microarrays would require probes to be designed that are specific to 
each splice-junction. Prior knowledge of exon-exon junctions are required before splice 
probes can be designed, and therefore this method may miss previously unknown exon 
splicing events and also previously unknown allelic variation within alternative exons (Lee 
and Roy 2004). Moreover, as with a qRT-PCR approach, splice probes for each exon-exon 
junction may be difficult to design due to similarities between alternative exons (see 
Srinivasan, Shiue et al. 2005), which could result in cross-hybridization of probes and 
ultimately affect measures of exon variant expression. Thus, although microarray technology 
has undoubtedly been a powerful tool in the study of Dscam, the study of combinatorial 
splicing and its possible implications would require a more practical and powerful method. 
 
The development of a new sequencing assay adopting Illumina technology 
The arrival of high-throughput sequencing and its ability to provide hundreds of thousands of 
counts for a specific expressed gene or gene variant, permits a considerably greater sampling 
of a cDNA pool (Mardis 2008). As such, a truer representation of Dscam gene variant 
expression and Dscam alternative splicing within the backgrounds of diverse immune 
challenges could be acquired and may provide more evidence for its role within the context 




sequencing assay using Illumina technology to enable the counting of many tens of 
thousands of Dscam exon variants. 
 
Illumina sequencing technology is one of several new powerful methods for sequencing on a 
genome-wide scale (Mardis 2008; Schuster 2008; Shendure and Ji 2008; Peng and Zhang 
2009). Illumina can yield tens of millions of reads per instrument-run using a massively 
parallel sequencing process. DNA templates are immobilised on a flow cell, and are then 
clonally amplified through a series of extensions and bridge amplifications generating many 
clusters containing millions of copies of the original copy. These clusters are then sequenced 
simultaneously base by base using four fluorescently-labelled nucleotides which naturally 
compete, minimising incorporation bias. After each sequencing cycle the clusters are excited 
by a laser. This emits a colour identifying the newly added base, which is called by 
measuring the signal intensity (Mardis 2008; Shendure and Ji 2008). Here, we have adopted 
Illumina technology in the development of a sequencing assay to study Dscam alternative 
splicing. I used PCR to amplify a fragment of Dscam spanning from the 3’ end of 
constitutive exon 3 to the 5’ end of constitutive exon 7, thus producing amplicons containing 
complete variable exons 4 and 6, and the constitutive exon 5. For each treatment in the 
experiment a unique 5bp Molecular ID (MID) tag was incorporated into the 5’ PCR primer 
allowing multiplexed reads to be assigned to their treatment (Fig. 1). Thus, many thousands 
of Dscam cDNAs were sequenced in this study, and the expression of exons 4 and 6, and the 






Drosophila immune responses as a model  
In this study, I challenged Drosophila melanogaster with an array of diverse immune 
elicitors. I aimed to expose flies to immune challenges which would provide the widest 
possible comparisons and as such, I chose two different bacteria (one gram-positive and one 
gram-negative), two different viruses (RNA and DNA), and a fungus. 
 
The gram-negative bacteria, Escherichia coli, triggers the up-regulation of the anti-bacterial 
peptide Diptericin in D. melanogaster, while the gram-positive bacterium, Micrococcus 
luteus, has been shown to up-regulate the anti-microbial compound Drosomycin (Lemaitre, 
Reichhart et al. 1997). Drosophila C virus (DCV) is a single-stranded RNA virus and has 
 
Figure 1: Dscam variable exons 4 and 6 were PCR-amplified simultaneously and MID tags 
were incorporated into the forward primers. D. melanogaster Dscam amplicons comprised 
variable exons 4 and 6, together with constitutive exon 5. Unique molecular ID (MID) tags (here 
with ACACG used as one example, shown in red) were incorporated into forward primers for 
each treatment in the study. This allowed the identification of treatments in multiplexed 
sequencing reactions. Prepared samples were then sequenced using Illumina technology and the 
expression of exon 4, exon 6, and the exon 4-6 combination for each cDNA was recorded. Primer 
sequences shown are those used in the experiment. Constitutive exons are represented by black 
squares and are prefixed with the letter ‘C’, and variable exons are represented by coloured 





been found to infect D. melanogaster and D. simulans in the wild (Jousset, Bergoin et al. 
1977; Kapun, Nolte et al. 2010). DCV infection up-regulates the expression of the Jak/STAT 
signalling pathway effector gene, vir-1 (Dostert, Jouanguy et al. 2005; Hedges and Johnson 
2008), and DCV induction of vir-1 is regarded as an important model for viral infection in 
Drosophila (Ip 2005). Flies were also exposed to Plodia interpunctella granulosis virus 
(PiGV). PiGV is a DNA virus of the Indian meal moth, Plodia interpunctella. No DNA virus 
infecting Drosophila was known when these experiments were performed, thus an aim of 
introducing PiGV into the fly was to attempt to provoke an atypical immune response. 
Finally, the fungus Beauveria bassiana is an entomopathogenic fungus found in soil that can 
parasitize various arthropod species (Tinsley, Blanford et al. 2006) and is naturally 
pathogenic to Drosophila. It has been shown to up-regulate Drosomycin in D. melanogaster 
(Lemaitre, Reichhart et al. 1997). 
 
Many Drosophila species including D. melanogaster are naturally infected with the 
endosymbiont Wolbachia, a cytoplasmically-inherited bacterium that appears to mediate 
virus protection (Hedges, Brownlie et al. 2008; Teixeira, Ferreira et al. 2008; Osborne, 
Leong et al. 2009). For example, after clearing Wolbachia infection in D. melanogaster with 
tetracycline, Teixeira and co-workers showed that both DCV viral load and viral sensitivity 
increased in the fly (Teixeira, Ferreira et al. 2008). This effect was seen for other RNA 
viruses but not for a DNA virus. In contrast, Wolbachia infection does not appear to confer 
antibacterial protection in D. melanogaster (Wong, Hedges et al. 2011). Thus, the presence 
or absence of Wolbachia in D. melanogaster may confer different outcomes to virus 
infections. Consequently, I also used Drosophila both naturally infected with Wolbachia, 
and cleared of Wolbachia using antibiotics, to investigate any detectable differences in 






Here, a new Illumina sequencing assay was employed to investigate the expression of the 
Drosophila Dscam gene in whole flies in response to diverse immune challenges including 
bacteria, viruses, and a fungus. I aimed to (1) investigate whether the deep sequencing assay 
could detect differences in exon variant expression, detect novel exons, and identify 
unexpressed exons, (2) investigate whether it could detect combinatorial splicing in 
Drosophila and determine whether this splicing is random or non-random, and (3) determine 
whether infection-responsive alternative splicing occurs in response to a wide array of 





3.2.1. Fly rearing 
Flies used in the experiment were the D. melanogaster Oregon R line (original stock 
provided by Brian Charlesworth, University of Edinburgh) and maintained in the lab on 
standard fly medium (1000ml water, 10.3g agar, 140.6g sugar, 103g maize, 28.1g yeast and 
22.5ml methylparaben; an antifungal and antibacterial agent) at 18°C or 25°C with a 12:12h 
light:dark cycle. Flies were treated with 0.03% tetracycline hydrochloride for three 
generations to clear Wolbachia intracellular bacteria for Wolbachia-negative treatments (see 
Harcombe and Hoffmann 2004). Tetracycline-treated lines were given two generations to 
recover from the effects of antibacterial treatment prior to use in experiments. Separate flies 
were reared for Wolbachia-positive treatments and were not treated with tetracycline. PCR-
detection assays were carried out to confirm the presence or absence of Wolbachia using 
primers for a Wolbachia surface protein (primers were: (F) 5'- 




Flies of both Wolbachia conditions were placed in separate cages and allowed to lay eggs on 
grape juice plates supplemented with yeast paste for up to 4 hours. Eggs were then collected 
and chemically dechorionated with a two-fold dilution of sodium hypochlorite (NaOCl) at 
4.8g per 100g (Commercial bleach) to remove microorganisms including viruses from the 
surface, washed thoroughly with distilled water, and grown at 25°C in standard fly medium 
supplemented with yeast. Three further generations were allowed to pass to avoid the risks of 
any possible confounding maternal effects. Virgin females were then isolated and aged for 3-
4 days. 
 
3.2.2. Immune challenge  
Escherichia coli (DH10B strain, Invitrogen) and Micrococcus luteus (LZB055 strain, Blades 
Biological Ltd, Edenbridge, UK) were cultured overnight in lysogeny broth (1% tryptone, 
0.5% yeast extract, 1% NaCl, ddH2O) and nutrient broth (0.5% peptone, 0.3% yeast extract, 
0.5% NaCl, ddH2O) respectively, until OD was ca. 0.5 at a wavelength of 600nm. Bacteria 
aliquots were then frozen at -80°C in 10% glycerol until required. On the day before the 
experiment bacteria aliquots were thawed and re-cultured overnight. Cells were then washed 
three times and re-suspended in isotonic Ringers solution, and gently vortexed before 
injection. For Drosophila C Virus, a tissue culture infective dose50 of 1000 TCID50 in 69nl 
was provided by Ben Longdon (see Longdon, Fabian et al. 2012). Plodia interpunctella 
granulosis virus stock was donated by Amy Pederson (University of Edinburgh) and 
preparations contained 6.9 x 10
7
 viral particles per ml (see Saejeng, Siva-Jothy et al. 2010 for 
full details). Beauveria bassiana was supplied by Matthew Tinsley (University of Stirling). 




, and the formulation was agitated briefly 
by gentle vortex prior to injection (see Tinsley, Blanford et al. 2006 for further details). 
 
Flies were anaesthetised with CO2, injected ventrally in the upper abdomen with 69nl of the 




immediately placed in vials containing a sugar-agar medium, and kept at 18°C for either 6 or 
30 hours (6 hours was chosen as a time when heightened responses to immune challenges 
have been previously shown (Lemaitre, Reichhart et al. 1997; Shia, Glittenberg et al. 2009), 
and 30 hours was selected to monitor gene expression well after the challenge). Challenges 
to Wolbachia-negative flies were: unwounded control (anaesthetised only), wounded control 
(isotonic Ringers solution for Drosophila; 182mM KCl, 46mM NaCl, 3mM CaCl2, 10mM 
Tris-Cl), E. coli (a gram-negative bacterium), M. luteus (a gram-positive bacterium), 
Drosophila C Virus (a natural Drosophila RNA virus), Plodia interpunctella granulosis 
virus (a DNA virus of the Indian meal moth), B. bassiana (an arthropod-infecting fungus; 
delivered in oil), and an oil control (87·5% Shellsol T, 12·5% Ondina EL). Challenges to 
Wolbachia-positive flies were: unwounded control (anaesthetised only), wounded control 
(isotonic Ringers solution), and Drosophila C Virus. Animals were placed in liquid nitrogen 
after 6 or 30 hours post-injection, and shortly after homogenised in TRIzol reagent 
(Invitrogen) and stored at -80°C pending RNA isolation. A total of 25 individual flies were 
used for each of 22 treatments. The entire experiment was replicated 6 times. However 
following initial Illumina sequencing results, only replicates 3 and 4 were sequenced. Thus, a 
total of 1,100 flies were used in this study. 
 
3.2.3. RNA isolation, reverse transcription and quantitative PCR 
RNA was extracted from whole insects using a standard TRIzol extraction protocol 
(Invitrogen). Total RNA was treated with RNase-Free DNase I (Ambion) to remove genomic 
DNA contamination, and complementary DNA was synthesised using a Promega reverse 
transcription system with random hexamers. Reverse transcription conditions were: 22°C for 
10 minutes, 42°C for 60 minutes, and 95°C for 5 minutes. Real-time quantitative PCR (qRT-
PCR) was carried out to determine whether immune responses were heightened following 
challenge. qRT-PCR assays were performed on an Applied Biosystems StepOnePlus cycler 




preferentially bind to dsDNA. Primers for fly ribosomal protein 49 (rp49) were used as the 
qRT-PCR reference in all cycler runs (rp49 primer sequences were: (F) 5' - 
GACGCTTCAAGGGACAGTACTTG - 3', (R) 5' - AAACGCCGTTCTGCATGAG - 3'). 
Immune markers were selected based on expected up-regulation of important immune genes 
in response to specific classes of pathogen. The anti-fungal peptide Drosomycin (primer 
sequences: (F) 5’ - TCCGTGAGAACCTTTTCCAATATG - 3’, (R) 5’ - 
CCAGGACCACCAGCATCAG - 3’) is induced in response to exposure to fungal peptides 
or gram-positive bacteria (Lemaitre, Reichhart et al. 1997; Rutschmann, Jung et al. 2000; 
Michel, Reichhart et al. 2001; Brennan and Anderson 2004; Zhang and Zhu 2009), the 
antibacterial polypeptide Diptericin (primer sequences: (F) 5’ - 
GCTGCGCAATCGCTTCTACT - 3’, (R) 5’ - TGGTGGAGTGGGCTTCATG - 3’) is 
induced in response to gram-negative bacteria (Lemaitre, Reichhart et al. 1997; Rutschmann, 
Jung et al. 2000; Brennan and Anderson 2004), and Vir-1 (primer sequences: (F) 5’ - 
GATCCCAATTTTCCCATCAA - 3’, (R) 5’ - GATTACAGCTGGGTGCACAA - 3’), a 
virus-induced target gene of the Jak/STAT host antiviral signalling pathway (Dostert, 
Jouanguy et al. 2005; Ip 2005) is shown to be up-regulated in response to DCV (Dostert, 
Jouanguy et al. 2005; Hedges and Johnson 2008). All cycler runs included serial dilutions of 
fly cDNA to calculate primer efficiency, controls for the presence of genomic DNA, and a 
melting curve analysis for product identification. Each reaction contained: 8μl Fast SYBR® 
Green Master Mix (Applied Biosystems), 10μl ddH2O, 1μl primer mix (10mM 
concentration), and 1μl template cDNA. qRT-PCR conditions were: holding stage: 95ºC for 
10 minutes; cycling stage: 40 cycles of 95ºC for 15 seconds, 60ºC for 60 seconds; and melt 
curve stage: 95ºC for 15 seconds, 60ºC for 60 seconds with temperature increment +0.3ºC 
for 15 seconds to 95ºC. The qRT-PCR assay included 3 technical replicates and two 
biological replicates. A further qRT-PCR assay was carried out to determine if immune 
responses had occurred at the time points chosen to harvest flies post-challenge. As such, 




immune marker genes (Diptericin and Drosomycin) were quantified across a time-course. 
Fly preparation, immune challenge, RNA isolation and qRT-PCR conditions were as 
described previously. 
 
3.2.4. PCR and Illumina sequencing 
Unique molecular ID (MID) tags were included on the 5’ end of all forward primers to 
identify treatments in multiplexed sequencing reactions. Primers were designed to amplify a 
fragment of D. melanogaster Dscam spanning from exon 3 to exon 7 (primer sequences 
were: (F) 5’ - ACGTCCATGTGCGAGCCGT - 3’, (R) 5’ - 
GTTCCTTCGATGAACTTGTACCAT - 3’). Thus, PCR amplicons comprised variable 
exons 4 and 6, and the conserved exon 5. PCR conditions were: 98°C for 30 seconds, then 35 
cycles of 98°C for 30 seconds, 55°C for 10 seconds, and 72°C for 60 seconds, and finally 
72°C for 10 minutes. PCR products were quantified using the Qubit® 2.0 Fluorometer 
(Invitrogen), and all MID-tagged samples were mixed evenly based on quantification. The 
final mixed product was concentrated using ethanol precipitation, and sequenced in an 
Illumina Genome Analyzer II (service provided by the GenePool Sequencing Facility, 
University of Edinburgh). 
 
3.2.5. Cloning and sequencing 
Cloning and sequencing was carried out on two different treatments to compare with 
Illumina sequencing data. PCR products were cloned using a TOPO TA cloning kit with 
pCR®4-TOPO® vector and transformed in chemically competent E. coli. Around 100 
clones per treatment were sequenced in a 96-capillary ABI 3730xl DNA Analyzer (service 
provided by the GenePool Sequencing Facility, University of Edinburgh). Sequences were 
aligned using BioEdit version 7.0.9.0 and identified by cross-referencing with the known D. 





3.2.6. Data analysis 
Raw data handling 
Sequencing data from the Illumina GAII was received as FASTQ files (containing multiple 
short-read sequences with quality scoring information), and was converted to FASTA files 
with the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Pre-processing of reads 
was carried out to produce better alignment results. A Perl Script was used to cut bad quality 
ends (ConDeTri v2.0 (Smeds and Kunstner 2011); content dependent read trimming 
software for Illumina/Solexa sequencing data). This involved the removal of non-ATGC 
characters and the trimming of poor quality sequence by setting stringency parameters. High 
and low quality thresholds were set at 25 and 20, respectively (Sanger Scale; Qsanger = -10 
log10p, where p is the probability of the corresponding base call being incorrect), and the 
fraction of the read which was to exceed high quality was set at 80%. Minimum read length 
was set at 50bp and reads without a valid MID-tag were discarded. Reads were identified by 
cross-referencing with the D. melanogaster genome (http://www.ensembl.org/index.html). 
 
Statistical analyses  
Quantification of immune marker expression in qRT-PCR assays: To approximate the 
change in expression of immune markers from qRT-PCR assays, mean cycle threshold (Ct) 
values for each treatment were firstly calculated from three technical replicates, and then a 
delta Ct (ΔCt) value was calculated for each treatment as the difference between the cycle 
thresholds (Ct) of the immune marker genes (Diptericin, Drosomycin or Vir-1) and the 
endogenous control gene (rp49). Relative difference between immune markers and rp49 was 
expressed as 2
-ΔCt
 and mean relative expression ± SE was calculated from two biological 
replicates. Average primer efficiencies for Diptericin, Drosomycin, Vir-1 and rp49 were 
101%, 99%, 91% and 100%, respectively. To approximate the fold change of immune 
marker expression over a time-course, the delta delta Ct (ΔΔCt) method was used (Livak and 




replicates. Delta Ct (ΔCt) was then calculated as the difference between mean Ct values of 
marker genes (here, Diptericin and Drosomycin) and rp49 for each time point, and fold 
change of expression compared to unchallenged samples was calculated as 2
-ΔΔCt
. Mean fold 
change ± SE was calculated from three biological replicates. Average primer efficiencies for 
Diptericin, Drosomycin, and rp49 were 109%, 104% and 103%, respectively. 
 
Analysis of constitutive exon expression: I tested for a departure from even expression using 
chi-square (χ
2
) tests on the mean raw counts of exons 4 and 6 of unchallenged Drosophila to 
determine whether the frequency distribution of each exon variant was consistent with a 
random expression model (i.e. all exon variants are equally likely to be expressed; 
expectation calculated as 1/n variants at a given exon cluster). Exon 4-6 combinations in 
unchallenged Drosophila were tested for even expression using Fisher’s Exact Tests on raw 
count data for each unwounded treatment due to low counts for some combinations. 
Generalised linear mixed models using MCMCglmm (Hadfield 2009) were also 
implemented to reveal non-random constitutive expression by providing estimates of the 
proportion of variance explained by exons 4 and 6. See below for description of 
MCMCglmm package. All analyses were handled in R (R Development Core Team 2011). 
 
Analysis of infection-responsive Dscam splicing in Drosophila: I used three approaches to 
detect infection-responsive splicing in Drosophila. Firstly, indices of diversity were 
calculated from count data using the Simpson’s Index of Diversity (see Chapter 2, and also 
Simpson 1949), and I fitted a GLM to the diversity indices to test for effects of time and 
pathogen, or an interaction between both. 
 
I then used two complementary methods to examine Dscam expression in response to 
immune challenge. Firstly, to infer the effect of immune challenge on Dscam expression 




mixed models) R/Bioconductor package v2.16 (Hadfield 2009). MCMCglmm combines 
Markov chain Monte Carlo (MCMC) sampling methods with generalised linear mixed 
models (GLMMs). Generalised linear models (GLM’s) extend simple regression to allow for 
the response variable having a non-Gaussian distribution when modelling of a relationship 
between experimental variables (Guisan, Edwards et al. 2002), while generalised linear 
mixed models (GLMM’s) extend this again by allowing explanatory variables to contain 
random as well as fixed effects (Breslow and Clayton 1993). Markov chain Monte Carlo 
methods are algorithms which sample from different probability distributions and follow a 
Markov Chain; a random process considered to be memory-less because as it undergoes 
transitions from one state to another during simulations, its next state depends only on its 
current state, and not of the prior state (Hastings 1970). As such, MCMCglmm fits GLMM’s 
using MCMC methods to find sources of variation, then estimate the proportion of variance 
explained by each variable (e.g. estimate the proportion of total variance explained by 
random effects). 
 
I used MCMCglmm to infer the effect of wounding or parasite-exposure on Dscam 
expression patterns. Specifically, I tested for changes in Dscam expression between (1) 
Wolbachia-cleared unwounded and Wolbachia-cleared Ringers-wounded treatments (i.e. to 
investigate any tissue-damage effects on Dscam expression) and whether there was any 
interaction with time (i.e. at 6 or 30 hours), (2) different pathogen treatments compared to 
sterile-wounded treatments (i.e. to investigate any effects of pathogen-exposure) and whether 
there was any interaction with time, and (3) Ringers and DCV treatments in both Wolbachia-
positive and Wolbachia-cleared flies to test for differences in Dscam expression in response 
to DCV between the Wolbachia infection states. To test for effects of wounding, I fitted the 
following model to exon read counts: reads ~ time + wounding + primer-pair + exon 4 + 
exon 6 + exon 4-6 + exon 4: time + exon 4: wounding + exon 6: time + exon 6: wounding + 




exon 4-6: time: wounding. Time and wounding were treated as fixed effects and pathogen-
exposed and Wolbachia-positive treatments were excluded from this analysis. To test for 
effects of pathogen-exposure, I fitted the model: reads ~ time + pathogen + primer-pair + 
exon 4 + exon 6 + exon 4-6 + exon 4: time + exon 4: pathogen + exon 6: time + exon 6: 
pathogen + exon 4: time: pathogen + exon 6: time: pathogen + exon 4-6: time + exon 4-6: 
pathogen + exon 4-6: time: pathogen. Time and pathogen were treated as fixed effects and 
unwounded and Wolbachia-positive treatments were excluded from this analysis. To test for 
effects of DCV-exposure in treatments with and without Wolbachia-infection, I fitted the 
model: reads ~ DCV + primer-pair + exon 4 + exon 6 + exon 4-6 + exon 4: Wolbachia + 
exon 4: DCV + exon 6: Wolbachia + exon 6: DCV + exon 4: Wolbachia: DCV + exon 6: 
Wolbachia: DCV + exon 4-6: Wolbachia + exon 4-6: DCV + exon 4-6: Wolbachia: DCV. 
The pathogen was treated as a fixed effect and time and unwounded treatments were 
excluded from this analysis. Relative expression was normalised as cube-root of percentages 
(expressed as reads per million) to ensure normally distributed residuals (see appendix figure 
S4 for Q-Q plot of distribution before and after transformation). Two runs of 1,000,000 
MCMC iterations were completed for each model. Each run was sampled every 100 steps 
and the first 10% of iterations was discarded as burn-in. 
 
I also used the R/Bioconductor package DESeq (v1.8.1) to analyse the discrete count data 
assigned to Dscam exon variants across different libraries. Count data are skewed and hence 
not well approximated by continuous distributions, especially for small samples and in lower 
count ranges (Oshlack, Robinson et al. 2010). Accordingly, DESeq tests for differential 
expression and accounts for biological variability by use of the negative binomial 
distribution and a shrinkage estimator for the distribution's variance (Anders and Huber 
2010). DESeq also accounts for sampling variance (the variance in numbers of reads that 
persists even if everything is exactly equal), technical noise (introduced by sample 




(Anders and Huber 2010). DESeq is used to analyze count data associated with different 
genes. In this study, numbers of reads were assigned to Dscam transcripts for each treatment 
and gene variants were treated as equivalent to genes for the purposes of DESeq analysis. 
Within-library normalisation was then carried out to remove technical effects. Normalisation 
by sequencing-depth usually adjusts by the total number of reads in the library (i.e. library 
size-scaling) which is expected to account for differences in sequencing-depth between 
samples, but does not account for either RNA composition effects or that a small number of 
highly expressed variants can consume a significant amount of the total sequence and may 
distort the ratio of total reads (Anders and Huber 2010; Oshlack, Robinson et al. 2010). As 
such, scaling factors were estimated for each library to allow more confident quantification 
of expression levels of each variant relative to other variants in the sample. Here, the 
sequencing-depth is estimated by the count of the Dscam exon variant with the median count 
ratio across all variants. Counts are multiplied by scaling factors and scaled data are used for 
detecting differential expression. 
 
Here, using DESeq, I tested for differential expression at 6 and 30 hours between (1) 
unchallenged and sterile-wounded flies with and without Wolbachia infection to test for an 
effect of wounding on exon 4 and 6 variant-expression, (2) sterile-wounded and septic-
wounded treatments to test for an effect of pathogen-exposure on the expression of exon 4 
and 6 variants, (3) sterile-wounded and DCV-exposed flies either harbouring or cleared of 
Wolbachia bacteria to test for a difference in Dscam expression between the infection states, 
(4) unchallenged flies and septic-wounded flies to examine the difference between 
significantly different exposures, and (5) comparisons 1-4 above but testing the expression of 
exon 4-6 combinations. DESeq corrects for multiple testing using Benjamini-Hochberg’s 
FDR (Benjamini and Hochberg 1995), and here FDR was controlled at 5% (q = 0.05). All 





Contingency tests: Finally, the mean proportions of expression of exons 4 and 6 between the 
Illumina sequencing data and those of the cloning sequencing assay were analysed using the 
Fisher’s Exact Test. The aim here was to test for an association between the data of two 
independent sequencing methods on the same RNA samples. All tests were handled in R (R 
Development Core Team 2011). 
 
3.3. Results 
3.3.1. qRT-PCR was used to confirm immune responses had occurred in challenged 
flies 
Firstly, to confirm whether immune responses occurred in the flies used in this study, I 
carried out qRT-PCR assays to detect changes in expression levels of common immune 
markers associated with exposure to specific immune elicitors. Figure 2 shows the mean 
expression of immune marker genes relative to an endogenous control gene. 
 
I found levels of Diptericin highest in E.coli-exposed treatments, with notable increases also 
seen post-exposure to M. luteus at 6 hours post-injection (pi) and to PiGV at 30 hours pi 
(Fig. 2). No other strong effects on the expression of Diptericin were found. Thus, a 
relatively strong Diptericin response appeared to occur in flies exposed to E. coli, with 
smaller but notable effects on expression also seen post-exposure to M. luteus and PiGV. 
Rises in relative expression levels of Drosomycin were found in treatments exposed to the 
gram-positive bacterium M. luteus at 6 hours pi with a further increase at 30 hours pi (Fig. 
2). Moreover, relatively strong effects of E.coli-exposure were also seen on Drosomycin 
expression (Fig. 2). Thus, flies exposed to M. luteus and also E. coli appeared to induce 
strong Drosomycin responses against the challenges. Exposure of flies to B. bassiana did not 
appear to up-regulate Drosomycin. This could have been due to the injection of the fungus in 




treatments and the complementary oil controls were not included in subsequent statistical 
analyses. Vir-1 levels have been shown to increase in the presence of virus in Drosophila 
(Dostert, Jouanguy et al. 2005). Here, no convincing effects of DCV-exposure could be seen 
on the relative expression levels of Vir-1 (Fig. 2). PiGV also had little effect on the 
expression of vir-1 compared to non-viral immune challenges, but the virus had an 
unexpected effect on Drosomycin expression. This suggested some form of contamination 
may have been present. As a consequence PiGV treatments were also disregarded in 
subsequent statistical analyses. Thus, no convincing effects of viral-exposure were found in 
this study following qRT-PCR. 
 
Notably, sterile-wounding and DCV-exposure in Wolbachia-positive flies resulted in higher 
expression of all markers than in corresponding Wolbachia-cleared treatments. This 
suggested that the immune responses were stronger in Wolbachia-infected flies. 
Accordingly, this observation encouraged further analyses on DCV-challenged treatments of 






Figure 2: Mean expression levels of immune markers relative to those of ribosomal protein 49 (rp49). 
Levels of Diptericin (top) were highest in E. coli treatments with notable increases in expression also seen in 
response to M. luteus at 6 hours, and to PiGV at 30 hours. Drosomycin (middle) showed increases in 
expression levels in response to challenge at 6 hours post-exposure in most treatments and in all cases 
expression levels had further increased by 30 hours (except in oil controls). Up-regulation of Drosomycin 
followed exposure to both bacteria-types as expected (Lemaitre, Reichhart et al. 1997), however exposure to 
B. bassiana had little effect. Expression of Vir-1 (bottom) showed minimal up-regulation across treatments. 
Notably, sterile-wounding and DCV-exposure in Wolbachia-positive flies resulted in higher expression of all 
three markers than in Wolbachia-cleared flies. All values are expressed on a log base 2 scale. Error bars 
represent SE calculated from two biological replicates. Key: +: Wolbachia-positive, -: Wolbachia-cleared, 
Ring: Ringers, DCV: Drosophila C Virus, Oil: oil control, Bass: B. bassiana, PiGV: Plodia interpunctella 




3.3.2. Illumina sequencing assay output 
Data received from the sequencing facility had 13,326,557 read-pairs. After quality trimming 
(see Methods), I had 11,480,363 reads which were still available in pairs of reads at least 
50nt long. Sequences without a valid MID-tag or affected by mis-priming or template 
switching were then discarded and a total of 8,983,816 reads remained and were attributable 
to exons 4 and 6, and combinations thereof. The mean number of high quality reads from 
each PCR primer-pair was 187,162 (sequencing-depth ranged from 59,373 to 295,885). 
 
3.3.3. Detecting differences in constitutive exon variant expression, detecting novel 
exon variants, and identifying unexpressed exons 
I used Pearson’s chi-square and MCMCglmm analyses to test for uneven expression of 
exons 4 and 6 in different tissues of unchallenged flies. I found significant differences in the 
relative expression between variants of both exons 4 (χ
2
 = 29147.1, DF = 11, p = <0.0001) 
and 6 (χ
2
 = 39209.5, DF = 47, p = <0.0001) across all unwounded treatments (Figure 3, see 
left columns). Using MCMCglmm, I found significant effects of exon 4- and exon 6-
expression (Table 1), indicating non-random expression of both exons. Thus, variants of 
exons 4 and 6 appear to be expressed in a non-random fashion in Drosophila. 
 
Exon 4.2 was by far the most abundant exon 4 variant expressed (Fig. 3), and exon 4.9 was 
the least abundant exon 4 variant. Furthermore, exons 4.4, 4.10 and 4.11 were under-
represented compared to expected levels (in a random distribution, i.e. 1/number of 
alternative variants at a given exon) in unwounded flies (Fig. 3). For exon 6, variant 6.25 
was the most abundant exon 6 variant (Fig. 3). Several exon 6 variants were over-
represented compared to expected levels in unwounded flies, while others were under-





Figure 3: Bar chart representing relative expression between different variants of exons 4 and 6 in 
unchallenged D. melanogaster compared to expression in flies challenged with E. coli. (A) Exon 4 variant 
expression (top) in unwounded Wolbachia-cleared treatments (see left bars) shows significant differences 
between the relative expression of individual variants (χ2 = 29147.1, DF = 11, p = <0.0001). Exon 4.2 is the 
most abundant variant in unchallenged adult flies, while exon 4.9 is the least abundant. Similarly, exon 6 
gene variant expression showed significant non-random expression (χ2 = 39209.5, DF = 47, p = <0.0001). 
Exon 6.25 was the most abundantly expressed exon 6 variant, while exon 6.39 was the least abundant. Exon 
6.11 was entirely absent. Expected proportion is shown as a horizontal line and based on a random expression 
of all variants equally (i.e. even expression = 1/number of variants at a given exon cluster). (B) Gene variant 
expression was also compared between E. coli-challenged flies (right bars) and unwounded flies (left bars). 
No statistically significant differences in the expression of any exon 4 variant (top) (DESeq, q-values ≥ 0.44), 
or any exon 6 variant (bottom) (q-values ≥ 0.52) was found between the treatments. All bars represent 
expression at 6 hours. Error bars for unwounded treatments are standard deviation (n=4), and error bars for E. 




Notably, exon-skipping was detected in unchallenged flies. Exon 6-skipping was detected at 
a frequency of 1.3x10
-3
. Exon 4-skipping was not expected as the 5’ primer nested in 
constitutive exon 3 overlapped variable exon 4 by one base. Nevertheless, a low frequency 
of exon 4-skipping was detected. 
 
To investigate whether our sequencing assay could detect novel exon variants, sequences in 
the data set were compared to those of the reference genome for D. melanogaster. 
Alternative alleles not represented in the reference genome were detected. Two allelic 
variations of exon 6.12 were found, containing one Single Nucleotide Polymorphism (SNP), 
and two allelic variations of exon 6.39 were found, which also differed from the reference 
genome at one base. In contrast, no allelic variations of exon 4 were detected. Overall, all 
possible exon 4 variants were expressed in all treatments in this study, while all exon 6 
variants were also detected with the exception of exon 6.11 which was entirely absent. 
 
3.3.4. Detecting constitutive combinatorial splicing in unwounded Drosophila and 
determining whether splicing is random or non-random 
I next tested whether the assay could detect combinatorial splicing in unchallenged flies and 
determine whether splicing is random or non-random in the absence of wounding or 
parasites. Figure 4 shows a heat map of relative expression levels of all possible exon 4-6 
combinations and visual inspection suggested that the splicing of these two exons is close to 
random (i.e. conditional on the frequency of each exon 4 and 6 variant independently). For 
example, as would be expected from random alternative splicing, exon-exon combinations 
containing variants 4.2 and 6.25 were the most highly abundant as these were the most 
abundant variants for each exon cluster independently (expected frequency was 0.184 x 
0.058 = 0.011, actual frequency was 0.011), and represented just over 1% of all reads (Fig. 
4). The least abundant exon 4 and 6 variants, 4.9 and 6.39 respectively, were also the least 




0.0001% of all reads (Fig. 4). Additionally, the frequency of expression of combination 4.1-
6.1 was expected based on independent frequencies of exons 4.1 and 6.1 (expected = 0.09 x 
0.025 = 0.002, actual = 0.002). However, some combinations appeared to show non-random 
splicing. Based on the independent frequencies of exons 4.4 and 6.31 for example, the 
expected frequency of this combination would be around 0.0009 (0.050 x 0.017), but the 
actual frequency was 0.0014, or nearly 60% higher than expected (Fig. 4). Additionally, the 
independent frequencies of 4.10 and 6.9 would suggest the two gene variants would combine 
at a frequency of 0.0016 (0.061 x 0.026), however the actual frequency was 0.0010, or 
around 60% lower than expected (Fig. 4). Following analysis with MCMCglmm, I found a 
small exon 4-6 combination effect (Table 1), indicating that a small number of combinations 
were non-randomly expressed. Thus, exon 4-6 combinatorial splicing appeared to be close to 
random in unwounded flies, however some combinations appeared to be expressed in a non-
random fashion. 
 
Overall, all possible exon 4-6 combinations were detected with the exception of those 
necessitating exon 6.11, resulting in a total of 564 exon 4-6 combinations expressed. Thus, 
high Dscam transcript diversity was present in unwounded flies which demonstrated a non-






Figure 4: Heat map representation of the relative expression of all possible exon 4-6 combinations in 
unwounded D. melanogaster. Combinatorial splicing appeared to be close to random. The most abundant 
combination was 4.2-6.25, which represented just over 1% of all sequencing reads obtained, and was 
expressed at an expected frequency based on independent frequencies of variants 4.2 and 6.25. Some 
combinations appeared to show non-random association however. For example, combination 4.4-6.31 was 
expressed around 60% higher than expected, and combination 4.10-6.9 was represented around 60% lower 
than expected. Indeed, Fisher’s Exact Tests carried out on the raw data counts of each exon combination 
found deviation from even expression in all unwounded treatments in the study (all, p = < 0.0001). Each cell 
represents the proportion of an exon 4-6 combination, calculated as the mean of biological replicates of 




3.3.5. Testing for differential Dscam expression in response to a wide array of 
immune elicitors in flies with or without Wolbachia infection 
Firstly, in line with the analysis carried out in Chapter 2, indices of diversity were calculated 
for exon 4, exon 6, and exon 4-6 combinations for each treatment in the study. As expected, 
all indices were high due to the high diversity of Dscam isoform expression (see Table S4). I 
fitted a GLM to expression diversity data as: Simpson’s Index of Diversity (1-D) ~ time + 
pathogen + time*pathogen. For exon 4 expression-diversity, I found no significant effects of 
time (F1,33 = 2.58, p = 0.122), pathogen (F10,33 = 1.91, p = 0.098), or an interaction between 
both (F2,32 = 0.85, p = 0.588). Equally, no significant effects were found for exon 6 (time: 
F1,33 = 1.92, p = 0.180; pathogen: F10,33 = 0.66, p = 0.748; interaction: F2,32 = 1.25, p = 0.314), 
or exon 4-6 combinations (time: F1,33 = 1.20, p = 0.285; pathogen: F10,33 = 1.68, p = 0.148; 
interaction: F2,32 = 0.85, p = 0.589). Thus, expression diversity was not significantly affected 
by pathogen-exposure at either 6 or 30 hours. 
 
Using MCMCglmm, I fitted models to the count data to test for an interaction between 
Dscam expression and experimental conditions. I firstly tested for effects of wounding. 
Table 1 outlines the analysis output which represents the variance structure (i.e. the 
proportions of variance explained by each of the variables in the model). The model mixed 
well (i.e. the model explored parameter space efficiently and effectively) and the average 
effective sample size was around 9000 (see appendix, figure S5). I found that a considerable 
proportion of the total variance was explained by exon 4 and by exon 6, with a relatively 
smaller proportion explained by exon 4-6 combination expression (Table 1). Otherwise, 
contributions to total variance were very low for all terms in the model and lower credibility 
bounds were very close to zero. Thus, non-random expression of exons 4 and 6 was detected 





Table 1: Variance structure summarising MCMCglmm analysis of a model testing for effects of 
wounding and time on Dscam expression. The variance components are of random effects. Key: RE 
= relative expression; cub_PC = cube-root of percentage; C.I. [L/U] = Lower/Upper highest posterior 









C.I. [L/U]1 % Total 
Variance2 
Primer-pair 0.031 0.015 0.012 [0, 0.10] 0.1 
Exon 4 11.919 10.230 7.758 [3.48, 24.10] 56.9 
Exon 6 6.053 5.871 5.180 [3.81, 8.74] 28.9 
Exon 4-6 0.129 0.129 0.129 [0.07, 0.20] 0.6 
Exon 4: Time 0.050 0.036 0.001 [0, 0.14] 0.2 
Exon 4: 
Wounding 
0.077 0.059 0.001 [0, 0.20] 0.4 
Exon 6: Time 0.013 0.009 0.0002 [0, 0.04] 0.1 
Exon 6: 
Wounding 
0.012 0.006 0.0002 [0, 0.04] 0.1 
Exon 4: Time: 
Wounding 
0.052 0.046 0.0280 [0, 0.12] 0.2 
Exon 6: Time: 
Wounding 
0.032 0.030 0.0002 [0, 0.07] 0.2 
Exon 4-6: 
Wounding 
0.013 0.007 0.0001 [0, 0.05] 0.1 
Exon 4-6: 
Time 




0.012 0.005 0.00008 [0, 0.04] 0.1 
Residuals 2.559 2.558 2.551 [2.44, 2.68] 12.2 
1 Credibility intervals less than 10-3 are rounded to zero. 
2 Percentage of the total variance explained by random effects in the model. 
  
I next tested for effects of pathogen. Table 2 outlines the analysis output representing the 
variance structure for the model. The model mixed well and the average effective sample 
size was around 9000 (see appendix, figure S6). In addition to the variance explained by the 
non-random expression of exons 4 and 6, I found a very small exon 4-by-time-by-pathogen 
effect, which contributed 0.5% to the total variance explained by random effects in the 
model and the lower credibility bound did not reach zero (Table 2). Otherwise, I found no 
discernible effects of pathogen-exposure on the expression of exons 4 and 6, or their 






Table 2: Variance structure summarising MCMCglmm analysis of a model testing for effects of 
pathogen-exposure and time on Dscam expression. The variance components are of random 
effects. Key: RE = relative expression; cub_PC = cube-root of percentage; C.I. [L/U] = Lower/Upper 









C.I. [L/U]1 % Total 
Variance2 
Primer-pair 0.014 0.012 0.007 [0, 0.03] 0.1 
Ex4 15.857 13.928 11.398 [5.59, 31.65] 64.5 
Ex6 6.168 6.002 5.424 [3.80, 8.85] 25.1 
Exon 4-6 0.186 0.186 0.187 [0.15, 0.23] 0.8 
Ex4: Time 0.012 0.005 0.0005 [0, 0.05] 0.0 
Ex4: Pathogen 0.034 0.028 0.0004 [0, 0.09] 0.1 
Ex6: Time 0.002 0.001 0.00002 [0, 0.01] 0.0 
Ex6: Pathogen 0.009 0.008 0.00007 [0, 0.02] 0.0 
Ex4: Time: 
Pathogen 
0.117 0.115 0.113 [0.06, 0.17] 0.5 
Ex6: Time: 
Pathogen 
0.008 0.006 0.0001 [0, 0.02] 0.0 
Exon 4-6: 
Pathogen 
0.005 0.002 0.00004 [0, 0.02] 0.0 
Exon 4-6: 
Time 




0.003 0.002 0.00005 [0, 0.01] 0.0 
Residuals 2.161 2.161 2.159 [2.10, 2.23] 8.8 
1 Credibility intervals less than 10-3 are rounded to zero. 
2 Percentage of the total variance explained by random effects in the model. 
 
Lastly, I tested for effects of DCV-exposure in treatments with and without Wolbachia-
infection. Table 3 outlines the analysis output representing the variance structure for the 
model. The model mixed well and the average effective sample size was around 5000 (see 
appendix, figure S7). Here, a very small exon 4-by-Wolbachia-by-DCV effect was found 
which explained around 0.2% of the total variance. In addition, a similarly sized proportion 
of the total variance was unexpectedly explained by primer-pair (Table 3). The lower 
credibility bounds of these effects did not reach zero but were very low. Otherwise, there 







Table 3: Variance structure summarising MCMCglmm analysis of a model testing for effects of 
DCV-exposure on Dscam expression in Wolbachia-positive and Wolbachia-cleared treatments. 
The variance components are of random effects. Key: RE = relative expression; cub_PC = cube-root 









C.I. [L/U]1 % Total 
Variance2 
Primer-pair 0.007 0.006 0.005 [0.002, 0.014] 0.2 
Ex4 3.166 2.827 2.349 [1.134, 6.039] 77.4 
Ex6 0.652 0.632 0.610 [0.400, 0.943] 16.0 





0.004 0.003 0.0001 [0, 0.012] 0.1 
Ex4: DCV
3
 0.003 0.002 0.00002 [0, 0.010] 0.1 
Ex6: 
Wolbachia 
0.0003 0.0002 0.00001 [0, 0.001] 0.0 








0.0003 0.0001 0.000002 [0, 0.001] 0.0 
Exon 4-6: DCV 0.001 0.0008 0.00002 [0, 0.004] 0.0 
Exon 4-6: 
Wolbachia 




0.0007 0.0004 0.00001 [0, 0.002] 0.0 
Residuals 0.244 0.244 0.244 [0.237, 0.251] 6.0 
1 Credibility intervals less than 10-3 are rounded to zero. 
2 Percentage of the total variance explained by random effects in the model. 
3 Wolbachia (yes/ no), DCV (yes/ no). 
 
I also used DESeq and MCMCglmm to test the number of reads for each Dscam exon 
variant for being differential between treatments. Figure 5 shows heat maps representative of 
exon 4- and exon 6-expression for all treatments in the study. Strong patterns were seen for 
exon variants across all treatments for both exons 4 and 6 (Fig. 5; columns), however visual 
inspection suggested that no patterns were obvious between different pathogens or pathogen 






Figure 5: Heat map representation of relative expression of exon 4 (left block) and exon 6 (right block) 
variants for all treatments in this study. Patterns of expression for individual variants of both exons 4 and 6 
across treatments were evident. For example, exon 4.2 was clearly the most abundantly expressed exon 4 
variant across all treatments, while exon 4.9 was the least abundant exon 4 variant across all treatments. For 
exon 6, exon 6.25 was expressed higher than any other across all treatments, with 6.39 showing the lowest 
relative expression levels across treatments. No discernible patterns were obvious between treatments. Exon 
6.11 was not detected and hence not included. The inclusion of exon 5 indicates relative abundance of exon-
skipping for each exon cluster. Each time point (6h, 30h) includes 2 biological replicates, and each cell 
represents the proportional expression of a given exon variant in a single sample. Dendrograms result from 
hierarchical clustering of exon variant-expression pattern using Euclidean distance measures. Key: 
Wolbachia Positive: flies harbouring Wolbachia, Wolbachia Negative: flies cleared of Wolbachia, UNW: 
Unwounded, CO2: carbon dioxide anaesthetised, Ring: Ringers solution, Oil: oil control, Fungus: B. 





Using DESeq, I found no evidence of differential expression between any pairwise 
comparisons, except that exons 4.2 and 4.9 were significantly lower in Wolbachia-infected 
flies at 30 hours following sterile-wounding (both q-values = 0.04), and exon 4.9 was 
significantly lower in Wolbachia-cleared flies following M. luteus-exposure at 6 hours (q = 
0.02). Consistent with DESeq, analysis with MCMCglmm detected a significant exon 4.9-
effect at 6 hours following M. luteus-exposure in Wolbachia-cleared flies (p = 0.0001). I also 
compared the relative expression of exons 4 and 6 between unwounded treatments and 
septic-wounded treatments exposed to E. coli (Fig. 3, see both columns). E. coli was the 
immune elicitor which resulted in the most significant up-regulation of its immune marker as 
confirmed from the qRT-PCR results (Fig. 2). After DESeq analysis, no differences in the 
relative expression levels of any exon 4 or 6 variants between unwounded and E. coli-
challenged treatments at 6 hours (exon 4: all q-values ≥ 0.44; exon 6: all q-values ≥ 0.52) or 
30 hours (exon 4: all q-values ≥ 0.76; exon 6: all q-values ≥ 0.96) were detected. Thus, no 
differential exon 4- or 6-expression was detected in this study using DESeq except exons 4.2 
and 4.9, which were significantly lower in Ringers-wounded Wolbachia-infected flies at 30 
hours, and exon 4.9, which was significantly lower in flies exposed to M. luteus at 6 hours 
compared to sterile-wounded flies. Following MCMCglmm analysis, an effect of M. luteus 
at 6 hours was seen on exon 4.9 in Wolbachia-cleared flies was seen, however, no other 
significant effects were revealed. 
 
Finally, I tested if patterns of expression of exon 4-6 combinations were apparent between 
treatments. Figure 6 shows a heat map of the relative expression of exon 4-6 combinations of 






Figure 6: Heat map representation of relative expression of exon 4-6 combinations of which each 
represented a minimum abundance of 0.5% in at least one treatment in this study. Patterns of 
expression for exon 4-6 combinations across treatments were evident. For example, transcripts containing the 
combination 4.2-6.25 were the most abundantly expressed in most samples across all treatments. No patterns 
were obvious between treatments. Each time point included 2 biological replicates, and each cell represents 
the proportional expression of a given combination in a single sample. Dendrograms result from hierarchical 
clustering of exon combination-expression pattern using Euclidean distance measures. Key: Wolbachia 
Positive: flies harbouring Wolbachia, Wolbachia Negative: flies cleared of Wolbachia, UNW: Unwounded, 
CO2: carbon dioxide anaesthetised, Ring: Ringers solution, Oil: oil control, Fungus: B. bassiana, Virus: DCV 




As with individual exons, visual inspection suggested that patterns were evident across 
treatments. For example, transcripts containing the combination 4.2-6.25 were the most 
abundantly expressed in most samples across treatments. However, no patterns of expression 
were apparent between treatments. After applying the same methods of analysis as for 
individual exons (see above), no significant differences of expression of exon 4-6 
combinations between any treatments in this study were detected. Thus, visual inspection of 
relative expression and analysis with DESeq and MCMCglmm revealed no effects of 
challenge between treatments. 
 
3.3.6. Comparing the data with an independent cloning and sequencing assay 
The study also included duplicated treatments where Illumina sequencing was carried out on 
a small number of samples from separate PCR reactions of the same cDNA samples. These 
duplicated treatments also showed dissimilar patterns of exon variant expression (not 
shown). Therefore, to investigate the reliability of the assay, I also carried out a separate 
cloning and sequencing assay to determine whether the results were comparable. I selected 
two treatments which showed the most contrasting differences in expression. As such, I 
cloned and sequenced 100 cDNAs for a DCV treatment and 100 cDNAs for a PiGV 
treatment. Figure 7 shows bar charts of the proportions of exon 4 and 6 variants for both 







Figure 7: Bar chart representation comparing proportions of exon 4 and 6 variant 
expression between Illumina sequencing results and cloning and sequencing assay results in 
a DCV treatment and a PiGV treatment. Mixed results showed no difference between methods 
for exon 4-expression in the DCV treatment (Fisher’s Exact Test, p = 0.298), whereas exon 6 in 
the DCV treatment showed a significant difference between assays (p = 0.007) possibly driven 
largely by the higher detected expression of exon 6.22 in the cloning and sequencing assay. 
Opposite results were seen for PiGV. Exon 6-expression showed no difference between assays (p 
= 0.145), however exon 4-expression was significantly different between the methods (p = 0.012), 






The results showed no difference in exon 4-expression in the DCV treatment between the 
two methods (Fisher’s Exact Test, p-value = 0.298), however exon 6-expression in the DCV 
treatment showed a statistically significant difference between the methods (p = 0.007). 
Opposite results were seen for PiGV. The proportion of exon 4 variants expressed between 
the two assays appeared to be different (p = 0.012), while no differences were seen in exon 
6-expression in the PiGV treatment (p = 0.145). 
 
3.3.7. qRT-PCR confirmed harvest time-points were appropriate 
To investigate whether I chose appropriate time-points to harvest flies, I carried out a 
separate qRT-PCR experiment infecting flies with different types of bacteria and found up-
regulation of classical immune markers Drosomycin and Diptericin at 6 hours post-exposure 
to M. luteus and E. coli, respectively (see appendix, figure S8). More specifically, levels of 
Diptericin had peaked between 4-8 hours after exposure to E. coli and had dropped to pre-
exposure levels between 24-48 hours (Fig. S8). Drosomycin levels in response to M. luteus 
increased steadily from the time of exposure throughout the time-course and levels remained 
up-regulated after 30 hours, peaking around 48 hours (Fig. S8). These data indicated that the 





3.4.1. Discerning and quantifying constitutive Dscam expression in Drosophila 
Here, the Illumina-based sequencing assay provided millions of reads of which were 
assigned to many Dscam exon variants across different treatments in this study. The method 




particular, it discerned and quantified non-random expression of both exons 4 and 6 in 
unchallenged D. melanogaster (Fig. 3). For example, chi-square analysis confirmed that 
expression of individual exon variants strongly deviated from even expression, and 
MCMCglmm analysis showed that much of the variance in each of the implemented models 
was explained by expression of exons 4 and 6 (see Tables 1 and 2). Thus, the data 
demonstrated that exon variant choice in Drosophila is non-random. 
 
The method was also able to detect the combinatorial splicing of exons 4 and 6 in 
Drosophila. The data suggests that most exon 4-6 combinations are expressed randomly 
(Fig. 4). However, some combinations seemed to be expressed in a non-random fashion. In 
other words, individual variants were combining at frequencies other than those expected as 
estimated from their individual frequencies. Examination of individual replicates showed 
similarities between exon-exon combination-expression suggesting that any effects 
introduced by technical variation or PCR-based stochasticity were minimal. These 
phenomena are discussed further below. 
 
Two allelic variations of exons 6.12 and 6.39 were discovered, both different at one base 
each, and the DNA sequence variations could be the result of SNPs. No allelic variation was 
detected for exon 4, possibly indicative of different selective pressures acting upon each 
exon cluster (see Chapter 1: General Introduction). Thus, the deep sequencing assay used in 
this study was effective in detecting allelic variation between alternatively spliced exon 
variants of Dscam and appears to have discovered non-classical alleles which would not 
have been detected using some other commonly used methods (see Introduction). The 
method is also capable of detecting novel exons. 
 
Exon 4- and 6-skipping was also detected in this study. It is thought that missed exons 




al. 2009), and as such, may represent failure of the splicing machinery or could be part of 
some regulatory mechanism. Here, the frequency of exon 6-skipping appeared to occur more 
than exon 4-skipping by over two orders of magnitude. However, as the forward primers 
used here were seated in conserved exon 3 and overlapped variable exon 4 by one base, a 
true estimate of exon 4-skipping-frequency was not possible. Thus, I found that both exon 4- 
and exon 6-skipping occurs in Drosophila, but the frequency of exon-skipping could not be 
directly compared between the exons. 
 
Lastly, exon 6.11 was entirely absent, an observation seen in earlier studies (Schmucker, 
Clemens et al. 2000; Hummel, Vasconcelos et al. 2003; Neves, Zucker et al. 2004; Watson, 
Puttmann-Holgado et al. 2005). The reason for the absence of expression of exon 6.11 
remains unknown but lack of necessary complementarity between the docking site and 
selector sequence may result in expression failure (see Graveley 2005). Future genomic 
analysis of Dscam may help explain why exon 6.11 is the only exon 6 variant that is not 
expressed in D. melanogaster. 
 
3.4.2. Dscam expression in response to wounding or pathogens 
As pathogen-specific effects on Dscam expression may have been too subtle for cloning and 
sequencing to detect (see Chapter 2), a more powerful method was required. However, the 
Illumina-based sequencing assay did not detect any definitive effects of treatment on the 
expression of exon 4, exon 6, or exon 4-6 combinations in whole adult Drosophila. Initial 
visual inspection suggested that pathogen-induced effects, should they exist, must be small 
or difficult to detect (see figures 5 and 6). 
 
I found only weak evidence of wounding effects on the expression of Dscam in Drosophila. 
Specifically, only DESeq analysis detected differential expression of some exon 4 variants in 




be significantly lower in flies receiving sterile-wounding harvested at 30 hours. This was not 
seen in Wolbachia-cleared flies. However, given that Wolbachia-infection is highly 
prevalent in most populations of D. melanogaster (Verspoor and Haddrill 2011), and that 
absence of Wolbachia appears to be the less natural state and may affect the efficiency of the 
immune response (Fig. 2), differences between the treatments are not necessarily 
unexpected. Thus, the very small but detectable effect of wounding on Dscam expression in 
Drosophila could be real. However, the results of different and complementary analyses 
were not consistent. 
 
Pathogen-exposure has been shown to affect Dscam splicing in Anopheles (Dong, Taylor et 
al. 2006) and Pacifastacus (Watthanasurorot, Jiravanichpaisal et al. 2011). Here, indices of 
expression diversity were no different between sterile-wounded or bacteria-challenged 
treatments. However, both DESeq and MCMCglmm analysis detected differential expression 
of exon 4.9 between sterile-wounded and M. luteus-exposed flies at 6 hours, suggesting this 
exon may play a part in the immune response to the bacterium. Thus, various statistical 
analyses of Dscam expression in Drosophila found only weak evidence of pathogen-specific 
responding of exon 4, and no evidence of pathogen-specific responding of exon 6. 
 
The pathogen-specific expression of Dscam reported in previous studies was only weakly 
supported here in Drosophila. Albeit comparing very different host organisms, this 
phenomenon could have been expected in Drosophila Dscam based on its implicated role in 
phagocytosis and the hyper-diversity of isoforms discovered in the fly’s immune cells 
(Watson, Puttmann-Holgado et al. 2005). However, no strong effects were detected. It is 
possible the assay did not work very well, resulting in a failure to detect strong effects of 
treatment on Dscam expression. For instance, stoichiometry of the PCR could have resulted 
in random errors in amplification in early cycles being propagated in subsequent cycles. This 




excess amounts of PCR reagents. The template DNA in this case also comprises of highly 
diverse, and subsequently very rare expressed Dscam exon transcripts, and PCR stochasticity 
in early rounds may make it very difficult to obtain accurate estimates of their relative 
abundances. Also spurious targets which are not the preferred targets can be amplified in the 
early stages of PCR, and the amplification of these extraneous products continues 
exponentially (Ruano, Brash et al. 1991). Furthermore, primer targets with identical 
annealing sites but with slightly different fragment lengths and base compositions could have 
been impaired by thermodynamic or kinetic effects which may render one variant a preferred 
template over another (Ruano, Brash et al. 1991). Effects which reside at the level of RNA 
extraction and/or cDNA synthesis cannot be excluded either. 
 
Appropriately, the mixed results from the cloning and sequencing assay (Fig. 7) encouraged 
the comparison between the Illumina sequencing results of this study with the expression 
data obtained from a past microarray analysis of Dscam (see Neves, Zucker et al. 2004). The 
microarray study was carried out on the same line of D. melanogaster as the present study, 
and fly-aging and conditions were comparable between the experiments. Mean proportions 
of expression of exon 4 and 6 variants of both studies was subjected to correlation and 
dependence testing. As such, Pearson’s correlation coefficients were calculated for exons 4 
and 6. Figure 8 compares the relative expression of exon 4 and exon 6 variants between the 
Illumina-based sequencing assay of the present study and a microarray analysis of Dscam in 





I found a positive association between the results of these studies (Pearson’s correlation 
coefficient: exon 4, r = 0.79, exon 6, r = 0.77). Thus, similarities between the Illumina 
sequencing data and those of an independent microarray study were encouraging. While 
some differences were present, these are to be expected as they were totally independent 
experiments using different insects and carried out by different people using two completely 
dissimilar methods. Indeed, differences could be attributed to the fact that sequencing offers 
much higher sensitivity and dynamic range, and compared to microarray assays, suffers from 
lower technical variation (Oshlack, Robinson et al. 2010). Interestingly, I noticed that the 
 
Figure 8: Scatter plot representations of relative expression levels of exons 4 (top) and 6 
(bottom) between the Illumina-based sequencing results of this study and data from an 
independent microarray study (Neves, Zucker et al. 2004). Pearson’s correlation coefficients 
were calculated for each exon using their mean relative proportions (exon 4, r = 0.79, exon 6, r = 




only two exons which were discovered to have allelic variation in the data set of the present 
study (exons 6.12 and 6.39, see above), also showed notable higher relative expression levels 
in the independent microarray study (Fig. 8). Results could differ between the methods due 
to the presence of SNPs, or if the microarrays did not match the reference genome. With 
regard to the cloning and sequencing results (Fig. 7), it was possible that not enough 
observations were taken, subsequently making it difficult to directly compare with high-
throughput sequencing data. Nevertheless, while some data did not correlate well between 
the sequencing assays, some data correlated strongly. Thus, the comparison of the Illumina-
based sequencing data with those of the independent cloning and sequencing assay and the 
independent microarray study lead me to propose that the method was not significantly 
compromised by stoichiometric effects of early-round PCR, and that the high-throughput 
sequencing assay used here was reliable and could be adopted for future study of Dscam 
gene expression. Nevertheless, the pooling of several independent PCRs for each treatment 
in future comparable studies may help reduce the likelihood of spurious amplification. 
 
It is also possible that the diversity of such an exceptionally diverse splicing gene is too high 
to detect effects of pathogen-exposure on Dscam expression in Drosophila even at this depth 
of coverage. This may also have been a consequence of having many (~25) whole flies in 
each treatment. High levels of Dscam present in the insect’s nervous system may contribute 
too much noise for a much smaller pathogen-effect to be detected should it exist. The 
solution to this may be the separation and comparison of tissues (e.g. heads, haemolymph 
and rest of body) to minimise the contribution of nervous-system Dscam. Investigation of 
tissue-specific Dscam expression may help detect and focus upon any pathogen-effects on 
Dscam splicing should they occur, as well as offer more insight into gene variant abundance 





Furthermore, pathogen-specific splicing of Dscam may simply not happen in Drosophila, or 
indeed pathogen-specific splicing in response to the challenges used in this study may not 
occur in Drosophila. In this study, the use of natural pathogens had no detectable effects of 
challenge on the expression of Dscam. However, the data from the qRT-PCR assays for both 
DCV and B. bassiana were unconvincing (Fig. 2). Therefore, that no effect on Dscam 
expression was detected for these pathogen-exposures may be due to the failure in induce a 
sufficient corresponding immune response in the flies. E. coli in particular produced more 
convincing effects of exposure (namely, highly increased levels of Diptericin, see figure 2) 
and although it is not a natural pathogen of Drosophila, it has been previously shown that 
recombinant Dscam isoforms may bind specifically to E. coli in the fly (Watson, Puttmann-
Holgado et al. 2005). Furthermore, E. coli has been reported to induce pathogen-specific 
effects on Dscam expression in other species (Dong, Taylor et al. 2006; Watthanasurorot, 
Jiravanichpaisal et al. 2011). Therefore, a pathogen-specific Drosophila Dscam response to 
E. coli could have been expected. 
 
Finally, in my previous work on Anopheles Dscam in Chapter 2, I found a statistically 
significant difference in expression diversity between unexposed and exposed treatments. 
Although it was the combined diversity of exons 4 and 6 that drove the pattern, the 
relationship between exon 4 expression-diversity and parasite diversity was close to 
significant in two independent experiments (field, p = 0.081; lab, p = 0.087). Thus, 
observations from two completely independent studies in Anopheles, and another here in 
Drosophila using three different methods of analysis, suggest that an exon 4-by-exposure 
effect in Anopheles and an exon 4-by-exposure effect in Drosophila could be real. It is 
interesting that any effects of Dscam expression detected, however small, are always 







In the present study, I found no supporting evidence of a strong effect of treatment on the 
expression of exon 4, exon 6, or exon 4-6 combinations in whole adult Drosophila. 
However, results from this study and those of Chapter 2 suggest that immune-challenge may 
have a small effect on Dscam exon 4-splicing. As such, a natural next step in the study of 
Dscam expression would be to investigate the tissue-specific expression of exon variants in 





Chapter 4: Tissue-specific Dscam 
gene expression in response to 
gram-negative and gram-positive 
immune elicitors  
 
This chapter was written with comments from Darren Obbard and Tom Little. Statistical 
analyses were done in collaboration with Darren Obbard. The quality trimming, counting 
and sorting of raw Illumina sequencing reads was done using a custom R pipeline written by 
Darren Obbard. Illumina library construction, sequencing and base-calling were performed 




















The Dscam locus contains many different versions of exons which code for variable regions 
of three extracellular immunoglobulin domains of the Dscam axon guidance receptor 
(Schmucker, Clemens et al. 2000) (see Chapter 1, General Introduction). Mutually exclusive 
alternative splicing of these exon variants provides high functional diversity which is 
essential for the development of the nervous system in Drosophila (Schmucker, Clemens et 
al. 2000; Chen, Kondo et al. 2006; Hattori, Millard et al. 2008). Dscam has also been 
implicated in pathogen-response in several species and may play an important part in the 
phagocytosis of pathogens after infection (Watson, Puttmann-Holgado et al. 2005; Dong, 
Taylor et al. 2006; Watthanasurorot, Jiravanichpaisal et al. 2011). For instance, RNAi-
knockdown of Dscam in both Drosophila and Anopheles results in a significantly reduced 
phagocytic capacity (Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006). 
Phagocytosis in insects is carried out by haemocytes, circulating cells in the haemolymph 
(Meister 2004), and a high diversity of Dscam isoform-expression has been found in 
Drosophila haemocytes in addition to the nervous system, indicating an importance of 
Dscam expression in different tissues (Watson, Puttmann-Holgado et al. 2005). 
 
Dscam splicing appears to be spatially regulated. For example, by comparing exon 4-
expression in different tissues (antennae, heads, wings and legs) of Drosophila, Celotto and 
Graveley (2001) found that the relative frequency of exon 4.2-usage was significantly higher 
in legs and wings than in heads or antennae. Independently, using custom-made oligo-arrays 
with probes for all alternatively spliced exons, Watson et al (2005) demonstrated that 
variants of both exons 6 and 9 showed restricted usage in haemocytes and the fat body 
compared to brain tissue, while exon 4 variants were expressed in all tissue types with 
moderate to high expression. Furthermore, microarray analysis of Dscam expression 




expression of exons 4 and 6, but a broad yet distinctive spectrum of isoforms were expressed 
between the tissue types due to diverse exon 9-inclusion (Neves, Zucker et al. 2004). Dscam 
may be regulated in a tissue-specific manner to enable neurons in different tissues to express 
different suites of Dscam receptors in order to direct their axons and dendrites to specific 
‘addresses’ (Celotto and Graveley 2001). 
 
Tissue-specific expression of Dscam variants has also been discovered in other species. In 
the crustacean, Daphnia, fewer variants of all variable exons encoding extracellular domains 
are expressed in haemocytes than in brain tissue (Brites, McTaggart et al. 2008). Moreover, 
some exon-exon combinations in Daphnia are ‘preferred’ in the brain compared with the 
haemocytes (Brites, McTaggart et al. 2008). Finally, tissue-specific expression of Dscam 
mRNA has been reported in the shrimp, Litopenaeus vannamei. Here, Dscam transcripts 
were highly expressed in heart and lymphoid tissue, in lower abundance in intestinal tissue 
and haemocytes, and not detected at all in the stomach or hepatopancreas (Chou, Chang et al. 
2009). 
 
In Chapter 3 I used Illumina sequencing technology to investigate Dscam gene expression in 
whole adult Drosophila exposed to multiple pathogen-types. However, it is possible that 
Dscam expression in the nervous system of Drosophila may have obscured smaller 
pathogen-effects on the expression of Dscam exon variants. Here, I recorded the expression 
of exons 4 and 6, and combinations thereof, in different tissues (head, hemolymph, and the 
remainder of the body including legs and wings, hereafter ‘body’) in adult Drosophila 
exposed to different immune elicitors. Separation of heads was chosen to isolate as much as 
possible the contribution of nervous system expression of Dscam from the rest of the insect, 
but also to compare expression in heads of flies exposed to different immune challenges. 




mediated immunity in invertebrates (Stuart and Ezekowitz 2008). The bacteria Escherichia 




4.2.1. Fly rearing and immune challenge 
Fly rearing was identical to Chapter 3. Escherichia coli (DH10B strain, Invitrogen) and M. 
luteus (LZB055 strain, Blades Biological Ltd, Edenbridge, UK) were used as immune 
elicitors. Bacterial preparation was the same as Chapter 3. Immune challenges were: 
unwounded control (anaesthetised only), wounded control (isotonic Ringers solution for 
Drosophila; 182mM KCl, 46mM NaCl, 3mM CaCl2, 10mM Tris-Cl), E. coli (gram-negative 
bacterium), and M. luteus (gram-positive bacterium). 
 
Flies were anaesthetised with CO2, and then pierced in the side of the thorax with a pin 
(diameter ~ 0.05mm) that had been dipped in either Ringers solution or bacterial suspension. 
Flies were then placed in vials containing a sugar-agar medium and kept at 18°C. After 6 
hours, flies were anaesthetised with CO2, and heads (with antennae) were removed and 
immediately placed into cold TRIzol reagent (Invitrogen). To extract haemolymph 
(containing haemocytes), the thorax was then pierced with a pin (diameter ~ 0.2mm), and 
flies were placed into chilled Eppendorf tubes punctured at the bottom using a hypodermic 
needle (diameter ~ 0.8mm). They were then immediately centrifuged at 9,000g for 5 minutes 
at 4°C to drain hemolymph directly into cold TRIzol reagent in a second Eppendorf tube 
supported below. Finally, haemolymph-depleted bodies (including legs and wings) were 
placed into cold TRIzol reagent in separate tubes. The separated tissues immersed in TRIzol 
reagent were immediately placed in liquid nitrogen and shortly after homogenised and 




of 4 treatments (unwounded, sterile-wounded, gram-negative, gram-positive), and the 
experiment was replicated 6 times. A total of 600 flies were used in this study. 
 
4.2.2. RNA isolation, reverse transcription, PCR and Illumina Sequencing 
Methods were identical to Chapter 3. All approaches using PCR to amplify cDNA from a 
sample can be affected by PCR stochasticity. The early rounds of PCR constitute a 
‘screening phase’ in which particular cDNA transcripts are chosen for amplification (Ruano, 
Brash et al. 1991). Thus, targets are selected for amplification prior to the amplification 
beginning. When attempting to determine accurate relative quantities of Dscam exon 
variants within a sample, stoichiometry of the PCR may distort the true pattern. As such, to 
reduce the possible effects of PCR stochasticity in this study, PCR of each cDNA sample 
was repeated 5 times and pooled together. 
 
4.2.3. Data analysis 
Raw data handling 
Raw data was handled as in Chapter 3. 
 
Statistical Analyses 
Analysis of constitutive exon expression within different tissues: I tested for a departure from 
even expression in different tissue types in Drosophila using different methods of analysis. 
Pearson’s chi-square (χ
2
) tests were carried out on the mean raw counts of exons 4 and 6 of 
unchallenged Drosophila to determine whether the frequency distribution of each exon 
variant was consistent with a random expression model (i.e. all exon variants are equally 
likely to be expressed; expectation calculated as 1/n variants at a given exon cluster). Exon 
4-6 combinations in unchallenged Drosophila were tested for a departure from even 
expression using Fisher’s Exact Tests on raw count data for each treatment due to low counts 




2009) were also implemented to reveal non-random constitutive expression in different 
tissues by providing estimates of the proportion of variance explained by exons 4 and 6. See 
Chapter 3 Methods for description of MCMCglmm package. All analyses were handled in R 
(R Development Core Team 2011). 
 
Comparisons of constitutive exon expression between different tissues: I compared the 
constitutive expression of exons 4 and 6 between tissues to test for tissue-specific Dscam 
expression using three different methods of complementary analysis. DESeq (Anders and 
Huber 2010) was used to test for tissue-specific expression of exons 4 and 6 by testing the 
number of reads for each Dscam exon variant for being differential between tissues. Here, 
gene variants were treated as equivalent to genes. DESeq corrects for multiple testing using 
Benjamini-Hochberg’s FDR (Benjamini and Hochberg 1995), and here FDR was controlled 
at 5% (q = 0.05). See Chapter 3 Methods for description of DESeq package. MCMCglmm 
was used to infer tissue-specific expression by providing estimates of the proportion of 
variance explained by exon-by-tissue effects in the model. Additionally, diversity of 
expression between tissues of unchallenged Drosophila was compared using Simpson’s 
Index of diversity (1-D) (Simpson 1949) and analysed using traditional one-way ANOVA of 
four treatments, each with six individual observations (biological replicates). All analyses 
were handled in R (R Development Core Team 2011). 
 
Analysis of infection-responsive Dscam splicing in Drosophila: I used the same three 
approaches to detect infection-responsive splicing as I did to detect tissue-specific splicing 
(see above). As Dscam can produce many thousands of isoforms through alternative splicing 
an estimate of diversity can be useful measure of the overall Dscam transcript-range present 
under different conditions. As such, expression diversity was estimated using Simpson’s 
Index of diversity (1-D). A general linear model (GLM) was fitted to indices of diversity to 




pathogen + tissue*pathogen. I used two complementary methods to examine differential 
expression of exons 4 and 6 in response to immune challenge. Firstly, I used MCMCglmm to 
infer the effect of wounding or pathogen-exposure on Dscam expression patterns. 
Specifically, I compared Dscam expression between (1) unwounded and Ringers-wounded 
treatments (i.e. to investigate any wounding effects on Dscam expression and in different 
tissues), and (2) different pathogen-exposed treatments compared to sterile-wounded 
treatments (i.e. to investigate any effects of pathogen-exposure and in different tissues). I 
fitted models to the count data to test for an interaction between Dscam expression and 
experimental conditions. To test for effects of wounding, the following model was fitted to 
exon read counts: reads ~ tissue + wounding + replicate + primer-pair + exon 4 + exon 6 + 
exon 4-6 + exon 4: tissue + exon 4: wounding + exon 6: tissue + exon 6: wounding + exon 4: 
tissue: wounding + exon 6: tissue: wounding + exon 4-6: tissue + exon 4-6: wounding + 
exon 4-6: tissue: wounding. Tissue and wounding were treated as fixed effects and pathogen-
exposed treatments were excluded from this analysis. To test for effects of pathogen 
exposure, I fitted the model: reads ~ tissue + pathogen + replicate + primer-pair + exon 4 + 
exon 6 + exon 4-6 + exon 4: tissue + exon 4: pathogen + exon 6: tissue + exon 6: pathogen + 
exon 4: tissue: pathogen + exon 6: tissue: pathogen + exon 4-6: tissue + exon 4-6: pathogen 
+ exon 4-6: tissue: pathogen. Tissue and pathogen were treated as fixed effects and 
unwounded treatments were excluded from this analysis. Relative expression was 
transformed as cube-root of percentages (expressed as reads per million) to ensure normally 
distributed residuals (see appendix figure S9 for Q-Q plot of distribution before and after 
transformation). Two runs of 1,000,000 MCMC iterations were completed for each model. 
Each run was sampled every 100 steps and the first 10% of iterations was discarded as burn-
in. Secondly, DESeq was also used to detect infection-induced differentially expressed 
variants of exons 4 and 6, and combinations thereof. Here, I tested for differential expression 
of exon variants between (1) unchallenged and sterile-wounded treatments to test for an 




of pathogen-exposure, and (3) comparisons 1-2 above but testing the expression of exon 4-6 
combinations. FDR was controlled at 5% (q = 0.05). All analyses were handled in R (R 
Development Core Team 2011). 
 
Correlation and dependence: I also tested whether proportional expression of exon 4 and 6 
variants correlated between the data of the present study and those of whole flies (Chapter 3) 
using Spearman’s rank correlation (rs). Correlation analyses were handled in R (R 




4.3.1. Illumina sequencing assay output 
Data received from the sequencing facility had 10,214,702 read pairs. After quality trimming 
(see Methods), I had 4,722,048 reads which were still available in pairs of reads at least 50nt 
long. Sequences without a valid MID-tag or affected by mis-priming or template switching 
were then discarded and a total of 1,469,404 million reads remained and were attributable to 
exons 4 and 6, and combinations thereof. The mean number of high quality reads from each 
PCR primer-pair was 20,408 (sequencing-depth ranged from 1,593 up to 60,218). 
 
4.3.2. Detecting differences in constitutive exon variant expression in different 
tissues 
I used Pearson’s chi-square and MCMCglmm analyses to test for uneven expression of 
exons 4 and 6 in different tissues of unchallenged flies. I found expression patterns in all 
tissues to be very similar to those found in whole flies (see Chapter 3, Fig. 3). Significant 
differences in expression between variants of both exons 4 and 6 were detected in all three 
tissue types (exon 4 heads: χ
2
 = 6394.42, DF = 11, p = <0.0001; exon 4 bodies: χ
2




DF = 11, p = <0.0001; exon 4 haemolymph: χ
2
 = 1728.10, DF = 11, p = <0.0001; exon 6 
heads: χ
2
 = 30015.2, DF = 47, p = <0.0001; exon 6 bodies: χ
2
 = 5327.09, DF = 47, p = 
<0.0001; exon 6 haemolymph: χ
2
 = 7586.46, DF = 47, p = <0.0001) (Fig. 1). Using 
MCMCglmm, I found significant effects of exon 4 and exon 6-expression, indicating non-
random expression of both exons. Specifically, exon 4 contributed around 53% of the total 
variance explained by random effects in the model, while exon 6 explained around 38% 
(Table 1). Thus, both methods of analysis showed that variants of exons 4 and 6 were 
expressed non-randomly, as seen previously in whole flies (Chapter 3). 
 
4.3.3. Constitutive exon variant expression between different tissues 
I used DESeq, MCMCglmm and Simpson’s Index of Diversity analyses to compare 
constitutive exon expression between different tissues in unchallenged Drosophila. Relative 
expression of some exon 4 variants appeared to be different between tissues. In other words, 
some exon 4 variants were more abundant in specific tissue types than other variants (Fig. 1). 
For example, exon 4.2 was significantly more abundant in bodies than in heads (DESeq, q = 
<0.001) or haemolymph (q = <0.001). In contrast, exon 4.2-expression was comparable 
between heads and haemolymph (q = 0.78). Exon 4.9-expression was significantly higher in 
heads than in bodies (q = <0.001) and in haemolymph (q = <0.001), but no difference in the 
relative abundance of exon 4.9 between bodies and haemolymph was detected (q = 0.38). 
Exon 4.11 was expressed at significantly higher levels in heads than in bodies (q = <0.001) 
or haemolymph (q = 0.007), and expressed significantly more in haemolymph than in bodies 
(q = <0.001). MCMCglmm analysis revealed significant exon 4-by-tissue effects and was 




4.9-by-head effect, p = 0.007; exon 4.11-by-head effect, p = 0.05). 
 
 
Figure 1: Bar chart representing relative expression of each exon 4 and 6 variant in different 
tissues in unchallenged D. melanogaster. Exon 4 and 6 variants in heads, bodies and 
haemolymph were expressed in a non-random fashion. Furthermore, analysis showed that 
expression of individual exon 4 variants appeared to be tissue-specific. For example, exon 4.2 
expression was significantly higher in bodies than in heads (DESeq, q = <0.001) or haemolymph 
(q = <0.001). Exon 4.11 was significantly higher in heads than in bodies (q = <0.001) or 
haemolymph (q = 0.007), while exon 4.9 was significantly higher in heads than in bodies (q = 
<0.001) or in haemolymph (q = <0.001). Moreover, significant exon 4-by-tissue effects were 
found following analysis with MCMCglmm (see text). In contrast, relative exon 6 variant 
expression did not differ between tissues. Error bars represent standard deviation calculated from 




Moreover, exon 4 expression-diversity was lower in bodies than in heads or haemolymph of 
unchallenged flies (One-way ANOVA; F2,15 = 32.21, p = <0.001). Thus, exon 4 variants 
appear to be expressed in a tissue-specific manner. 
 
For exon 6 variants, the relative expression across tissues was remarkably similar (Fig. 1). 
For example, the most abundant variant found was exon 6.18 and was expressed in the same 
relative abundance in all tissues (between heads and bodies; DESeq, q = 1, heads and 
haemolymph; q = 0.99, and bodies and haemolymph; q = 0.83). Exon 6.25 was the second 
most abundant variant expressed in all tissues and no differences in expression of this variant 
were seen between tissues (between heads and bodies; q = 1, heads and haemolymph; q = 
0.99, and bodies and haemolymph; q = 0.84). Analysis of the expression of the remaining 
variants of exon 6 found no differences in relative expression of any variant between heads 
and bodies (all q-values = 1), between heads and haemolymph (all q-values ≥ 0.99), or 
between bodies and haemolymph (all q-values ≥ 0.63). MCMCglmm analysis revealed no 
significant exon 6-by-tissue effects (Table 1). Moreover, diversity of exon 6-expression was 
no different between tissues (One-way ANOVA: F2,15 = 0.89, p = 0.801). Thus, the 
expression of exon 6 variants did not show the apparent tissue-specificity of exon 4 variants, 
and two exon 6 variants in particular (6.18 and 6.25) showed strikingly higher relative 
expression than any others (Fig. 1). 
 
Notably, exon-skipping was detected in all tissues. Exon 6-skipping was detected at a 
frequency of 2.8x10
-3
 in heads, a frequency of 3.1x10
-3
 in bodies, and at a frequency of 
2.6x10
-3
 in haemolymph. In this experiment, although exon 4-skipping was detected in all 
tissues, I could not measure the rate with any accuracy as the forward primers which were 
nested in constitutive exon 3 also overlapped variable exon 4 by one base. Thus, both exon 
4- and exon 6-skipping was detected in all tissues of unwounded flies, and exon 6-skipping 




4.3.4. Detecting normal combinatorial splicing in different tissues in unwounded 
Drosophila and determining whether splicing is random or non-random 
I next compared the constitutive combinatorial splicing between the tissue types of 
unchallenged flies and attempted to determine whether splicing appeared to be random or 
non-random in each tissue in the absence of wounding or parasites. Figure 2 shows heat 
maps of relative expression levels of all possible exon 4-6 combinations, and as in whole 
flies (see Chapter 3), visual inspection suggests that the splicing of these two exons is close 
to random in all three tissue types. However, deviation from even expression was detected in 
a small number of treatments and was seen in all three tissue types (see Table S5). Moreover, 
MCMCglmm analysis revealed a very small but significant exon-exon combination-by-tissue 
effect, which explained 0.1% of the total variance in the model (Table 1), indicating that a 
small number of exon 4-6 combinations were not evenly expressed. Thus, as seen in whole 
flies (Chapter 3), in general, combinatorial splicing appears to be close to random in 
different tissues in the fly, but some exon-exon combinations were detected at non-random 
frequencies in heads, bodies and in haemolymph. 
 
Overall, all possible exon 4-6 combinations were detected in all three tissue types except 
those requiring exon 6.11, resulting in a total of 564 combinations expressed in heads, in 
bodies and in haemolymph of D. melanogaster. Thus, high Dscam transcript diversity was 
present in unwounded flies which demonstrated a non-restricted expression for both studied 






Figure 2: Heat map representation of the relative expression of all possible exon 4-6 
combinations in heads (left block), bodies (middle block), and haemolymph (right block) in 
unwounded D. melanogaster. Combinatorial splicing was close to random in all three tissues. For 
example, combination 4.10-6.28 found in heads (left block), and combination 4.2-6.9 found in 
haemolymph (right block), combined at frequencies expected based on the independent 
frequencies of each variant detected in these tissue types. However, some combinations appeared 
to show non-random association. For example, the most abundant combination in bodies was 4.2-
6.18, which represented approximately 1.5% of all sequencing reads obtained from this tissue, was 
detected ~30% higher than would be expected in a random combinatorial splicing model based on 
independent frequencies of variants 4.2 and 6.18. Variants are in order of relative abundance for 
each tissue. Each cell represents the proportion of an exon 4-6 combination, calculated as the mean 




4.3.5. Testing for differential Dscam expression in different tissues in response to 
different immune elicitors 
I used Simpson’s Index of Diversity, MCMCglmm and DESeq analyses to test whether 
Dscam expression was altered in response to immune challenges. Figure 3 shows bar charts 
of the mean Simpson’s Index of Diversity values calculated for exon 4, exon 6, and exon 4-6 
combinations for each tissue and each immune challenge (see Table S6 for diversity 
estimates for all treatments in the study). 
 
There was a significant effect of tissue on the expression diversity of exon 4 (F2,68 = 112.73, 
p = <0.001), where diversity was lowest in bodies. No effect of pathogen was found on exon 
4 diversity (F3,68 = 1.66, p = 0.184), and I found no significant interaction between tissue and 
pathogen (F2,67 = 0.83, p = 0.549). For exon 6, no significant effects were found (tissue: F2,68 
= 0.21, p = 0.652; pathogen: F2,68 = 0.98, p = 0.410; interaction: F2,67 = 0.77, p = 0.598). 
Finally, a significant tissue-effect was found for exon 4-6 combination diversity (F2,68 = 
43.05, p = <0.001) where diversity was lowest in bodies, and no effect of pathogen (F2,68 = 
0.75, p = 0.526), or effect of interaction was seen (F2,67 = 0.78, p = 0.589) (Fig. 3). Thus, 
while between-tissue differences were seen in expression diversity, no significant effects of 






Figure 3: Expression diversity for exon 4, exon 6, and exon 4-6 combinations between tissues and 
treatments. I fitted a GLM to expression diversity data as: (1-D) ~ tissue + pathogen + tissue*pathogen. 
Exon 4, and exon 4-6 combination expression diversity was lower in bodies than any other tissue, and exon 6 
expression diversity appeared to be similar across all tissues. No effects of pathogen or interaction were 
detected (see text). Diversity is represented as mean 1-D of six independent replicates. Error bars represent 
SEM calculated from six independent experiments. Key: UNW: unwounded, Ring: Ringers-wounded, Ecoli: 




Using MCMCglmm, I fitted models to the count data to test for an interaction between 
Dscam expression and experimental conditions. I firstly tested for effects of wounding. 
Table 1 outlines the analysis output which represents the variance structure. The model 
mixed well and the average effective sample size was over 7000 (see appendix, figure S10). 
 
Table 1: Variance structure summarising a MCMCglmm model testing for effects of wounding 
on Dscam expression. The variance components are of random effects. Key: RE = relative 










C.I. [L/U]1 % Total 
Variance2 
Primer-pair 0.001 0.0002 0.0001 [0, 0.002] 0.0 
Replicate 0.001 0.001 0.00001 [0, 0.003] 0.0 
Exon 4 10.388 8.983 7.792 [3.27, 20.99] 53.0 
Exon 6 7.479 7.248 6.869 [4.54, 10.74] 38.1 
Exon 4-6 0.253 0.252 0.251 [0.21, 0.29] 1.3 
Exon 4: Tissue 0.287 0.266 0.248 [0.11, 0.49] 1.5 
Exon 4: 
Wounding 
0.007 0.004 0.0003 [0, 0.02] 0.0 
Exon 6: Tissue 0.003 0.003 0.00004 [0, 0.007] 0.0 
Exon 6: 
Wounding 








0.002 0.002 0.00002 [0, 0.006] 0.0 
Exon 4-6: 
Wounding 
0.001 0.001 0.00001 [0, 0.004] 0.0 
Exon 4-6: 
Tissue 




0.001 0.001 0.00002 [0, 0.005] 0.0 
Residuals 1.136 1.136 1.132 [1.11, 1.16] 5.8 
1 Credibility intervals less than 10-3 are rounded to zero. 
2 Percentage of the total variance explained by random effects in the model. 
  
As expected following previous χ
2
 analysis of constitutive expression, a considerable amount 
of the total variance explained by random effects in the model was attributable to exon 4, 
exon 6, and exon 4-6 combinations (Table 1). In addition, 1.5% of the total variance was 




attributable to an exon 4-by-tissue-by-wounding effect (0.2%) and an exon 4-6 combination-
by-tissue effect (0.1%). The lower credibility bound of each of these effects did not reach 
zero. Otherwise, contributions to total variance were negligible for all terms in the model. 
Thus, only a weak effect of wounding was evident, but notable effects of tissue were 
detected. 
 
I next tested for effects of pathogen. Table 2 outlines the analysis output representing the 
variance structure for the model. The model mixed well and the average effective sample 
size was above 7500 (see appendix, figure S11). 
 
Table 2: Variance structure summarising a MCMCglmm model testing for effects of pathogen-
exposure on Dscam expression. The variance components are of random effects. Key: RE = relative 













Primer-pair 0.001 0.0004 0.0002 [0, 0.004] 0.0 
Replicate 0.003 0.003 0.002 [0, 0.005] 0.0 
Ex4 10.861 9.254 6.977 [2.82, 22.31] 54.3 
Ex6 7.234 7.022 6.488 [4.52, 10.36] 36.2 
Exon 4-6 0.280 0.278 0.272 [0.24, 0.32] 1.4 
Ex4: Tissue 0.351 0.329 0.287 [0.16, 0.59] 1.8 
Ex4: Pathogen 0.007 0.006 0.00004 [0, 0.02] 0.0 
Ex6: Tissue 0.003 0.003 0.003 [0, 0.006] 0.0 
Ex6: Pathogen 0.0003 0.0001 0.000002 [0, 0.001] 0.0 
Ex4: Tissue: 
Pathogen 
0.021 0.021 0.019 [0.012, 0.032] 0.1 
Ex6: Tissue: 
Pathogen 
0.0004 0.0002 0.00001 [0, 0.002] 0.0 
Exon 4-6: 
Pathogen 
0.0003 0.0002 0.000005 [0, 0.001] 0.0 
Exon 4-6: 
Tissue 




0.0004 0.0002 0.00001 [0, 0.002] 0.0 
Residuals 1.227 1.227 1.227 [1.21, 1.25] 6.1 
1 Credibility intervals less than 10-3 are rounded to zero. 





Here, nearly 2% of the total variance was explained by an exon 4-by-tissue effect, with 
smaller proportion of the total variance being attributable to an exon 4-6 combination-by-
tissue effect (0.1%). In addition, a very small exon 4-by-tissue-by-pathogen effect was seen 
(0.1%). The lower credibility bound of each of these effects did not reach zero. Thus, effects 
of tissue were apparent, closely reflecting the results seen in the model testing for effects of 
wounding (Table 1), and only a weak effect of pathogen-exposure was evident. 
 
To investigate whether I could detect differential expression of Dscam exon variants 
between different tissues and between different types of bacteria in Drosophila, I employed 
DESeq and MCMCglmm analyses to test the number of reads for each Dscam exon variant 
for being differential between treatments. Figure 4 shows heat maps representative of exon 4 
and exon 6-expression for all treatments in the study. Strong patterns were seen for exon 
variants across all treatments for both exons 4 and 6, and patterns were detected between 
tissues. However, visual inspection suggested that no discernible patterns were obvious 
between treatments. 
 
To firstly test for differential expression following wounding, I compared exon variant 
expression between unchallenged and sterile-wounded flies. Using DESeq, I found no 
difference in the expression of any exon 4 or exon 6 variant between the unwounded and 
Ringers-wounded flies in heads (exon 4: all q-values ≥ 0.90; exon 6: all q-values ≥ 0.98), 
bodies (exon 4: all q-values ≥ 0.82; exon 6: all q-values ≥ 0.74), or haemolymph (exon 4: all 
q-values ≥ 0.35; exon 6: all q-values ≥ 0.87). Following MCMCglmm analysis however, I 






Figure 4: Heat map representation of relative expression of exon 4 (left block) and exon 6 (right block) 
variants for all treatments in this study. Patterns of expression for individual variants of both exons 4 and 6 
across treatments and between tissues were evident. For example, exon 4.2 was clearly the most abundantly 
expressed exon 4 variant in bodies regardless of treatment, while exon 4.11 was expressed at lower levels in 
bodies than in heads or haemolymph in all exposures. Moreover, exon 4.9 appeared to be expressed at higher 
levels in heads than any other tissue. For exon 6, variants 6.18 and 6.25 were significantly more abundant 
than any other exon 6 variants across all treatments, while exons 6.29 and 6.39 were the least abundant across 
all treatments. No obvious patterns of expression were detected between treatments. Exon 6.11 was not 
detected and hence not included. The inclusion of exon 5 indicates relative abundance of exon-skipping for 
each exon cluster. Each tissue type, i.e. Head, Body, Haem (haemolymph) include 6 biological replicates, and 
each cell represents the proportional expression of a given exon variant in a single sample. Dendrograms 




To investigate differential expression between exon variants following septic-wounding, I 
used DESeq to compare expression in sterile-wounded flies with expression in flies exposed 
to the bacteria E.coli and M. luteus. I found no differences in expression of any exon 4 
variants across any tissue type in response to E. coli (exon 4-expression in heads: all q-
values ≥ 0.96; in bodies: all q-values ≥ 0.91; and in haemolymph: all q-values ≥ 0.92). 
Similarly, exposure to M. luteus revealed no significant differences in exon 4-expression 
(heads: all q-values ≥ 0.97; bodies: all q-values ≥ 0.98; haemolymph: all q-values ≥ 0.39). 
Moreover, exon 6 variant expression in any tissue was not affected by either E. coli or M. 
luteus. Following analysis with MCMCglmm, an effect on the expression of exon 4.4 was 
seen in haemolymph in response to M. luteus exposure (p = 0.01). The lower credibility 
bound did not reach zero for this effect, but was very close to zero. Thus, no detectable 
effects of pathogen-exposure were seen following analysis with DESeq, but a very small 
effect of M. luteus-exposure was seen on the expression of exon 4.4 in haemolymph 
following analysis with MCMCglmm. 
 
I next tested if patterns of expression of exon 4-6 combinations were apparent between 
tissues and between treatments. Figure 5 shows a heat map of the expression of exon 4-6 
combinations of which all represented an abundance of over 0.5% in at least one treatment in 
the study. As with individual exons, visual inspection suggested that patterns were evident 
across treatments. For example, transcripts containing the combinations 4.2-6-18 and 4.12-6-
18 were the most abundantly expressed across all treatments which reflected the relatively 





Figure 5: Heat map representation of expression of exon 4-6 combinations of which each represented a 
minimum abundance of 0.5% in at least one treatment in this study. Patterns of expression for exon 4-6 
combinations across treatments were evident. For example, transcripts containing the combinations 4.2-6-18 
and 4.12-6-18 were the most abundantly expressed across all treatments. No discernible patterns were 
obvious between treatments. Each cell represents the proportional expression of a given exon combination in 
a single sample. Dendrograms result from hierarchical clustering of exon combination expression pattern 




However, there was no difference between treatments. Applying DESeq analysis for the 
same pairwise comparisons carried out for individual exons (see above), I found no evidence 
of differential expression of any exon 4-6 combinations in response to wounding or 
pathogens in this study. Moreover, analysis using MCMCglmm detected no effects of 
wounding or pathogen-exposure on the expression of exon-exon combinations (see Tables 1 
and 2). Thus, no significant changes of expression of exon 4-6 combinations between 
treatments were evident. 
 
4.3.6. Correlating the tissue-specific data with those of Chapter 3 
To test the consistency of the Illumina sequencing assay between two independent 
experiments, I tested for correlation between data obtained from whole flies (see Chapter 3, 
figure 3) with those obtained from each tissue in the present study (Fig. 1). Figure 6 shows a 
bar chart comparing proportional expression of exon 4 (top) and exon 6 (bottom) variants 
between the studies. 
 
Data from Chapter 3 positively correlated with those of the present study. An especially 
strong positive correlation was found for exon 4-expression between whole flies and fly 
bodies (exon 4: whole flies with bodies, rs = 0.881, p = <0.0001), but also the other tissues 
(exon 4: whole flies with heads, rs = 0.853, p = 0.0004; exon 4: whole flies and 
haemolymph, rs = 0.874, p = 0.0002). Strong positive correlation was also seen for exon 6 
between the data sets (exon 6: whole flies with heads, rs = 0.789, p = <0.0001; exon 6: whole 
flies and bodies, rs = 0.794, p = <0.0001; exon 6: whole flies with haemolymph, rs = 0.784, p 
= <0.0001). Thus, positive correlations were found between the data of two independent 
experiments that utilised Illumina-based sequencing technology to study Dscam gene variant 







4.4.1. Exon 4 and 6 variants are constitutively expressed in a non-random fashion 
in different tissues in Drosophila and exon 4, but not exon 6, is expressed in a 
tissue-specific manner 
Exon 4 and 6 variants were expressed in a non-random fashion in all tissues assayed in this 
study. Moreover, exon 4 variants appeared to be spliced in a tissue-specific manner. For 
example, exon 4.2 was expressed in significantly higher amounts in bodies than in heads or 
 
Figure 6: Bar chart comparing Dscam expression data from whole flies of an independent study 
with those of tissues of the present study. Expression data from both exons positively correlated 
between experiments (see text). Bars represent mean proportion of exon variant expression in pooled 




haemolymph (Fig. 1). Exon 4.2 was found to be the most abundantly expressed variant from 
the exon 4 cluster in whole flies in my previous experiment (see Chapter 3, figure 3), and 
was also the most abundant exon 4 variant found in both legs and wings in an independent 
SSCP assay in D. melanogaster (Celotto and Graveley 2001). As the body tissue in the 
present study contained legs and wings, the abundance of exon 4.2 in these appendages 
could be driving the pattern. Celotto and Graveley (2001) also discovered that exon 4.2 
displayed the most striking developmental changes of any exon 4 variant. Only ~1% of 
transcripts in embryos contained this variant but the expression steadily increased throughout 
development becoming the most predominant exon 4 variant in adults, consistent with the 
appearance of legs and wings. The characteristics of exon 4.2-expression appears to be 
conserved in D. yakuba (Celotto and Graveley 2001), estimated to have diverged from D. 
melanogaster ~3-15 million years ago (Powell 1997; Li, Satta et al. 1999; Tamura, 
Subramanian et al. 2004; Obbard, Maclennan et al. 2012), indicating a relative importance of 
the tissue-specific function of exon 4.2 across different Drosophila species. Additionally, the 
expression diversity of exon 4 was shown to be lower in bodies than in heads or 
haemolymph. This indicates a less-restricted usage of exon 4 variants in heads and 
haemolymph compared to bodies, and may be driven largely by the relatively high 
abundance of exon 4.2 in body tissue of this study. 
 
The expression of exon 4.9 was significantly higher in heads than in bodies or haemolymph 
(Fig. 1). In SSCP gel electrophoresis, exon 4.9 co-migrates with exons 4.5 and 4.7 (Celotto 
and Graveley 2001), therefore no comparison could be made between independent studies. 
Nevertheless, the data here suggest that exon 4.9 may have a more important role in 
heads/antennae than in any other tissues. Exon 4.11 was expressed significantly higher in 
heads than any other tissue. Around 7% of exon 4 variants in heads were exon 4.11 in this 
study and this reflected data from a past SSCP study (exon 4.11 in heads, 6.9 ± σ 1.3%, see 




exon 4.11 was significantly lower in the other tissues assayed (bodies and haemolymph in 
the present study, wings and legs in the SSCP experiment), and this suggests that exon 4.11 
may also be a relatively more important variant in heads/antennae than other tissue types in 
Drosophila. Thus, the data confirm that choice of exon 4 variant is regulated as evidenced by 
the non-random expression of each variant, and also that alternative splicing of exon 4 
variants happens in a tissue-dependent manner. 
 
In contrast to exon 4-expression, exon 6 variant-expression revealed no evidence of tissue-
specific alternative splicing. Nevertheless, exon 6 variants were expressed in a non-random 
fashion in all tissues indicative of some level of regulation (Fig. 1). Moreover, mean 
expression diversity of exon 6 did not differ between tissues, also indicating very similar 
non-random usage of exon 6 variants in all tissues (Fig. 3). To my knowledge this has never 
been reported. Watson et al (2005) using microarrays to compare exon 6-usage between 
haemocytes, fat bodies and brain tissue found that these variants were expressed in all three 
tissues, but the authors could not determine with any accuracy the relative abundances within 
each tissue. Thus, as in exon 4, non-random expression occurred in exon 6 in all tissues, but 
the proportional inclusion of exon 6 variants in transcripts found in all tissue types was 
similar confirming a lack of tissue-dependent expression for this exon. 
 
Combinatorial splicing in unchallenged flies appears to be close to random in heads, bodies 
and haemolymph. However, separate tissues reflected the patterns seen in whole flies 
(Chapter 3) where most combinations were detected at expected frequencies but some 
appeared to be expressed non-randomly (Fig. 2). Indeed, MCMCglmm analysis detected 
small exon 4-6 combination-by-tissue effects in both models (see Tables 1 and 2), indicative 
of a small difference in exon 4-6 combination expression between tissues. Departures from 
randomness may be a result of PCR stochasticity. As discussed in depth in Chapter 3, effects 




efficiently than others, resulting in the patterns seen. However, it should be noted that no 
striking differences were found between individual replicates in this study. Nevertheless, it 
would be interesting to discover whether these same patterns of exon 4-6 combination 
expression occurred in future experiments in the same tissues under the same conditions. 
 
As seen in Chapter 3 in whole flies, exon-skipping was detected in this study and in all 
tissues. Interestingly, despite the evaluation of Dscam transcript expression in very different 
tissue types, exon 6-skipping was detected at remarkably similar frequencies in each. 
Whether the phenomenon of exon-skipping is a result of splicing failure or is part of a 
regulatory mechanism, it does not appear to show any tissue-specificity for the exon 6 cluster 
at least. 
 
4.4.2. Tissue-specific Dscam expression in response to wounding and pathogens 
Dscam expression diversity was comparable between unwounded and sterile-wounded 
treatments, suggesting that Drosophila do not respond to tissue damage with profound 
changes in expression diversity of Dscam gene variants (Fig. 3). Moreover, I found no 
differential expression of any exon 4 or 6 variants in response to wounding using DESeq. 
However, I found a small exon 4-by-tissue-by-wounding effect following analysis with 
MCMCglmm (Table 1). Specifically, wounding appeared to affect the expression of exon 4.6 
in bodies. However, unlike DESeq analysis, MCMCglmm does not correct for multiple 
testing. As such, care must be taken in interpreting the results. 
 
E. coli and M. luteus are strong immune elicitors in Drosophila and provoke substantial 
upregulation of the immune markers Diptericin and Drosomycin, respectively (Lemaitre, 
Reichhart et al. 1997). Here I found comparable Dscam expression diversity between sterile-
wounded and pathogen-exposed treatments, indicating overall expression diversity does not 




reflect results seen in Anopheles, where Dscam expression diversity increased following 
exposure to Plasmodium parasites (see Chapter 2). A model used to examine the effects of 
pathogen-exposure detected a very small exon 4-by-tissue-by-pathogen effect. Specifically, 
analysis with MCMCglmm suggested that the expression of exon 4.4 in haemolymph was 
affected by M. luteus-exposure. However the effect did not dominate over tissue effects 
(Table 2). Lastly, following DESeq analysis of differential expression, I found no difference 
in expression between any exon 4 or 6 variants between Ringers and E. coli treatments, or 
between Ringers and M. luteus treatments, in any tissue type after adjusting for multiple 
testing. Thus, only weak evidence that Drosophila respond to the presence of pathogen-
exposure with any marked changes of Dscam expression was found. 
 
4.4.3. Supporting the sequencing assay as a reliable method for the study of 
alternative splicing of Dscam 
As this Illumina-based sequencing method was relatively novel for the study of Dscam 
expression, it is important to determine as much as possible its reliability. As such, I looked 
for a correlation between the data of this experiment with those of a previous experiment 
(Chapter 3). I found positive correlations between the expression data from whole flies and 
those of the present study suggesting a high level of consistency between the independent 
experiments. Similarities included the expression of exon 4.2, which was the most 
abundantly expressed exon 4 variant in both studies, with exon 4.9 being the least abundant 
in both experiments. However, differences were found between the studies. For instance, the 
expression of some exon 6 variants was surprisingly different between the independent 
experiments despite the use of the same Drosophila strain. For example, in whole flies 
(Chapter 3), exon 6.25 was the most abundantly expressed variant from this exon cluster, 
while in the present study, exon 6.18 was the most abundant exon 6 variant in all tissues 





The possibility of early-round PCR stochasticity here remains a possibility. However, this 
phenomenon would arguably be expected to have been more of a problem in the experiment 
reported in Chapter 3, which unlike the present study, did not benefit from pooling several 
replicate PCR products. Nevertheless, data from Chapter 3 correlated well with independent 
microarray data (see Chapter 3, Discussion), and data in the present study correlated well 
with Chapter 3. Furthermore, both the comparable relative expression of exon 6 across 
tissues, and the comparable frequency of exon 6-skipping-events across tissues, indicate a 
level of consistency in PCR amplification between samples in the present study. Thus, 
although early-round PCR stochasticity remains a threat with this method, it may not have 
significantly affected the landscape of Dscam gene variant expression seen in the fly. 
Therefore, the data from the present study may be a more accurate representation of Dscam 
gene expression as a result of pooling PCR products to reduce effects of PCR stochasticity. 
Regardless, future studies using this approach would no doubt benefit from complementary 
microarray and/or qRT-PCR assays of the relative abundances of exon variants to help 
control for any possible early-round PCR stochasticity in high-throughput sequencing assays 




Previous research has shown exon 4-expression differs between tissues (Celotto and 
Graveley 2001) and this was detected here using Illumina sequencing. Exon 6-expression did 
not appear to be tissue-specific. However, neither expression of exon 4, exon 6, or exon 4-6 
combinations appeared to be significantly affected by Drosophila immune elicitors. 
Nevertheless, the experiment could not rule out a small effect of challenge on Dscam 
expression in Drosophila. However, the data suggest that it does not dominate over the 




variance explained by random effects in the models (Tables 1 and 2), while an effect of 
pathogen-exposure on exon 4 was a mere 0.1% (Table 2). 
 
Nevertheless, at present two independent experiments in Anopheles (Chapter 2), and now 
two independent experiments in Drosophila (Chapters 3 and 4) all suggest the presence of a 
small but detectable exon 4-by-challenge effect. Future Illumina-based sequencing of Dscam 
expression in Drosophila may be best served by examining the technology against a low 
background-noise model. For instance, well-characterised pathogen-challenge of Drosophila 
S2 cells, cultured immune-competent cells thought to have derived from macrophage-like 
lineage of haemocytes (Schneider 1972), would exclude background noise of non-immune-
related tissues and hopefully direct further informative studies of the specifics of Dscam 





Chapter 5: Tissue-specific Dscam 
gene expression in response to 
within-pathogen species diversity 
in the crustacean Daphnia magna 
 
This chapter was written with comments from Darren Obbard and Tom Little. Statistical 
analyses were done in collaboration with Darren Obbard. The quality trimming, counting 
and sorting of raw Illumina sequencing reads was done using a custom R pipeline written by 
Darren Obbard. Illumina library construction, sequencing and base-calling were performed 
by the GenePool Sequencing Facility (University of Edinburgh). Daphnia rearing, immune 
challenge, and tissue separation was carried out by Carolyn Riddell and Phil Wilson. RNA 


















Down syndrome cell adhesion molecule, Dscam, was first discovered and described as a 
single-pass neuronal membrane receptor of the vertebrate nervous system (Yamakawa, Huo 
et al. 1998). Soon after, a hyper-diverse form of the gene was discovered in Drosophila, 
where it functions as an axon guidance receptor in invertebrate neuronal development 
(Schmucker, Clemens et al. 2000). A capacity to produce many thousands of isoforms from a 
single gene through the mechanism of alternative splicing is an essential feature of its role in 
controlling nerve cell interactions in invertebrates (Chen, Kondo et al. 2006; Hattori, Demir 
et al. 2007). So far, this hypervariable form of the receptor has not been discovered outside 
the Pancrustacea, a clade consisting of the subphyla Hexapoda (which includes the insects), 
and Crustacea. Several studies have predicted that the alternative splicing Dscam gene 
originated along the lineage leading to the insects and crustaceans, which are thought to have 
diverged from a common ancestor around 450-500 million years ago (Crayton, Powell et al. 
2006; Brites, McTaggart et al. 2008; Lee, Kim et al. 2010; Armitage, Freiburg et al. 2012). 
 
Both insect and crustacean Dscams have been implicated in immunity. In Anopheles and 
Drosophila, depletion of Dscam in immune cells results in a significant reduction of 
phagocytic activity (Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006). In 
addition, pathogen-specific Dscam isoforms have been reported to be expressed in the 
Anopheles mosquito in response to diverse pathogens (Dong, Taylor et al. 2006), and in the 
crustacean, Pacifastacus leniusculus, in response to bacteria-exposure (Watthanasurorot, 
Jiravanichpaisal et al. 2011). In another crustacean, Daphnia magna, diverse Dscam 
isoforms have been detected in haemocytes, the effector cells of immunity, suggesting a role 





Interestingly, Daphnia Dscam appears to have fundamental differences compared to the 
insect Dscams. For example, whereas two different transmembrane domains have been 
discovered in the Dscams of insects, Daphnia Dscam has only one (Brites, McTaggart et al. 
2008). Perhaps surprisingly, Dscam of the crayfish, P. leniusculus, shares more similarity 
with the insect than Daphnia by having two transmembrane domains (Watthanasurorot, 
Jiravanichpaisal et al. 2011). This could imply a more restricted role for Daphnia Dscam 
compared with Dscams in other members of the Pancrustacea. However, multiple 
cytoplasmic domains have been found in both Daphnia and Pacifastacus Dscams, but not in 
those of the insects (Brites, McTaggart et al. 2008; Watthanasurorot, Jiravanichpaisal et al. 
2011). Thus, Dscams in crustaceans may have different roles to play in both neuronal wiring 
and immunity compared with other Dscams found across the clade. 
 
The immunoglobulin (Ig) and fibronectin type III (FnIII) domain structure of Daphnia 
Dscam is otherwise the same as the insect Dscam. The arrangement is 9Ig-4FnIII-Ig-2FnIII, 
and as in insects, the three highly variable exon clusters of Daphnia encode the first half of 
Ig2 and Ig3, and the entire Ig7. Figure 1 illustrates the protein and gene structure of Daphnia 
Dscam compared with Drosophila Dscam. Like Dscam in many Drosophila species, 
different Daphnia species have very similar copy numbers at each variable exon cluster. For 
instance, in D. magna, variable exons 4, 6 and 11 contain 8, 24 and 17 alternative variants, 
respectively, while in D. pulex, the same variable exons contain 8, 26 and 16 variants, 
respectively (Fig. 1). Including four alternative cytoplasmic tail forms, D. magna Dscam has 




produce up to 13,312 isoforms. 
 
As D. magna and D. pulex, the only studied Daphnia species, are thought to have diverged 
~7-15 mya (Haag, McTaggart et al. 2009), and the variable exons are believed to have 
diverged before the split of these two species (Brites, McTaggart et al. 2008), the exons 
 
Figure 1: Protein and gene structure of Dscam in Daphnia magna, D. pulex, and Drosophila 
melanogaster. (a) Protein structures of Daphnia and Drosophila Dscams, (b) Gene structures of 
Daphnia and Drosophila Dscams, and (c) Variable exon clusters of Daphnia and Drosophila 
Dscams. Crustacean protein structure is comparable to insect protein structure with a 9Ig-4FnIII-
Ig-2FnIII arrangement. Unlike insect Dscams which have two variants for the transmembrane 
region (shown as vertical yellow lines), Daphnia Dscam has only one. Moreover, Daphnia Dscam 
can express 4 different forms of its cytoplasmic tail. The cytoplasmic tail is coded by exons 26 to 
31, however exon 30 (blue arrow) can be skipped, resulting in exon 31 being translated in an 
alternative reading frame. Additionally, exon 27 (red arrow) can also be skipped, facilitating two 




appear to be under similar selective constraints. Similarities between insect and crustacean 
Dscams suggest that the receptor may share comparable functions across the Pancrustacea, 
however that Daphnia and other crustacean Dscams have multiple intracellular signalling 
domains suggests that outcomes to receptor activation may be more diverse in these species. 
 
Daphnia are planktonic freshwater crustaceans of the order Cladocera, and are thought to be 
keystone species in freshwater pelagic habitats such as ponds and rivers (Steiner 2002). They 
are filter feeders of small suspended organisms such as green algae, and are frequently 
infected with various parasites including microsporidians, fungi and bacteria (Green 1974; 
Ebert, Payne et al. 1997; Stirnadel and Ebert 1997). Female Daphnia reach maturity at 
around 10 days and produce clutches of parthenogenetic eggs after each adult molt (Ebert 
2005). They reproduce by cyclical parthenogenesis, where they can switch between 
apomictic parthenogenesis and sexual reproduction. Sexual reproduction is usually triggered 
by environmental cues, and in the absence of these cues Daphnia can be kept in the 
laboratory in a state of clonal reproduction (Carvalho and Hughes 1983; Hobaek and Larsson 
1990; Slusarczyk, Dawidowicz et al. 2005). Importantly, clonal reproduction of Daphnia 
facilitates not only the study of genetics but also of host-parasite interactions (Ebert, 
Zschokke-Rohringer et al. 1998). In the present study, I used a single clone of Daphnia 
magna to investigate Dscam expression in response to parasite-exposure. 
 
The obligate endoparasitic gram-negative bacterium, Pasteuria ramosa, has been found to 
frequently infect D. magna in the wild and has a very high virulence (Ebert 2008). It is an 
endospore-forming bacterium transmitted horizontally through the ingestion of waterborne 
spores only (newborns are always free of infection) (Ebert, Rainey et al. 1996). The fitness 
consequences of infection are severe (reproduction is halted), and infection can cause death 
after around 30 to 50 days post-infection (Ebert, Zschokke-Rohringer et al. 1998). P. ramosa 




size compared to that of an uninfected individual, a phenomenon believed to be adaptive for 
the parasite (Ebert 2005). Importantly, P. ramosa shows a high degree of genotype-
specificity within species. It has been shown that host-clones differ in their resistance and 
susceptibility to different isolates of P. ramosa (Carius, Little et al. 2001). 
 
Previous research has found that a cellular immune response occurs in D. magna following 
exposure to P. ramosa (Auld, Scholefield et al. 2010). Specifically, haemocyte counts in 
susceptible hosts increased significantly after exposure to the parasite, while in resistant 
hosts, haemocyte counts remained at control levels. Accordingly, the expression of high 
Dscam diversity detected in Daphnia haemocytes (Brites, McTaggart et al. 2008), together 
with the implication of Dscam’s involvement in phagocytosis (carried out by haemocytes) in 
other species (Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006; 
Watthanasurorot, Jiravanichpaisal et al. 2011), make this model suitable for the study of 
Dscam expression in response to infection. Moreover, as Daphnia reproduces mostly 
clonally, this permitted the study of Dscam expression in a controlled genetic background, 
excluding the confounding effects of germline polymorphisms introduced by sexual 
reproduction. 
 
Here, D. magna was exposed to two different strains of P. ramosa. One of which the host-
clone is known to be highly susceptible to infection, and the other highly resistant to 
infection (Carius, Little et al. 2001). I hypothesised that if Dscam is involved in the immune 
response of Daphnia to a natural parasite, the Dscam expression profile may reflect 
differences between these exposures, especially in a host-parasite association known to show 
strong host-genotype-parasite-genotype interactions (Carius, Little et al. 2001; Ebert 2008). I 
examined Dscam gene expression in response to parasite-exposure in three different tissue 
types. Haemolymph was chosen as it contains haemocytes, immune cells of the host. 




of Daphnia (Duneau, Luijckx et al. 2011) and thus an appropriate tissue to examine Dscam 
expression. Furthermore, this interaction represents an early stage of the infection process. 
Finally, the remainder of the host (hereafter, ‘carcass’) was collected and also examined for 
effects of parasite-exposure. Exon 4, exon 6, and exon 4-6 combination-usage was detected 
by high-throughput sequencing (see Chapters 3 and 4) and counts were assigned to each 
exon variant or exon-exon combination for each treatment. I aimed to (1) detect the patterns 
of constitutive expression in different tissue types in D. magna not exposed to parasites, and 
(2) determine whether infection-responsive alternative splicing of Daphnia Dscam occurs in 




5.2.1. Daphnia rearing 
Daphnia were cloned in the lab by propagating iso-female lines under constant 
environmental conditions. The Daphnia clone used in this study was originally isolated from 
a pond near Gaarzerfeld in Northern Germany and has been kept in the laboratory as a clonal 
line for many years (Carius, Little et al. 2001). Experimental animals were isolated from the 
second clutch after three asexual generations were allowed to pass to minimise conditional 
variation and to increase independence of replicates. Environmental effects were kept 
constant for all replicates by using uniform conditions throughout. Daphnia were kept in 
250ml jars of synthetic pond water (sodium bicarbonate (NaHCO3), calcium chloride 
(CaCl2.2H2O dihydrate), selenium oxide (SeO3), and Instant Ocean® sea salt concentration), 
replaced every two days during rearing and throughout the duration of the experiment. 
Animals were fed 5x10
6
 chemostat-grown Chlorella vulgaris (non-motile colonial single-cell 
green algae) per day. Experimental animals were all female, and aged for 5 days at 20°C 





5.2.2. Immune challenge 
Spores of the obligate endoparasitic bacterium P. ramosa were originally obtained from the 
grinding of cadavers of deceased wild-caught D. magna females and maintained by passage 
through susceptible female Daphnia as they cannot be cultured in vitro. As such, the spore 
solution used in this experiment was made by homogenising infected hosts in double 
distilled H20 (ddH20). Two different strains were used, a strain to which the host is known to 
be susceptible to (s), and another to which the host is known to be resistant to (r) (Carius, 
Little et al. 2001). Uninfected D. magna were homogenised in ddH20 and used as a parasite-
free control exposure. 
 
Immune challenge was carried out in 96-well plates. Dosage was 5 x 10
4
 parasite spores per 
Daphnia for a 4-hour exposure time (previous research has shown a cellular immune 
response at 4 hours; see Auld, Scholefield et al. 2010). After 4 hours, hemolymph was 
withdrawn from each individual in cell extraction chambers containing ice-cold 
anticoagulant buffer (see Lavine, Chen et al. 2005 for details) by piercing the heart with a 
25-gauge needle and allowing it to drain by capillary action directly into RNAlater storage 
solution (Ambion). The hemolymph and RNAlater were then mixed thoroughly by pipetting, 
and removed to -80°C. Guts were then carefully dissected, leaving the rest of the carcass, 
and these tissues were immediately and separately placed into RNAlater and removed to -
80°C. The Daphnia were exposed to one of three treatments (control, spore s, or spore r), 
and the experiment was replicated 8 times. Every treatment contained 6 Daphnia, of which 
one was allowed to grow for up to 30 days to indicate infection status of the replicate. The 
other 5 individuals were used for the tissue-extraction process. A total of 144 Daphnia were 





5.2.3. RNA isolation, reverse transcription, PCR and Illumina Sequencing 
RNA was extracted from Daphnia tissues using a standard TRIzol extraction protocol 
(Invitrogen). Total RNA was treated with RNase-Free DNase I (Ambion) to remove genomic 
DNA contamination, and complimentary DNA was synthesised using a Promega Reverse 
Transcription system with random hexamers. Reverse transcription conditions were as 
Chapters 3 and 4. Primers were designed to amplify a fragment of D. magna Dscam 
spanning from exon 3 to exon 7 (primer sequences were: (F) 5’ – 
GACATCCACGTCCGAGCAG – 3’, (R) 5’ – CTTCCTTCCACGTATTTGTACCAT – 3’). 
Thus, PCR amplicons comprised variable exons 4 and 6, and the conserved exon 5. All 
forward primers incorporated unique molecular ID (MID) tags on the 5’ end to assign reads 
to their treatments in multiplexed sequencing reactions. PCR conditions were as Chapters 3 
and 4. PCR was repeated 5 times for each treatment and products were pooled to reduce 
effects of early-round PCR stochasticity. PCR products were quantified using the Qubit® 2.0 
Fluorometer (Invitrogen), and all MID-tagged samples were mixed evenly based on 
quantification. The final mixed product was concentrated using ethanol precipitation, and 
sequenced in an Illumina Genome Analyzer II (service provided by the GenePool 
Sequencing Facility, University of Edinburgh). 
 
5.2.4. Data analysis 
Raw data handling 
Raw data was handled exactly as Chapters 3 and 4. Sequencing data was pre-processed to 
produce better alignment results. Bad quality ends were cut, and poor quality sequence was 
trimmed by setting stringency parameters as Chapters 3 and 4. Minimum read length was set 








Analysis of constitutive exon expression within different tissues: I tested for a departure from 
even expression in different tissue types in D. magna. Pearson’s chi-square (χ
2
) tests were 
carried out on the raw counts of exons 4 and 6 of control D. magna to determine whether the 
frequency distribution of each exon variant was consistent with a random expression model 
(i.e. all exon variants are equally likely to be expressed; expectation calculated as 1/n 
variants at a given exon cluster). I tested exon 4-6 combinations in control D. magna for a 
departure from even expression using Fisher’s Exact Tests on raw count data for each 
treatment due to low counts for some combinations. Generalised linear mixed models using 
MCMCglmm (Hadfield 2009) were also implemented to reveal non-random constitutive 
expression in different tissues by providing estimates of the proportion of variance explained 
by exons 4 and 6. See Chapter 3 Methods for description of MCMCglmm package. All 
analyses were handled in R (R Development Core Team 2011). 
 
Comparisons of constitutive exon expression between different tissues: I compared the 
constitutive expression of exons 4 and 6 between tissues to test for tissue-specific Dscam 
expression using DESeq and MCMCglmm. I used DESeq (Anders and Huber 2010) to test 
for differential expression of exons 4 and 6 between tissues. DESeq is widely used to 
analyze count data associated with different genes. Here, gene variants were treated as 
equivalent to genes for the purposes of analysis. DESeq corrects for multiple testing using 
Benjamini-Hochberg’s FDR (Benjamini and Hochberg 1995), and here FDR was controlled 
at 5% (q = 0.05). See Chapter 3 Methods for description of DESeq package. I used 
MCMCglmm to infer tissue-specific expression by providing estimates of the proportion of 
variance explained by exon-by-tissue effects in a generalized linear mixed model. All 





Analysis of infection-responsive Dscam splicing in D. magna: I used three approaches to 
detect immune-responsive Dscam splicing. I estimated expression diversity using Simpson’s 
index of diversity (Simpson 1949), and I fitted a general linear model (GLM) to indices of 
diversity to test for effects of tissue, pathogen, and an interaction between both as: 
Simpson’s Index of Diversity (1-D) ~ tissue + parasite + tissue*parasite. I then used two 
complementary analyses to detect differential expression in response to parasites. Firstly, I 
used MCMCglmm to infer the effect of parasite-exposure on Dscam expression patterns. 
Specifically, I tested Dscam expression between control and parasite-exposed Daphnia (i.e. 
to investigate any effects of different parasite exposures and in different tissues) by fitting 
the model: reads ~ tissue + parasite + replicate + primer-pair + exon 4 + exon 6 + exon 4-6 + 
exon 4: tissue + exon 4: parasite + exon 6: tissue + exon 6: parasite + exon 4: tissue: parasite 
+ exon 6: tissue: parasite + exon 4-6: tissue + exon 4-6: parasite + exon 4-6: tissue: parasite. 
I tested the fixed effects of tissue and challenge, and all interaction terms (outlined in 
Results). Relative expression was transformed as cube-root of percentages (expressed as 
reads per million) to ensure normally distributed residuals (see appendix figure S12 for Q-Q 
plot of distribution before and after transformation). Two runs of 1,000,000 MCMC 
iterations were completed for each model. Each run was sampled every 100 steps and the 
first 10% of iterations was discarded as burn-in. Secondly, I used the DESeq R package to 
detect differentially expressed variants in response to parasite-exposure. Specifically, I tested 
for differential expression of exons 4 and 6, and combinations thereof, between control and 
parasite strain s- or parasite strain r-exposed Daphnia. FDR was controlled at 5% (q = 0.05). 
All analyses were handled in R (R Development Core Team 2011). After assessment of 
results MCMCglmm analysis was repeated excluding data from haemolymph treatments (see 
appendix figure S13 for Q-Q plot of distribution before and after transformation with 







5.3.1. Illumina sequencing assay output 
Data received from the sequencing facility had 134,498,169 read pairs. After quality 
trimming I had 19,719,327 reads which were still available in pairs of reads at least 60nt 
long. Sequences without a valid MID-tag or affected by mis-priming or template-switching 
were then discarded and a total of 14,265,039 million read pairs remained and were 
attributable to exons 4 and 6, and combinations thereof. The mean number of high quality 
reads from each PCR primer-pair was 200,915 (sequencing depth ranged from 44,787 up to 
1,907,737). 
 
5.3.2. Detecting differences in constitutive exon variant expression in different 
tissues 
To test for uneven expression of exons 4 and exon 6 variants in different tissues in D. magna 
not exposed to parasites, I used Pearson’s chi-square and MCMCglmm analyses. I found 
significant differences in relative expression between variants of both exons 4 and 6 in all 
three tissue types (Exon 4 gut: χ² = 27676.5, DF = 7, p = <0.0001; Exon 4 carcass: χ² = 
51853.8, DF = 7, p = <0.0001; Exon 4 haemolymph: χ² = 68805.3, DF = 7, p = <0.0001; 
Exon 6 gut: χ² = 12577.6, DF = 23, p = <0.0001; Exon 6 carcass: χ² = 22828.3, DF = 23, p = 
<0.0001; Exon 6 haemolymph: χ² = 133995.0, DF = 23, p = <0.0001) (Fig. 2). Using 
MCMCglmm, I found significant effects of exon 4 and exon 6-expression, indicating non-
random expression of both exons (see Tables 1 and 2). Thus, variants of exons 4 and 6 were 







Figure 2: Bar chart representing relative constitutive expression of each exon 4 and 6 
variant in different tissues in control D. magna. Exons 4 and 6 in guts, carcasses and 
haemolymph (cells) were expressed in a non-random fashion (see text). The inclusion of exon 5 
indicates the mean proportion of exon-skipping for each exon. Even expression is shown as a 
horizontal line and based on a random expected proportion of all variants equally (i.e. even 
expression = 1/number of variants at a given exon cluster). Error bars represent standard 




5.3.3. Constitutive exon combinatorial splicing in different tissues of D. magna 
I next compared the constitutive combinatorial splicing between the tissue types of D. magna 
and attempted to determine whether splicing was random or non-random in each tissue in the 
absence of parasites. Figure 3 shows a heat map of relative expression levels of all possible 
exon 4-6 combinations in each tissue and visual inspection suggests that the splicing of these 
two exons is close to random (i.e. conditional on the frequency of each exon 4 and 6 variant 
independently) in carcasses and guts, but that some exon-exon combinations were detected at 
frequencies deviating from random expression in these tissues. Indeed, Fisher’s Exact Tests 
carried out on each exon 4-6 combination confirmed while most exon-exon combinations 
were evenly expressed, some combinations appeared to be non-randomly expressed. In 
contrast to carcasses and guts, much of the splicing detected in haemolymph deviated from 
random expression. Notably, I found that exon combination-expression in haemolymph was 
highly variable between individual replicates, whereas exon-exon splicing in guts and 
carcasses was similar between the biological replicates. 
 
Overall, all eight expected exon 4 variants and an expected total of 24 exon 6 variants were 
expressed in all treatments in this study. However, exons 6.2 and 6.3 could not be confirmed 
with reference to the genome, and two alternative alleles not represented in the reference 
genome were detected and may be a result of allelic variation of these exons. The 
unidentifiable sequences were designated 6.aa and 6.bb for the purposes of further analysis. I 
aligned the unidentifiable sequences with the known exon 6 sequences and I constructed a 
phylogenetic tree using maximum likelihood methods for DNA sequences (Fig. 4). I found 
sequence 6.bb to be most similar to the D. magna exon 6.3 variant, while 6.aa was most 







Figure 3: Heat map representation of the relative expression of all possible exon 4-6 
combinations in carcass (left block), gut (middle block), and haemolymph (right block) in D. 
magna not exposed to parasites. Combinatorial splicing appeared to be close to random in gut 
and carcass tissues, but some combinations were detected at non-random frequencies. Splicing in 
haemolymph showed more non-random association than the other tissues. Each cell represents the 
proportion of an exon 4-6 combination, calculated as the mean of biological replicates of control 





Lastly, exon-skipping was detected in all tissues. Unlike the Drosophila studies (see 
Chapters 3 and 4), the forward primers used in this study did not overlap the first base of D. 
magna exon 4 due to differences in sequences between exon variants. Therefore, a rate of 
exon 4-skipping could be estimated. In gut tissue, exon 4-skipping was detected at a 
frequency of 1.5x10
-2
, and exon 6-skipping was double that of exon 4-skipping in guts at a 
frequency of 3x10
-2
. Exon 6-skipping in guts appeared to be relatively common in D. magna 
 
Figure 4: Phylogenetic relationships between D. magna exon 6 variants from the reference 
genome and two allelic variations found in this study. The maximum likelihood method for 
DNA sequences was used to construct the tree. Variant 6.bb was closest to 6.3, while variant 6.aa 
was closest to exon 6.17. Sequences were aligned using BioEdit Sequence Alignment Editor 




and appeared to occur at a frequency higher than that of the expression of several exon 6 
variants in the same tissue (Fig. 2). In carcasses exon 4-skipping was detected at a frequency 
of 3.9x10
-2
 and was comparable to the expression of exon 4.7 in the same tissue, and exon 6-
skipping at a frequency of 3x10
-2
, again occurring at a frequency higher than several exon 6 
variants (Fig. 2). Finally, exon 4-skipping detected in haemolymph was at a frequency of 
5.6x10
-4
, while exon 6-skipping in haemolymph was detected at a frequency comparable to 
the frequencies seen in the other tissue types (3.3x10
-2
). Thus, exon 4- and exon 6-skipping 
appeared to be relatively common in D. magna Dscam. Exon 4-skipping was proportionally 
higher in carcasses than in guts or haemolymph, and exon 6-skipping was similar in all 
tissues. 
 
5.3.4. Detecting differences in constitutive exon variant expression between tissues 
I used two methods of analysis to examine constitutive expression between tissues in control 
D. magna. I used DESeq to test the number of reads for each Dscam exon 4 and 6 variant for 
being differential between tissue types. I found no difference in the relative expression of 
any exon 4 or 6 variant between guts and carcasses (exon 4: all q-values = 1; exon 6: all q-
values ≥ 0.99), guts and haemolymph (exon 4: all q-values ≥ 0.58; exon 6: all q-values ≥ 
0.91), or between carcasses and haemolymph (exon 4: all q-values = 1; exon 6: all q-values ≥ 
0.92). Analysis with MCMCglmm however revealed a significant exon 4-by-tissue effect in 
models including and excluding haemolymph treatments (Tables 1 and 2). Specifically, some 
2.5% of the total variance explained in the models was attributable to an exon 4-by-tissue 
effect (Tables 1 and 2). Furthermore, small exon 6-by-tissue effects were also seen in both 
models (Tables 1 and 2). Thus, subtle tissue-specific exon 4- and 6-expression may occur in 





5.3.5. D. magna Dscam expression in response to different parasite genotypes 
I estimated indices of diversity, and used DESeq and MCMCglmm to test whether Dscam 
expression in D. magna was altered in response to different parasite-exposures. Firstly, I 
estimated tissue-specific Dscam expression diversity for each treatment in the study (see 
Table S7). Figure 5 shows the mean Simpson’s Index of Diversity values estimated for exon 
4, exon 6, and exon 4-6 combinations for each tissue and each immune challenge. 
 
There was a significant effect of tissue on exon 4 diversity (F2,68 = 19.34, p = <0.001), but no 
effect of parasite (F2,68 = 0.05, p = 0.949) or tissue-parasite interaction (F2,67 = 0.07, p = 
0.991) was evident on exon 4 diversity. For exon 6 diversity, a significant effect of tissue 
was also found (tissue: F2,68 = 44.96, p = <0.001), but no effect of parasite (F2,68 = 0.52, p = 
0.597) or interaction between tissue and parasite (F2,67 = 0.52, p = 0.721) was found. Finally, 
a significant tissue-effect was found for exon 4-6 combination diversity (F2,68 = 38.51, p = 
<0.001), but there were no effects of parasite (F2,68 = 0.22, p = 0.800) or tissue-parasite 
interaction (F2,67 = 0.22, p = 0.924) (Fig. 5). Thus, while between-tissue differences in 
expression diversity were evident, no significant effects of parasite-exposure on expression 






Figure 5: Expression diversity for exons 4, 6, and 4-6 combinations between tissues and between 
treatments. I fitted a GLM to diversity data as: (1-D) ~ tissue + parasite + tissue*parasite. Significant tissue 
effects were found, but no effects of parasite were evident for exon 4, exon 6, or exon 4-6 combination 
expression diversity. Diversity is represented as mean 1-D. Error bars represent SEM calculated from eight 
independent experiments. Key: Carc: carcass, Haem: haemolymph, Resist: resistant, Suscept: susceptible, 




Using MCMCglmm, I fitted a model to the count data to test for an interaction between 
Dscam expression and experimental conditions. Table 1 outlines the output representing the 
variance structure for the model. The model mixed well and the average effective sample 
size was around 7500 (see appendix, figure S14). 
 
Table 1: Variance structure summarising MCMCglmm analysis of a model testing for effects of 
pathogen-exposure on Dscam expression. The variance components are of random effects. Key: RE 
= relative expression; cub_PC = cube-root of percentage; C.I. [L/U] = Lower/Upper highest posterior 















Replicate 0.453 0.237 0.070 [0, 1.59] 1.0 
Primer-Pair 3.322 3.248 3.138 [2.13, 4.61] 7.3 
Ex4 18.168 14.804 11.939 [3.33, 40.66] 40.0 
Ex6 3.232 3.014 2.595 [1.38, 5.52] 7.1 
Ex4:Ex6 0.922 0.915 0.900 [0.69, 1.17] 2.0 
Ex4:Tissue 1.044 0.924 0.712 [0.27, 2.13] 2.3 
Ex4:Parasite 0.054 0.029 0.001 [0, 0.20] 0.1 
Ex6:Tissue 0.313 0.302 0.284 [0.17, 0.50] 0.7 
Ex6: Parasite 0.013 0.007 0.000 [0, 0.043] 0.0 
Ex4:Tissue: 
Parasite 
0.512 0.492 0.440 [0.26, 0.78] 1.1 
Ex6:Tissue: 
Parasite 
0.025 0.017 0.000 [0, 0.08] 0.1 
Ex4:Ex6: 
Parasite 
0.007 0.003 0.000 [0, 0.03] 0.0 
Ex4:Ex6: 
Tissue 




0.007 0.003 0.000 [0, 0.03] 0.0 
Residuals 17.297 17.297 17.314 [16.91, 17.67] 38.1 
1 Credibility intervals less than 10-3 are rounded to zero. 
2 Percentage of the total variance explained by random effects in the model. 
 
Much of the variance was explained by non-random exon 4, exon 6, and exon 4-6 
combination expression. In addition, 2.3% of the total variance explained by random effects 
in the model was attributable to an exon 4-by-tissue effect, with a smaller exon 6-by-tissue 
effect also detected (0.7%). An exon 4-by-tissue-by-parasite effect was also seen, 
representing 1.1% of the total variance. The credibility bounds of each of these effects did 




pair, representing some 7.3% of the total variance. Significant effects caused by primer-pairs 
in this analysis were associated with several haemolymph treatments, but not any gut or 
carcass treatments (data not shown). Accordingly, after examining these results, and also 
discovering that expression patterns obtained from haemolymph were highly variable 
between biological replicates in heat maps representative of expression (see figure 6 below), 
the analysis was repeated with haemolymph treatments excluded. Table 2 outlines the output 
representing the variance structure for the model excluding haemolymph treatments. The 
model mixed well and the average effective sample size was around 7000 (e.g. see appendix, 
figure S15). 
 
Table 2: Variance structure summarising MCMCglmm analysis of a model testing for effects of 
pathogen-exposure on Dscam expression. Haemolymph treatments were excluded from this 
analysis. The variance components are of random effects. Key: RE = relative expression; cub_PC = 















Replicate 0.001 0.001 0.000 [0, 0.004] 0 
Primer-pair 0.004 0.004 0.003 [0, 0.007] 0 
Ex4 19.977 16.235 11.726 [4.67, 45.52] 76.0 
Ex6 3.918 3.693 3.311 [1.84, 6.50] 14.9 
Ex4:Ex6 0.904 0.897 0.894 [0.72, 1.12] 3.4 
Ex4:Tissue 0.707 0.541 0.340 [0.13, 1.72] 2.7 
Ex4:Parasite 0.001 0.000 0.000 [0, 0.004] 0 
Ex6:Tissue 0.030 0.027 0.027 [0.008, 0.07] 0.1 
Ex6: Parasite 0.000 0.000 0.000 [0, 0.001] 0 
Ex4:Tissue: 
Parasite 
0.016 0.015 0.014 [0.008, 0.03] 0.1 
Ex6:Tissue: 
Parasite 
0.000 0.000 0.000 [0, 0.001] 0 
Ex4:Ex6: 
Parasite 
0.000 0.000 0.000 [0, 0.001] 0 
Ex4:Ex6: 
Tissue 




0.000 0.000 0.000 [0, 0.001] 0 
Residuals 0.646 0.646 0.647 [0.63, 0.66] 2.5 
1 Credibility intervals less than 10-3 are rounded to zero. 





Here, non-random expression of exon 4, exon 6, and exon 4-6 combination expression was 
detected. The effect of primer-pair seen previously (Table 1) disappeared when haemolymph 
treatments were excluded from the analysis. In addition, tissue effects were again seen and 
included an exon 4-by-tissue effect which represented 2.7% of total variance explained by 
random effects in the model. Moreover, a very small exon 6-by-tissue effect (0.1%), and an 
exon 4-6 combination-by-tissue effect (0.3%) was apparent. The credibility bounds of each 
of these effects did not reach zero but the lower bounds were very close to zero. Notably, a 
very small exon 4-by-tissue-by-parasite effect (0.1%) was also apparent. Thus, effects of 
tissue were detected as before (Table 1), but only a weak effect of parasite-exposure was 
evident when haemolymph treatments were excluded from the analysis. 
 
I then used DESeq and MCMCglmm to test for an effect of parasite treatment on the Dscam 
splicing pattern. Figure 6 shows heat maps representative of exon 4- and exon 6-expression 
for all treatments in the study. Strong patterns were seen for exon variants across treatments 
for both exons 4 and 6. For example, exon 4 variants 4.1, 4.4 and 4.8 were more abundant 
across treatments relative to other exon 4 variants. However, visual inspection suggested that 
no discernible patterns were obvious between different treatments. 
 
I also investigated whether patterns of expression of exon 4-6 combinations were apparent 
between tissues and between treatments. Figure 7 shows a heat map of the relative 
expression of exon 4-6 combinations of which all represented over 0.5% in at least one 






Figure 6: Heat map representation of relative expression of exon 4 (left block) and exon 6 
(right block) variants for all treatments in this study. Patterns of expression for individual 
variants of both exons 4 and 6 across treatments were evident. For example, exons 4.1, 4.4 and 
4.8 were the most abundantly expressed exon 4 variants in all treatments. Notably exon 4 and 
exon 6 expression in haemolymph appeared to show more variation in proportional expression of 
variants between biological replicates. No obvious patterns of expression were detected between 
treatments. The inclusion of exon 5 indicates relative abundance of exon-skipping for each exon 
cluster. Each tissue type, i.e. Gut, Carcass, Haem (haemolymph) included 8 biological replicates, 
and each cell represents the proportional expression of a given exon variant in a single sample. 
Dendrograms result from hierarchical clustering of exon variant expression pattern using 






Figure 7: Heat map representation of relative expression of exon 4-6 combinations of which 
each represented a minimum of 0.5% in at least one treatment in this study. Patterns of 
expression for exon 4-6 combinations across treatments were evident. For example, transcripts 
containing the combinations 4.1-6.1 and 4.8-6.11 (red arrows) were higher in abundance across all 
treatments than transcripts containing the combinations 4.2-6.21 and 4.2-6.22 (green arrows). 
Notably, exon 4-6 combination expression in haemolymph showed more variation in proportional 
expression of many combinations between biological replicates. Each cell represents the 
proportional expression of a given exon combination in a single sample. Dendrograms result from 




As with individual exons, visual inspection suggested that patterns were evident across 
treatments. For example, transcripts containing the combinations 4.1-6.1 and 4.8-6.11 were 
higher in abundance across all treatments than transcripts containing the combinations 4.2-
6.21 and 4.2-6.22. However, as with independent exon 4- and 6-expression (Fig. 6), visual 
inspection suggested that no discernible patterns were obvious between different treatments. 
 
Notably, haemolymph in all treatments showed significantly more variation in exon 4- and 
6-expression patterns between biological replicates (see Figures 6 and 7). For example, 
patterns of higher variation in exon 4-6 combination expression were seen in haemolymph 
compared to other tissues of Daphnia exposed to both strains of P. ramosa (Fig. 7). This 
variation between biological replicates was not seen in guts or carcasses. Moreover, separate 
examination of the 8 individual replicates for each tissue type showed high variation between 
them in haemolymph, but variation between biological replicates in guts and carcasses were 
much more similar (not shown). 
 
Following DESeq analysis, I found no differential expression of any exon 4 or 6 variant in 
any tissue in response to exposure to either strain of P. ramosa (all q-values ≥ 0.99). Equally, 
no differential expression in response to pathogen-exposure was detected in any exon 4-6 
combination in any tissue (all q-values = 1). Following MCMCglmm analysis inclusive of 
haemolymph treatments, I found that exon 4.1 in haemolymph appeared to be affected by 
strain r of P. ramosa (p = 0.01). However, in analysis excluding haemolymph treatments, no 









5.4.1. Dscam is non-randomly expressed in D. magna but tissue-regulated 
expression could not be confirmed 
Constitutive expression in Daphnia  
As seen in Drosophila (see Chapter 4), variants of exons 4 and 6 are non-randomly 
expressed in all tissues examined in D. magna. This was observed as strong deviation from 
even expression, and is indicative of some level of regulation (Fig. 2). In addition, analysis 
with MCMCglmm confirmed that effects of exon 4, exon 6, and exon 4-6 combinations 
made significant contributions to total variance found in the model whether haemolymph 
treatments were included or excluded (see Tables 1 and 2). The results are also partly 
consistent with previous work on D. magna Dscam. Brites et al (2008) observed that patterns 
of expression of exons 4, 6 and 11 strongly deviated from random expectation in 
haemocytes. 
 
Patterns of combinatorial splicing of exons 4 and 6 were comparable to those detected in 
Drosophila (see Chapters 3 and 4). Exon 4-6 combinations in control Daphnia appeared to 
be close to random in guts and carcasses, with some combinations detected at frequencies 
deviating from random expectation (Fig. 3). MCMCglmm analysis including haemolymph 
treatments found no significant exon combination-by-tissue effects (Table 1). However, 
analysis excluding haemolymph treatments detected a significant exon combination-by-
tissue effect (Table 2). Following analysis with DESeq, no significant differences in exon 
combination expression between tissues was detected. In contrast to gut and carcass tissues, 
exon-exon splicing in haemolymph appeared to be much more variable (Fig. 3). Separate 
examination of the 8 individual replicates showed high variation between them in 
haemolymph, but not in other tissues. Moreover, a high level of variance was attributed to 




were caused only by primer-pairs associated with haemolymph treatments. Thus, effects of 
early-round PCR stochasticity may have occurred, but that high variation exists in Dscam 
expression in haemolymph at an individual level cannot be excluded. 
 
Unlike expression in Drosophila, where some exon 4 variants appeared to show tissue-
specific expression (see Chapter 4), expression of exon 4 and 6 variants appears to be similar 
between tissues in Daphnia. However subtle tissue-specific expression in the crustacean 
could not be excluded. While I could detect no difference in the relative expression levels of 
exon 4 and 6 variants between tissues with DESeq analysis, I found significant exon-by-
tissue effects for both exons 4 and 6 using MCMCglmm (Table 1). Moreover, a model 
excluding the highly variable haemolymph treatments also found a significant exon-4-by-
tissue effect (Table 2). In the latter analysis, the exon-6-by-tissue effect also remained, 
however the effect was much smaller with the lower credibility bound very close to zero. 
 
Exon-skipping occurs at relatively high frequencies in D. magna 
Exon 4- and 6-skipping was detected in D. magna. Exon 4-skipping was higher in carcasses 
than in guts, and lowest in haemolymph. Contrastingly, exon 6-skipping was comparable 
between all tissues assayed, a pattern also seen in my Drosophila study (Chapter 4). 
Interestingly, exon-skipping for both exons appeared to occur as frequently as the expression 
of some exon variants, especially true of exon 6. As speculated previously (see Chapter 4, 
Discussion), exon-skipping may be a failure of the splicing mechanism or possibly part of a 
regulatory mechanism. Based on the present data, it appears to show tissue-specific 
occurrence in exon 4, but not in exon 6. This could be indicative of different regulation of 
splicing for each exon, or a difference in splicing-fidelity between the exons. Interestingly, 
the sequencing motifs thought to be involved in alternative splicing of exons 4 and 6 in 




2008). Thus, the splicing mechanism may be preserved between the diverged species and the 
purpose (or consequence) of exon-skipping may be comparable between the species. 
 
Novel D. magna Dscam alleles were discovered 
All expected exon 4 variants were found in this study, and all expected exon 6 variants were 
also found with the exception of exons 6.2 and 6.3. However, I discovered two variants of 
exon 6 which did not match the reference genome, designated 6.aa and 6.bb. Following 
phylogenetic tree construction based on maximum likelihood method (Fig. 4), I found the 
amino acid sequence of variant 6.bb to be closest to the classical exon 6.3. Interestingly, 
previous work in D. magna Dscam failed to detect exon 6.3 (Brites, McTaggart et al. 2008). 
Thus, 6.bb is very likely an allelic variation of the reference exon 6.3. Exon 6.aa however, 
although most similar to exon 6.17, did not closely match the amino acid sequence of any 
classical D. magna exon 6 variant. That 6.aa is a novel exon 6 variant cannot be excluded. 
However it should be noted that only a part of the exon sequence was available for clustering 
analysis and a full-length sequence would be required for a more accurate comparison. 
 
5.4.2. D. magna Dscam expression in response to natural parasite diversity 
I investigated whether D. magna Dscam gene expression was affected by exposure to 
different isolates of P. ramosa. I used three methods of analysis as previously employed in 
Chapters 3 and 4, and found only weak effects of parasite-exposure on Dscam expression in 
D. magna. A small exon 4-by-tissue-by-parasite effect was detected using a MCMCglmm 
model inclusive of haemolymph treatments (Table 1), however analysis excluding the highly 
variable haemolymph treatments found that the effect was dramatically reduced, and 
although credibility bounds did not reach zero, the lower bound was very close (Table 2). 
Moreover, following DESeq analysis, no differential expression of variants of exon 4 or 6, or 
combinations thereof, were detected in response to any strain of P. ramosa. The calculation 




small differences seen. Additionally, a GLM fitted to estimates of expression diversity found 
no effects of parasite-exposure. This suggested that either no change in expression diversity 
occurs in D. magna in response to the parasites used in this study, or that the strength of the 
analysis is too weak to detect any changes. This reflects expression diversity analysis seen in 
Drosophila (Chapter 4), which also showed no effect of pathogen-exposure in any tissue.  
 
Interestingly, Brites (2010) also examined Dscam exon 4-expression between two different 
isolates of P. ramosa (one of which the host was susceptible to infection, one of which the 
host was resistant) using qRT-PCR and also found no supporting evidence that regulation of 
alternative Dscam exons occurred in response to parasite-exposure. Additionally, using qRT-
PCR to measure levels of overall Dscam transcripts in response to parasite-exposure, no 
change in total Dscam transcript abundance was found in either resistant or susceptible hosts 
(Brites 2010). Incidentally, this was also consistent with studies in Anopheles, where no 
overall changes of Dscam transcript abundance accompanied parasite-exposure, indicating 
that Dscam transcripts are not up-regulated in response to parasites (Dong, Taylor et al. 
2006). Brites (2010) concedes that the critical time point to detect such effects may have 
been missed, having harvested Daphnia one week post-exposure. Nonetheless, the present 
study and an independent Daphnia study have found no strong supporting evidence of 
effects of parasite-exposure on the usage of alternative exons 4 or 6 in D. magna. 
 
It was possible that changes in Dscam expression were missed because the wrong time point 
(4 hours) was chosen. Interestingly, an independent study in another crustacean, P. 
leniusculus, reported the significant induction of Dscam mRNA expression post-exposure to 
bacteria after 6 hours. Nevertheless, as a cellular immune response has been previously 
shown in Daphnia at 4 hours (Auld, Scholefield et al. 2010), Dscam-mediated expression to 





Finally, despite the use of a cloned host-line of synchronised individuals, the haemolymph in 
all treatments showed significantly more variation in exon 4- and 6-expression (Fig. 6), and 
many exon 4-6 combinations (Fig. 7) between biological replicates. Whether the source of 
this variation originated from early-round PCR stochasticity, originated at the level of RNA 
extraction or cDNA synthesis, or is a true reflection of Dscam expression in D. magna 
haemolymph, is unknown. It will be important to increase as much as possible the amount of 
mRNA extracted from haemolymph to ensure samplings of the cDNA pool can be reliably 
representative of Dscam expression in this tissue type. Future studies may benefit from the 
use of flow cytometry and fluorescence-activated cell sorting to both purify and quantify 




It appears that although a significant cellular response can occur in Daphnia following 
exposure to natural parasites (Auld, Scholefield et al. 2010), it is not accompanied by any 
discernible change in Dscam expression. The cellular response which occurs in susceptible 
hosts, but not in resistant hosts, could indicate that resistance is borne from prevention of 
parasite-entry rather than triggered immune mechanisms (Auld, Scholefield et al. 2010). As 
such, one could have expected detectable differences in Dscam expression patterns between 
the exposures where one parasite drives gene expression while the other has little or no 
effect, however this was not apparent. In the present study and in an independent study on 
Daphnia Dscam expression (Brites 2010), no obvious effects of parasite-exposure were seen 
on Dscam exon 4- or 6-expression, or indeed on the total abundance of Dscam transcripts 





To date, I have discovered subtle exon 4-by-challenge effects in independent experiments 
with Anopheles (Chapter 2), and in Drosophila (Chapters 3 and 4), with a very small effect 
here in Daphnia (Table 2). If Dscam is involved in the Daphnia response to isolates of P. 
ramosa it could be constitutive, in other words, not influenced further by immune challenge. 
Future work comparing Dscam expression between different host genotypes in response to 
natural parasites may reveal differences in constitutive Dscam expression which could be 





6. General Discussion  
 



























6.1. Pathogen-specificity in immunity 
In vertebrates, an understanding of pathogen-specificity is well established. Through 
antibody diversification, vertebrates can recognise and respond discriminately to millions of 
antigens. Vertebrates also benefit from long-term pathogen-specific memory, which results 
in a more rapid and efficient response to repeat exposures. Whether invertebrates have 
pathogen-specific immunity remains uncertain, but some level of specificity in invertebrate 
immunity is known. Similar to vertebrates, invertebrates show specific recognition of 
pathogen associated molecular patterns (PAMP) through pattern recognition receptors 
(PRRs) (Medzhitov and Janeway 2000). For example, peptidoglycan recognition proteins 
(PGRPs) respond to the presence of peptidoglycan (PG), an essential and highly conserved 
component of the bacterial cell wall, by inducing antimicrobial effects (Dziarski and Gupta 
2005). This could be described as pathogen class-specific immunity. 
 
Invertebrates were thought to lack pathogen-specific immunity or specific memory primarily 
because they seem to lack the equivalent molecules which confer these phenomena in 
vertebrates, such as antibodies. Moreover, the necessity of relatively short-lived invertebrates 
requiring a complex immune system could be questioned. Nevertheless, an ‘enhanced 
immunity’ to repeat infection was found in invertebrates some 40 years ago (Boman, Nilsson 
et al. 1972), and several examples of a higher level of specificity in the immune response of 
invertebrates have been discovered since (Kurtz and Franz 2003; Sadd, Kleinlogel et al. 
2005; Sadd and Schmid-Hempel 2006; Sadd and Schmid-Hempel 2007; Johnson, van Hulten 
et al. 2008), indicative of a more complex immune system than previously supposed. 
Furthermore, fitness benefits of invertebrates possessing an apparently complex immune 
system have been discovered (Little, O'Connor et al. 2003; Moret and Siva-Jothy 2003), and 
experimental data has even suggested that specific memory exists in an invertebrate (Pham, 




exposed to infectious micro-organisms for over 400 million years (Grimaldi 2009), could 
have evolved pathogen-specificity and specific memory to defend against disease. Yet, 




6.2. Dscam and pathogen-specificity 
Dscam is currently the best candidate for the underlying mechanism for a pathogen-specific 
response in invertebrate immunity. Implicated in having a role in phagocytosis, a great deal 
of excitement has surrounded Dscam’s possible involvement in specificity in invertebrate 
immunity (Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006; 
Watthanasurorot, Jiravanichpaisal et al. 2011). However, evidence of pathogen-specific 
Dscam splicing is limited. So far, a pathogen-specific expression of Dscam isoforms has 
been reported in the mosquito and crayfish only (Dong, Taylor et al. 2006; Watthanasurorot, 
Jiravanichpaisal et al. 2011).  
 
In the mosquito study, quantitative RT-PCR (qRT-PCR) was used to determine the fold 
change in relative expression of Dscam exon 4 variants in response to different immune 
elicitors (Dong, Taylor et al. 2006). The study reported levels of over- and under-
representation of exon variants, detecting up to 4-fold changes in either direction. The 
implications of infection-responsive splicing of Dscam in a malaria vector would be 
significant. However, qRT-PCR may not be the most reliable method to study relative 
Dscam exon variant-expression. For instance, different methods of analysis of qRT-PCR 
data can differ in their accuracy and reproducibility, and can even lead to opposing 
biological conclusions (Skern, Frost et al. 2005; Cikos, Bukovska et al. 2007). It has been 




made from qRT-PCR data (Skern, Frost et al. 2005). To my knowledge, Dong et al (2006) 
used only one method of analysis. Moreover, only exon 4 variant-expression was assayed in 
the mosquito, and only three replica assays were carried out to determine fold-changes of 
expression in the qRT-PCR analysis. Qualitative information gathered from the splicing of 
two or more alternative exons (e.g. variable exons 4, 6 and 10 in A. gambiae), and an 
increase of biological replication may have led to more robust or even different results. 
 
Both Anopheles and Pacifastacus studies do show evidence of pathogen-specific binding of 
some exon variants (Dong, Taylor et al. 2006; Watthanasurorot, Jiravanichpaisal et al. 2011). 
In the Anopheles study, bacterial binding assays showed that the affinity of immune 
challenge-responsive Dscam exon 4 variants correlated with their induction specificity 
determined by qRT-PCR (Dong, Taylor et al. 2006). For example, exon 4.8 appeared to be 
significantly over-expressed by cells challenged with E. coli and splice forms containing 
exon 4.8 had a higher binding affinity to E. coli. However, after a similar binding assay but 
with selective silencing of exon 4.8 through RNAi-targeting, decreased binding of Dscam to 
E. coli and another gram-negative bacterium, Pseudomonas veronii, was seen. In addition, 
expression patterns generated by these two gram-negative bacteria were very similar in 
challenged Sua5B cells (Pearson’s correlation coefficient, r = 0.80), while cells exposed to 
lipopolysaccharide (characteristic of gram-negative bacteria) or peptidoglycan (characteristic 
of gram-positive bacteria) showed only some degree of correlation (data not given). This is 
suggestive of pathogen class-specific splice-form expression. In the crayfish study, different 
representatives of gram-negative or gram-positive bacteria were not compared 
(Watthanasurorot, Jiravanichpaisal et al. 2011). Therefore, it could not be determined 
whether pathogen-specific rather than pathogen class-specific Dscam expression patterns 
and binding activity occurs in this crustacean. While both studies showed that Dscam 
mediates in phagocytosis, and is associated with immune function, they did not show 





In this thesis, I examined the Dscam splicing pattern in response to immune challenge using 
a powerful sequencing method. The hypervariable form of the Dscam gene has never been 
found outside the Pancrustacea (Crayton, Powell et al. 2006; Armitage, Freiburg et al. 2012). 
Accordingly, I examined infection-responsive Dscam expression in three host species 
representative of both the insects and crustaceans. 
 
 
6.3. Findings of the present study 
In Chapter 2, I followed on from the work of Dong et al (2006) where pathogen-specific 
splicing of Dscam was first reported in the Anopheles mosquito. Using a cloning and 
sequencing approach, and examining Dscam expression diversity in the mosquito in 
response to different genotypes of its natural parasite, P. falciparum, I demonstrated that 
diversity increased in parasite-exposed mosquitoes. However, I found only weak evidence 
that diversity increased further in response to increasing parasite diversity. I also discovered 
that although it was the combined diversity of exons 4 and 6 that drove the patterns seen in 
both the field and the laboratory, exon 4 had a close-to-significant effect on the relationship 
between expression diversity and parasite diversity. 
 
In Chapter 3, I extended the study to a more experimentally amenable organism and adopted 
a much more powerful method of approach. Using a specially-designed Illumina-based 
sequencing method, I examined both constitutive and infection-responsive Dscam expression 
in Drosophila. I confirmed that Dscam exons 4 and 6 are non-randomly expressed, indicative 
of some level of regulation, and that the method was capable of detecting allelic variations of 
exon variants and novel exons of Drosophila Dscam. Interestingly, I also found a small but 




expression in Drosophila analysed with deep sequencing technology fell short of the striking 
results previously reported in Anopheles (Dong, Taylor et al. 2006). 
 
As the background of the whole fly may have obscured pathogen-induced effects on the 
expression of Dscam, I next examined expression in separated tissues in response to immune 
elicitors of Drosophila (Chapter 4). I reasoned that analysing tissue-specific patterns of 
expression should reduce the nervous-system background. As such, the signal of an immune-
related pattern would be less obscured, especially in response to well-characterised immune 
elicitors such as the bacteria Escherichia coli and Micrococcus luteus. I again found small 
pathogen-induced effects on Dscam exon 4-expression, which also appeared to be dependent 
upon tissue. Moreover, results of the high-throughput sequencing approach confirmed that 
exon 4 was expressed in a tissue-specific manner, and determined that unlike exon 4-
expression, exon 6-expression did not appear to be tissue-dependent. 
 
Finally, in Chapter 5 I switched to another member of the Pancrustacea, namely the 
crustacean Daphnia. By exposing a clonally propagated host to different strains of its natural 
parasite to which different infection outcomes had been previously reported (Carius, Little et 
al. 2001), I hoped to determine whether significant differences in Dscam expression could be 
seen between Daphnia exposed to the different challenges. Again, I found a small tissue-
dependent effect on the expression of Dscam exon 4 in response to parasite-exposure. I also 
determined that exons 4 and 6 in Daphnia Dscam were non-randomly expressed in the 
different tissues assayed, and found that tissue-specific expression appears to be more subtle 
compared to that seen in Drosophila. 
 
The results outlined in this thesis cannot rule out pathogen-specific Dscam splicing in the 
three different species used in this study, but they consistently suggest that effects, if they 




artefact cannot be ruled out either. Interestingly however, all detected effects appeared to be 
attributable only to the exon 4 cluster. 
 
Comparison with other work 
What may have led to the differences seen between the present work and others? Dong et al 
(2006) reported pathogen-specific Dscam splicing in Anopheles after exposure to an array of 
immune elicitors in a mosquito cell line. It is possible the use of cell culture provides more 
power as it eliminates the background of the whole insect. However, the same study also 
reported infection-responsive splicing in adult mosquitoes in response to different types of 
Plasmodium (Dong, Taylor et al. 2006). My work included an estimation of the diversity of 
expression of many possible Dscam isoforms, and in whole insects exposed to different 
treatments (Smith, Mwangi et al. 2011). This turned out to be a relatively weak form of 
analysis, seemingly lacking the capacity to detect the pathogen-specificity previously 
reported of Anopheles Dscam (Dong, Taylor et al. 2006). Should the high-throughput 
sequencing method developed for the Drosophila and Daphnia studies (Chapters 3-5) have 
been employed to study Dscam in Anopheles (Chapter 2), results may have been different. 
Nevertheless, a failure to find definitive infection-responsive Dscam splicing in Drosophila 
and Daphnia is interesting. It is possible that Anopheles mosquitoes benefit from having 
Dscam-mediated pathogen-specificity but other invertebrates do not. After all, profound 
differences in the lifestyles and environmental exposures exist between Anopheles, 
Drosophila, and Daphnia. However, pathogen-specific splicing has also been reported in the 
crayfish, and therefore may be apparent in both insect and crustacean species. As such, 







6.4. Future directions 
Is Dscam hyper-diversity important in immunity? 
How important the hyper-diversity of Dscam is within the context of invertebrate immunity 
remains uncertain. Does it confer a greater capacity for pathogen-recognition? Is the nature 
of the diversity what matters, or is arbitrary diversity enough for Dscam’s role in the immune 
system? It has been established that although individual Dscam-expressing neurons are 
required to express distinct isoforms, the specific identity of the isoforms expressed in an 
individual nerve cell does not appear to be important (Hattori, Demir et al. 2007). Brites 
(2010) has proposed that Dscam may simply confer cell-to-cell recognition of haemocytes in 
order to prevent aggregation. In other words, the gene may have comparable roles in both the 
nervous and immune systems.  
 
Measuring cell function after gene silencing 
It has been shown that by silencing Dscam, significant reduction in phagocytosis is seen in 
different species (Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006). This 
strongly suggests that Dscam may have a role in the pathogen-recognition and destruction 
process. However, if Dscam is otherwise involved in general cellular functions, such as 
cellular extensions, its silencing may simply render a cell less competent at many biological 
processes, including phagocytic uptake of pathogens. Additionally, it is entirely feasible that 
Dscam plays a role in immunity but does so in cooperation with other molecules serving 
common functions such as pathogen-clearance. For example, Dscam may be part of a multi-
protein complex on the surface of haemocytes, but carries out a cellular function important 
for phagocytosis but not directly related to pathogen-specificity. As such, relating loss-of-
function directly to a particular silenced gene may be useful in elucidating the mechanism of 
a cellular process such as pathogen-recognition, but it cannot determine exactly what part the 






A better understanding of the constitutive expression dynamics of Dscam may reward 
subsequent approaches to investigate infection-responsive expression. For example, it is 
currently uncertain how the expression of Dscam mRNAs and protein isoforms change over 
time. As such, it would be extremely useful to determine the approximate half-life of Dscam 
mRNAs (Neves, Zucker et al. 2004). Methods such as pulse-chase analysis (Jansens and 
Braakman 2003) may allow the incorporation of a labelled compound into Dscam molecules 
to help determine not only the movement of Dscams within a cell, but exactly for how long 
Dscams are expressed and under different conditions. This method would be of particular 
interest to monitor Dscam isoforms in an adherent cell-line which both expresses Dscam and 
undergoes phagocytosis. 
 
Soluble forms of Dscam have been found in Anopheles and Drosophila haemolymph 
(Watson, Puttmann-Holgado et al. 2005; Dong, Taylor et al. 2006), and may be produced by 
proteolytic cleavage of the membrane-bound forms (Watson, Puttmann-Holgado et al. 2005). 
Secreted isoforms circulating in haemolymph are unlikely to be involved in neural activity 
(Brites 2010), and they have been proposed to play a role in opsonisation, a process which 
facilitates phagocytosis by recruiting antigens to the surfaces of haemocytes (Watson, 
Puttmann-Holgado et al. 2005). An assessment of the expression and function of soluble 
forms of Dscam may help elucidate how Dscam mediates phagocytosis. For example, 
determining whether soluble Dscams bind to the surface of phagocytic cells may strengthen 
the hypothesis that they act as opsonins. Moreover, measuring phagocytic activity in the 






Lastly, the most striking report of Dscam splicing within the context of immunity originated 
in Anopheles (Dong, Taylor et al. 2006). Thus, a natural next step may be to investigate 
Dscam splicing in the haemocyte-like immune competent Sua5B mosquito cell-line in 
response to different species of Plasmodium but applying high-throughput sequencing 
technology. This would enable the quantification of the expression pattern, exclude the 




6.5. Concluding remarks  
This thesis introduces a novel Illumina-based sequencing method useful for the 
quantification of the Dscam expression pattern and analysis of complex alternative splicing 
of Dscam in different organisms under different conditions. Prospects for its adoption 
include the investigation of Dscam splicing in more insect and crustacean species where the 
hypervariable form of the gene has been found (e.g. Anopheles, Apis, Pacifastacus, 
Litopenaeus), and the examination of Dscam expression in both the nervous and immune 
systems. Finally, the implications of pathogen-specific recognition in invertebrates could be 
huge, but I found only weak evidence that Dscam responds in a pathogen-specific manner in 
Anopheles, Drosophila and Daphnia. When examining expression of exon 4 in the three 
different species, I could not rule out effects of immune challenge on the expression of 
variants of this exon cluster. Specifically, small exon 4-by-challenge effects were seen in 
independent studies of all three tested host species. Thus, the possibility remains that a 
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7.1. Chapter 2 appendices 
7.1.1. Neighbour-Joining tree construction and chi-square contingency table 
analysis 
 
Methods: Full AgDscam exon variant DNA sequences were aligned using ClustalW and 







Figure S1: Neighbour-Joining tree of AgDscam exon 4 variants clustered into 3 groups. Full-
length DNA sequences of the 14 variants of exon 4 were aligned using BioEdit software version 




Table S1a: Cross tabulation and chi-square results for exon 4 clustered into 3 groups in our NJ 
tree between control and exposed treatments in the field. Analysis was carried out using Minitab® 
15.1.1.0. Exon 4 variants 4.11, 4.12 and 4.13 are represented as Group 3 and were under-represented 
in control mosquitoes compared to exposed treatments in the field (Pearson Chi-Square = 6.318, DF = 
2, p = 0.042). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 82 59 12 
Expected 79.7 52.3 21.0 
Exposed 
Observed 255 162 77 
Expected 257.3 168.7 68.0 
 
Table S1b: Cross tabulation and chi-square results for exon 4 clustered into 3 groups in our NJ 
tree between controls, single-, double- and triple-exposed treatments in the field. Analysis was 
carried out using Minitab® 15.1.1.0. Differences between observed and expected values were not 
statistically significant (Pearson Chi-Square = 8.970, DF = 6, p = 0.175). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 82 59 12 
Expected 79.7 52.3 21.1 
Single 
Observed 82 51 18 
Expected 78.7 51.6 20.8 
Double 
Observed 94 63 33 
Expected 99.0 64.9 26.1 
Triple 
Observed 79 48 26 
Expected 79.7 52.3 21.1 
 
Table S1c: Cross tabulation and chi-square results for exon 4 clustered into 3 groups in our NJ 
tree between control and exposed treatments in the lab. Analysis was carried out using Minitab® 
15.1.1.0. Differences between observed and expected values were not statistically significant (Pearson 
Chi-square = 3.231, DF = 2, p = 0.199). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 169 108 43 
Expected 159.3 121.6 39.0 
Exposed 
Observed 558 447 135 







Table S1d: Cross tabulation and chi-square results for exon 4 clustered into 3 groups in our NJ 
tree between controls, 3D7, HB3 and mixed exposed treatments in the lab. Analysis was carried 
out using Minitab® 15.1.1.0. Differences between observed and expected values were not statistically 
significant (Pearson Chi-Square = 4.724, DF = 6, p = 0.580). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 169 108 43 
Expected 159.3 121.6 39.0 
3D7 
Observed 193 148 42 
Expected 190.7 145.6 46.7 
HB3 
Observed 173 144 49 
Expected 182.2 139.1 44.6 
3D7/HB3 
Observed 192 155 44 
Expected 194.7 148.6 47.7 
 
Table S1e: Cross tabulation and chi-square results for exon 4 clustered into 3 groups in our NJ 
tree between 3D7 and HB3 treatments in the lab. Analysis was carried out using Minitab® 
15.1.1.0. Differences between observed and expected values were not statistically significant (Pearson 
Chi-Square = 1.301, DF = 2, p = 0.522). 
Treatment  
Count 
Group 1 Group 2 Group 3 
3D7 
Observed 193 148 42 
Expected 187.2 149.3 46.5 
HB3 
Observed 173 144 49 









Figure S2: Neighbour-Joining tree of AgDscam exon 6 variants clustered into 3 groups. Full-
length DNA sequences of 28 variants of exon 6 were aligned using BioEdit software version 




Table S2a: Cross tabulation and chi-square results for exon 6 clustered into 3 groups in our NJ 
tree between control and exposed treatments in the field. Analysis was carried out using Minitab® 
15.1.1.0. Differences between observed and expected values were not statistically significant (Pearson 
Chi-Square = 5.243, DF = 2, p = 0.073). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 105 29 19 
Expected 94.6 30.4 27.9 
Exposed 
Observed 315 106 105 
Expected 325.4 104.6 96.1 
 
Table S2b: Cross tabulation and chi-square results for exon 6 clustered into 3 groups in our NJ 
tree between controls, single-, double- and triple-exposed treatments in the field. Analysis was 
carried out using Minitab® 15.1.1.0. Exon 6 variants 6.1 and 6.9 are represented as Group 3 and 
appeared to be under-represented in control mosquitoes but over-represented in mosquitoes exposed to 
a single parasite genotype in the field (Pearson Chi-Square = 19.975, DF = 6, p = 0.003). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 105 29 19 
Expected 94.6 30.4 27.9 
Single 
Observed 87 25 47 
Expected 98.4 31.6 29.0 
Double 
Observed 122 43 31 
Expected 121.2 39.0 35.8 
Triple 
Observed 106 38 27 
Expected 105.8 34.0 31.2 
 
Table S2c: Cross tabulation and chi-square results for exon 6 clustered into 3 groups in our NJ 
tree between control and exposed treatments in the lab. Analysis was carried out using Minitab® 
15.1.1.0. Differences between observed and expected values were not statistically significant (Pearson 
Chi-Square = 1.446, DF = 2, p = 0.485). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 182 56 68 
Expected 172.8 60.4 72.8 
Exposed 
Observed 599 217 261 







Table S2d: Cross tabulation and chi-square results for exon 6 clustered into 3 groups in our NJ 
tree between controls, 3D7, HB3 and mixed exposures in the lab. Analysis was carried out using 
Minitab® 15.1.1.0. Differences between observed and expected values were not statistically 
significant (Pearson Chi-Square = 3.984, DF = 6, p = 0.679). 
Treatment  
Count 
Group 1 Group 2 Group 3 
Control 
Observed 182 56 68 
Expected 172.8 60.4 72.8 
3D7 
Observed 209 64 90 
Expected 205.0 71.6 86.4 
HB3 
Observed 189 71 79 
Expected 191.4 66.9 80.6 
Mix 
Observed 201 82 92 
Expected 211.8 74.0 89.2 
 
Table S2e: Cross tabulation and chi-square results for exon 6 clustered into 3 groups in our NJ 
tree between 3D7 and HB3 exposures in the lab. Analysis was carried out using Minitab® 15.1.1.0. 
Differences between observed and expected values were not statistically significant (Pearson Chi-
Square = 1.265, DF = 2, p = 0.531). 
Treatment  
Count 
Group 1 Group 2 Group 3 
3D7 
Observed 209 64 90 
Expected 205.8 69.8 87.4 
HB3 
Observed 189 71 79 















 7.1.2. PCR detection of Plasmodium species 
 
Methods: Existing primer sequences for Plasmodium falciparum, P. malariae, P. ovale and 
P. vivax 18s rRNA, and nested PCR conditions were taken from (Snounou, Viriyakosol et al. 
1993). Template DNA was extracted from blood samples spotted onto Whatman® paper 
using a Chelex-100 isolation technique (Wooden, Kyes et al. 1993). 
 
Results: All blood samples were infected with P. falciparum, no blood was infected with P. 
ovale or P. vivax, while two samples contained P. malariae in addition to P. falciparum 
(Table S3). 
 
Table S3: Scoring of presence or absence of four species of Plasmodium following PCR detection. 
Treatment P. falciparum P. malariae P.ovale P.vivax 
SH158 (triple 
infection_#1) 
+ - - - 
SH93 (triple 
infection_#2) 
+ - - - 
SH79 (double 
infection_#1) 
+ - - - 
SH25 (double 
infection_#2) 
+ - - - 
K10(single 
infection_#1) 
+ + - - 
IG14 (single 
infection_#2) 
+ + - - 







7.1.3. Plasmodium falciparum intensity 
 
Methods: Real-time quantitative PCR assays were performed on an Applied Biosystems 
StepOnePlus cycler and we used the non-specific nucleic acid stain SYBR Green I which 
preferentially binds to dsDNA. For our reference gene, human-specific Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) primers were designed using Primer3 software 
(http://frodo.wi.mit.edu/) and checked for quality (tendency to dimerise, cross-dimerise, 
hairpin etc) with NetPrimer (http://www.premierbiosoft.com/netprimer/index.html) (primers 
were: F: 5’ – CGACCACTTTGTCAAGCTCA – 3’, R: 5’ - 
GGTGGTCCAGGGGTCTTACT – 3’) and amplified an 112bp fragment. Existing primers 
were used to amplify Plasmodium falciparum SSU rRNA (primers were: F: 5’ – 
TCTAGGGGAACTATTTTAGCTT – 3’, R: 5’ – CACAGTAAATGCTTTAACTGTT – 3’) 
isolating an 180bp fragment (Bell and Ranford-Cartwright 2004). All cycler runs included 
serial dilutions of parasite DNA to indicate primer efficiency and included a melting curve 
analysis for product identification. Each reaction contained: 8µl SYBR Green Master Mix, 
10µl ddH2O, 1µl primer mix (10mM concentration) and 1µl template genomic DNA. PCR 
conditions were: holding stage: 95ºC for 10 minutes; cycling stage: 40 cycles of 95ºC for 15 
seconds, 55ºC for 60 seconds; and melt curve stage: 95ºC for 15 seconds, 55ºC for 60 
seconds, temperature increment +0.3ºC, 95ºC for 15 seconds. 
 
We quantified relative parasite intensity for two blood samples which were confirmed (using 
microsatellite loci sizing) to contain a minimum of one P. falciparum genotype (K10, IG14; 
single infections), two blood samples containing a minimum of two P. falciparum genotypes 
(SH79, SH25; double infections), and two blood samples containing a minimum of three P. 
falciparum genotypes (SH158, SH93; triple infections). Mean Ct values were calculated from 




– Mean Ct,reference), and we plotted fold difference between target DNA and reference DNA 
(2
-delta Ct






Key: +++; triple infection, ++; double infection, +; single infection. 
Figure S3: Fold difference in relative DNA quantity between human reference gene 
(GAPDH) and target (Plasmodium falciparum). Error bars represent standard error and 












Figure S4: Quantile-Quantile (Q-Q) plot of Illumina sequencing raw count data of Chapter 3 




Table S4: Simpson’s Index of Diversity values for all treatments in the study (Chapter 3). 
Diversity indices for exon 4, exon 6, and exon 4-6 combinations are shown and were calculated as 
Simpson's Index of Diversity (D) = 1-sum((Exoni/sum(Exoni))^2). 
Ref Treatment Exon 4 (1-D) Exon 6 (1-D) Exon 4-6 (1-D) 
R01 UNW_wol+_6H_3 0.8993 0.9723 0.9970 
R02 UNW_wol+_30H_3 0.8939 0.9730 0.9967 
R03 RING_wol+_6H_3 0.9019 0.9716 0.9967 
R04 RING_wol+_30H_3 0.9061 0.9724 0.9970 
R05 DCV_wol+_6H_3 0.8986 0.9723 0.9967 
R06 DCV_wol+_30H_3 0.8992 0.9737 0.9973 
R07 UNW_wol-_6H_3 0.8982 0.9731 0.9971 
R08 UNW_wol-_30H_3 0.9023 0.9738 0.9972 
R09 RING_wol-_6H_3 0.8933 0.9734 0.9971 
R10 RING_wol-_30H_3 0.8983 0.9722 0.9967 
R11 OIL_wol-_6H_3 0.9021 0.9716 0.9970 
R12 OIL_wol-_30H_3 0.8999 0.9721 0.9967 
R13 BASS_wol-_6H_3 0.8997 0.9724 0.9970 
R14 BASS_wol-_30H_3 0.9010 0.9715 0.9970 
R15 DCV_wol-_6H_3 0.9041 0.9716 0.9970 
R16 DCV_wol-_30H_3 0.9023 0.9733 0.9973 
R17 PiGV_wol-_6H_3 0.8964 0.9728 0.9967 
R18 PiGV_wol-_30H_3 0.9020 0.9728 0.9970 
R19 Ecoli_wol-_6H_3 0.8991 0.9722 0.9969 
R20 Ecoli_wol-_30H_3 0.9051 0.9715 0.9971 
R21 Mlut_wol-_6H_3 0.9017 0.9725 0.9972 
R22 Mlut_wol-_30H_3 0.9023 0.9732 0.9972 
R23 UNW_wol+_6H_4 0.8966 0.9717 0.9970 
R24 UNW_wol+_30H_4 0.8930 0.9732 0.9969 
R25 RING_wol+_6H_4 0.9016 0.9721 0.9971 
R26 RING_wol+_30H_4 0.8983 0.9729 0.9971 
R27 DCV_wol+_6H_4 0.9028 0.9724 0.9971 
R28 DCV_wol+_30H_4 0.9031 0.9727 0.9971 
R29 UNW_wol-_6H_4 0.8929 0.9721 0.9966 
R30 UNW_wol-_30H_4 0.8966 0.9728 0.9969 
R31 RING_wol-_6H_4 0.8991 0.9726 0.9971 
R32 RING_wol-_30H_4 0.8975 0.9724 0.9970 
R33 OIL_wol-_6H_4 0.8977 0.9733 0.9971 
R34 OIL_wol-_30H_4 0.9006 0.9732 0.9973 
R35 BASS_wol-_6H_4 0.9040 0.9726 0.9973 
R36 BASS_wol-_30H_4 0.9053 0.9725 0.9972 
R37 DCV_wol-_6H_4 0.8956 0.9733 0.9972 
R38 DCV_wol-_30H_4 0.9003 0.9733 0.9972 
R39 PiGV_wol-_6H_4 0.8872 0.9724 0.9963 
R40 PiGV_wol-_30H_4 0.8990 0.9718 0.9967 
R41 Ecoli_wol-_6H_4 0.8982 0.9733 0.9972 
R42 Ecoli_wol-_30H_4 0.8968 0.9724 0.9969 
R43 Mlut_wol-_6H_4 0.8977 0.9725 0.9970 








Figure S5: Mixing and posterior distributions of significant effects found in model testing for 
effects of wounding and time on D. melanogaster Dscam expression. Results are outlined in 








Figure S6: Mixing and posterior distributions of significant effects found in model testing for 
effects of pathogen-exposure and time on D. melanogaster Dscam expression. Results are 







Figure S7: Mixing and posterior distributions of significant effects found in model testing for 
effects of DCV-exposure on D. melanogaster Dscam expression in Wolbachia-cleared and 







Figure S8: Mean fold change of Diptericin and Drosomycin expression in bacteria-exposed 
flies relative to controls. Diptericin levels peaked in response to both E. coli and M. luteus 
between 4-8 hours post-exposure (top). Drosomycin levels steadily increased following exposure 
to M. luteus until a peak of around 48 hours, while levels peaked around 8 hours following 











Figure S9: Quantile-Quantile (Q-Q) plot of Illumina sequencing raw count data of Chapter 4 




Table S5: Significance of departure from even expression of exon 4-6 combinations in each 
tissue of unwounded D. melanogaster (Chapter 4). P-values are from Fisher’s Exact Tests and 
significant p-values are asterisked. 
Ref Treatment p-value 
1 UNW_1_Head 0.274 
2 UNW_1_Body 0.021* 
3 UNW_1_Cells 0.326 
4 RING_1_Head 0.149 
5 RING_1_Body 0.299 
6 RING_1_Cells 0.525 
7 Ecoli_1_Head 0.692 
8 Ecoli_1_Body 0.369 
9 Ecoli_1_Cells 0.409 
10 Mlut_1_Head 0.004* 
11 Mlut_1_Body 0.347 
12 Mlut_1_Cells 0.459 
13 UNW_2_Head 0.353 
14 UNW_2_Body 0.193 
15 UNW_2_Cells 0.386 
16 RING_2_Head 0.334 
17 RING_2_Body 0.059 
18 RING_2_Cells 0.245 
19 Ecoli_2_Head 0.061 
20 Ecoli_2_Body 0.078 
21 Ecoli_2_Cells 0.037* 
22 Mlut_2_Head 0.498 
23 Mlut_2_Body 0.441 
24 Mlut_2_Cells 0.242 
25 UNW_3_Head 0.704 
26 UNW_3_Body 0.806 
27 UNW_3_Cells 0.204 
28 RING_3_Head 0.003* 
29 RING_3_Body 0.519 
30 RING_3_Cells 0.088 
31 Ecoli_3_Head 0.022* 
32 Ecoli_3_Body 0.239 
33 Ecoli_3_Cells 0.570 
34 Mlut_3_Head 0.0006* 
35 Mlut_3_Body 0.467 
36 Mlut_3_Cells 0.856 
37 UNW_4_Head 0.185 
38 UNW_4_Body 0.218 
39 UNW_4_Cells 0.070 
40 RING_4_Head 0.634 




42 RING_4_Cells 0.344 
43 Ecoli_4_Head 0.535 
44 Ecoli_4_Body 0.316 
45 Ecoli_4_Cells 0.032* 
46 Mlut_4_Head 0.255 
47 Mlut_4_Body 0.848 
48 Mlut_4_Cells 0.163 
49 UNW_5_Head 0.020* 
50 UNW_5_Body 0.909 
51 UNW_5_Cells 0.675 
52 RING_5_Head 0.143 
53 RING_5_Body 0.877 
54 RING_5_Cells 0.065 
55 Ecoli_5_Head 0.446 
56 Ecoli_5_Body 0.299 
57 Ecoli_5_Cells 0.477 
58 Mlut_5_Head 0.027* 
59 Mlut_5_Body 0.075 
60 Mlut_5_Cells 0.244 
61 UNW_6_Head 0.881 
62 UNW_6_Body 0.169 
63 UNW_6_Cells 0.503 
64 RING_6_Head 0.205 
65 RING_6_Body 0.070 
66 RING_6_Cells 0.516 
67 Ecoli_6_Head 0.532 
68 Ecoli_6_Body 0.452 
69 Ecoli_6_Cells 0.514 
70 Mlut_6_Head 0.473 
71 Mlut_6_Body 0.201 













Table S6: Simpson’s Index of Diversity values for all treatments in the study (Chapter 4). 
Diversity indices for exon 4, exon 6, and exon 4-6 combinations are shown and were calculated as 
Simpson's Index of Diversity (D) = 1-sum((Exoni/sum(Exoni))^2). 
Ref Treatment Exon 4 (1-D) Exon 6 (1-D) Exon 4-6 (1-D) 
R01 UNW_1_Head 0.9042 0.9657 0.9967 
R02 UNW_1_Body 0.8950 0.9645 0.9961 
R03 UNW_1_Cells 0.9034 0.9663 0.9967 
R04 RING_1_Head 0.9033 0.9656 0.9967 
R05 RING_1_Body 0.8954 0.9656 0.9964 
R06 RING_1_Cells 0.9028 0.9660 0.9966 
R07 Ecoli_1_Head 0.9030 0.9658 0.9967 
R08 Ecoli_1_Body 0.8966 0.9662 0.9964 
R09 Ecoli_1_Cells 0.9040 0.9656 0.9966 
R10 Mlut_1_Head 0.9032 0.9659 0.9967 
R11 Mlut_1_Body 0.8964 0.9655 0.9964 
R12 Mlut_1_Cells 0.9026 0.9637 0.9963 
R13 UNW_2_Head 0.9046 0.9659 0.9967 
R14 UNW_2_Body 0.8978 0.9659 0.9964 
R15 UNW_2_Cells 0.9004 0.9661 0.9966 
R16 RING_2_Head 0.9042 0.9659 0.9967 
R17 RING_2_Body 0.8947 0.9641 0.9958 
R18 RING_2_Cells 0.9061 0.9659 0.9968 
R19 Ecoli_2_Head 0.9045 0.9660 0.9967 
R20 Ecoli_2_Body 0.8971 0.9655 0.9964 
R21 Ecoli_2_Cells 0.8989 0.9659 0.9963 
R22 Mlut_2_Head 0.9044 0.9656 0.9967 
R23 Mlut_2_Body 0.8916 0.9636 0.9955 
R24 Mlut_2_Cells 0.9021 0.9660 0.9966 
R25 UNW_3_Head 0.9053 0.9658 0.9967 
R26 UNW_3_Body 0.8963 0.9650 0.9963 
R27 UNW_3_Cells 0.9057 0.9664 0.9968 
R28 RING_3_Head 0.9051 0.9652 0.9967 
R29 RING_3_Body 0.8963 0.9647 0.9962 
R30 RING_3_Cells 0.9046 0.9660 0.9967 
R31 Ecoli_3_Head 0.9033 0.9661 0.9967 
R32 Ecoli_3_Body 0.8923 0.9661 0.9963 
R33 Ecoli_3_Cells 0.9062 0.9666 0.9968 
R34 Mlut_3_Head 0.9044 0.9656 0.9967 
R35 Mlut_3_Body 0.8975 0.9656 0.9964 
R36 Mlut_3_Cells 0.9061 0.9660 0.9967 
R37 UNW_4_Head 0.9054 0.9658 0.9968 
R38 UNW_4_Body 0.8968 0.9656 0.9964 
R39 UNW_4_Cells 0.9025 0.9647 0.9964 
R40 RING_4_Head 0.9029 0.9661 0.9967 




R42 RING_4_Cells 0.9045 0.9661 0.9967 
R43 Ecoli_4_Head 0.9007 0.9653 0.9965 
R44 Ecoli_4_Body 0.8958 0.9658 0.9962 
R45 Ecoli_4_Cells 0.9018 0.9659 0.9966 
R46 Mlut_4_Head 0.9028 0.9657 0.9966 
R47 Mlut_4_Body 0.8976 0.9650 0.9960 
R48 Mlut_4_Cells 0.9057 0.9662 0.9966 
R49 UNW_5_Head 0.9059 0.9654 0.9967 
R50 UNW_5_Body 0.9012 0.9657 0.9965 
R51 UNW_5_Cells 0.9059 0.9656 0.9967 
R52 RING_5_Head 0.9062 0.9656 0.9968 
R53 RING_5_Body 0.8971 0.9654 0.9964 
R54 RING_5_Cells 0.9048 0.9658 0.9967 
R55 Ecoli_5_Head 0.9058 0.9657 0.9967 
R56 Ecoli_5_Body 0.8956 0.9653 0.9963 
R57 Ecoli_5_Cells 0.9044 0.9665 0.9967 
R58 Mlut_5_Head 0.8961 0.9659 0.9964 
R59 Mlut_5_Body 0.8977 0.9654 0.9964 
R60 Mlut_5_Cells 0.9030 0.9655 0.9966 
R61 UNW_6_Head 0.9049 0.9654 0.9967 
R62 UNW_6_Body 0.8958 0.9662 0.9964 
R63 UNW_6_Cells 0.9026 0.9662 0.9966 
R64 RING_6_Head 0.9040 0.9667 0.9967 
R65 RING_6_Body 0.8979 0.9649 0.9963 
R66 RING_6_Cells 0.9050 0.9652 0.9965 
R67 Ecoli_6_Head 0.9059 0.9656 0.9967 
R68 Ecoli_6_Body 0.8953 0.9664 0.9964 
R69 Ecoli_6_Cells 0.9004 0.9655 0.9965 
R70 Mlut_6_Head 0.9052 0.9658 0.9967 
R71 Mlut_6_Body 0.8972 0.9667 0.9965 









Figure S10: Mixing and posterior distributions of significant effects found in model testing 
for effects of wounding on D. melanogaster Dscam expression. Results are outlined in Table 1 






Figure S11: Mixing and posterior distributions of significant effects found in model testing 
for effects of pathogen-exposure on D. melanogaster Dscam expression. Results are outlined in 








Figure S12: Quantile-Quantile (Q-Q) plot of Illumina sequencing raw count data of Chapter 5 











Figure S13: Quantile-Quantile (Q-Q) plot of Illumina sequencing raw count data of Chapter 5 





Table S7: Simpson’s Index of Diversity values for all treatments in the study (Chapter 5). 
Diversity indices for exon 4, exon 6, and exon 4-6 combinations are shown and were calculated as 
Simpson's Index of Diversity (D) = 1-sum((Exoni/sum(Exoni))^2). 
Ref Treatment Exon 4 (1-D) Exon 6 (1-D) Exon 4-6 (1-D) 
R41 Control_Carc_13 0.8530 0.9558 0.9934 
R47 Control_Carc_14 0.8504 0.9559 0.9933 
R59 Control_Carc_15 0.8538 0.9553 0.9934 
R69 Control_Carc_16 0.8500 0.9556 0.9932 
R03 Control_Carc_3 0.8541 0.9561 0.9935 
R12 Control_Carc_5 0.8594 0.9558 0.9937 
R23 Control_Carc_8 0.8563 0.9551 0.9935 
R30 Control_Carc_9 0.8597 0.9553 0.9937 
R38 Control_Cells_13 0.6819 0.7641 0.8856 
R52 Control_Cells_14 0.7707 0.8921 0.9501 
R56 Control_Cells_15 0.8393 0.9013 0.9552 
R70 Control_Cells_16 0.4631 0.7629 0.7689 
R06 Control_Cells_3 0.8383 0.9188 0.9559 
R14 Control_Cells_5 0.7715 0.9027 0.9438 
R26 Control_Cells_8 0.8231 0.9074 0.9434 
R34 Control_Cells_9 0.8330 0.9300 0.9825 
R45 Control_Gut_13 0.8459 0.9552 0.9930 
R49 Control_Gut_14 0.8492 0.9545 0.9930 
R62 Control_Gut_15 0.8459 0.9546 0.9928 
R65 Control_Gut_16 0.8421 0.9551 0.9928 
R02 Control_Gut_3 0.8431 0.9549 0.9928 
R13 Control_Gut_5 0.8449 0.9550 0.9929 
R21 Control_Gut_8 0.8443 0.9549 0.9928 
R29 Control_Gut_9 0.8440 0.9548 0.9928 
R39 Resistant_Carc_13 0.8524 0.9558 0.9934 
R50 Resistant_Carc_14 0.8511 0.9555 0.9933 
R60 Resistant_Carc_15 0.8530 0.9556 0.9934 
R71 Resistant_Carc_16 0.8493 0.9556 0.9932 
R01 Resistant_Carc_3 0.8565 0.9558 0.9936 
R11 Resistant_Carc_5 0.8587 0.9557 0.9937 
R19 Resistant_Carc_8 0.8562 0.9551 0.9934 
R31 Resistant_Carc_9 0.8517 0.9555 0.9933 
R44 Resistant_Cells_13 0.7530 0.8293 0.8638 
R53 Resistant_Cells_14 0.6272 0.8299 0.8479 
R57 Resistant_Cells_15 0.8240 0.9305 0.9752 
R66 Resistant_Cells_16 0.7696 0.8704 0.9167 
R05 Resistant_Cells_3 0.7906 0.9030 0.9322 
R18 Resistant_Cells_5 0.6502 0.7867 0.7990 
R27 Resistant_Cells_8 0.7922 0.8530 0.9229 
R32 Resistant_Cells_9 0.8315 0.9406 0.9733 




R54 Resistant_Gut_14 0.8463 0.9542 0.9928 
R61 Resistant_Gut_15 0.8477 0.9547 0.9930 
R72 Resistant_Gut_16 0.8463 0.9551 0.9929 
R04 Resistant_Gut_3 0.8454 0.9547 0.9929 
R16 Resistant_Gut_5 0.8460 0.9547 0.9929 
R20 Resistant_Gut_8 0.8501 0.9551 0.9931 
R28 Resistant_Gut_9 0.8448 0.9542 0.9928 
R43 Susceptible_Carc_13 0.8532 0.9558 0.9934 
R51 Susceptible_Carc_14 0.8554 0.9556 0.9935 
R58 Susceptible_Carc_15 0.8511 0.9549 0.9932 
R67 Susceptible_Carc_16 0.8503 0.9557 0.9933 
R07 Susceptible_Carc_3 0.8536 0.9559 0.9935 
R10 Susceptible_Carc_5 0.8539 0.9559 0.9935 
R24 Susceptible_Carc_8 0.8562 0.9554 0.9935 
R33 Susceptible_Carc_9 0.8566 0.9555 0.9935 
R37 Susceptible_Cells_13 0.5870 0.8453 0.8535 
R48 Susceptible_Cells_14 0.8512 0.9481 0.9909 
R64 Susceptible_Cells_16 0.7685 0.9180 0.9437 
R08 Susceptible_Cells_3 0.8215 0.8676 0.9064 
R17 Susceptible_Cells_5 0.6826 0.8357 0.8517 
R25 Susceptible_Cells_8 0.7758 0.8847 0.8948 
R35 Susceptible_Cells_9 0.8120 0.9072 0.9325 
R42 Susceptible_Gut_13 0.8434 0.9550 0.9928 
R46 Susceptible_Gut_14 0.8448 0.9545 0.9927 
R63 Susceptible_Gut_15 0.8438 0.9549 0.9928 
R68 Susceptible_Gut_16 0.8461 0.9548 0.9929 
R09 Susceptible_Gut_3 0.8440 0.9549 0.9928 
R15 Susceptible_Gut_5 0.8455 0.9547 0.9928 
R22 Susceptible_Gut_8 0.8455 0.9546 0.9928 








Figure S14: Mixing and posterior distributions of significant effects found in model testing 
for effects of parasite exposure on D. magna Dscam expression. Results are outlined in Table 1 







Figure S15: Mixing and posterior distributions of significant effects found in model testing 
for effects of pathogen-exposure on D. magna Dscam expression. Haemolymph treatments are 
excluded. Results are outlined in Table 2 of Chapter 5. 
